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ABSTRACT 
 
i 
 
 
This thesis focuses on the synthesis and characterisation of antimony(III) and 
aluminium(III) amidates with an emphasis on structural characterisation, presenting the 
isolation of 22 new complexes. In addition, some chemistry of (2,6-di–tert-butyl-4-
methyl) antimony and aluminium (III) complexes is added in the appendix of this thesis. 
Below is a general outline for each chapter of original research (2-4), showing the 
diverse range of compounds obtained from the following formamidinate and 
polyfluorophenylamidate ligands.  
 
 
Ligands used throughout Chapters Two-Four 
 
ABSTRACT 
 
ii 
 
 
Chapter 1 gives an overall introduction to antimony and aluminium (III) chemistry. 
This chapter describes the general aspects and overview of the relevant literature 
highlighting the most common synthetic methods used to synthesis antimony and 
aluminium compounds, particularly formamidinates, amidates, phenolates and their 
applications.  
  
Chapter 2 describes the metathesis reactions employed for the preparation of a range 
of mono- and bis-substituted formamidinato antimony (III) complexes. The bis-
substituted complexes include [Sb(DippForm)2Cl] (2.2), [Sb(DippForm)2Br] (2.3) and  
[Sb(DippForm)2I] (2.4) and mono-substituted products include [Sb(DippForm)Br2] 
(2.5) and [Sb(DippForm)I2] (2.6). Other complexes have been prepared as dimers 
[Sb(DippForm)(NSiMe3)]2 (2.8) and [Sb(DippForm)Cl(C6F5)]2.(THF)2 (2.12), also the 
formamidinato-bridged distibane [Sb2{µ-(DippForm}2].(THF)8 (2.1) that represents an 
example of monovalent antimony. Fundamentally, the synthesis of antimony (I) and 
(III) formamidinate complexes was accomplished through deprotonation of N,N′-2,6-
diisopropylphenylformamidine (DippFormH) by a metal alkyl/amide reagent (n-BuLi, 
LiN(SiMe3)2, NaN(SiMe3)2) in a donor solvent THF or in PhMe and then combined with 
SbX3 in THF and/or PhMe. The unexpected [(DippForm)ClSb(µ-
O)SbCl2(Me2NC2H4NMe2)]2.(C6D6) (2.11) was the only type of halogenated hetero 
dinuclear complex isolated in this study.      
 
Chapter 3 details the synthesis and characterisation of a series of heteroleptic and 
homoleptic N,N-dimethyl-N'-2,3,5,6-tetrafluorophenylethane-1,2-diaminate antimony 
(III) complexes. [Sb(p-HC6F4NC2H4NMe2)2Cl] (3.2) and [Sb(p-HC6F4NC2H4NMe2)3] 
(3.3) complexes were isolated by metathesis reactions between SbCl3 and Li(p-
HC6F4N(CH2)2NMe2), a common synthetic route to antimony complexes; while the direct 
reaction between SbCl3 and p-HC6F4NH(CH2)2NMe2 was used to synthesise [Sb(p-
HC6F4NC2H4NMe2)Cl2] (3.1). Halo- and nonhalo-polyfluorophenylamido antimony 
(III) complexes were gained as monomers in the solid state.  
 
 
 
ABSTRACT 
 
iii 
 
 
Chapter 4 Extending this chemistry to formamidinate aluminium resulted in the 
isolation of a group of new and interesting formamidinato aluminium (III) complexes 
ranging from mono- to bis-substituted, involving different bonding modes. Metathesis 
reactions between AlX3 (X = Cl, Br, I) and two different deprotonated N,N'-chelating 
ligands (XylForm) and (DippForm) of varying steric bulk and functionality were used 
to increase the range of the haloorgano(formamidinato) aluminium (III) system. These 
complexes are [Al(XylForm)2Cl] (4.1), [Al(XylForm)2I].PhMe (4.2), 
[Al(XylFormH)Br3] (4.3), [Al(DippFormH)Br3] (4.5) and [Al(DippForm)2Cl] (4.8). 
Using the bulkier formamidinate ligand (DippForm) allowed the isolation of 
[Al(DippForm)Cl2(thf)] (4.6) and [Al(DippForm)ClBr(thf)] (4.7). The heteroleptic 
[Al3(XylForm)2(µ3-O)(OH)Cl4]2.PhMe (4.4) was isolated as a monomer and represents 
a compound contained three aluminium atoms bridged by an oxygen atom. In a 
different approach, a chlorine/methyl exchange reaction was used for forming 
bimetallic Al/Sb (III) ionic complexes [Me3Sb-SbMe2][AlCl4] (4.9) and [Br3Sb-µBr-
SbBr3][AlCl2(thf)4] (4.10), showing relatively rare coordination modes. 
 
Overall, the knowledge regarding amidato antimony and aluminium (III) complexes 
has been enhanced and more information has been obtained regarding their structural 
motifs and bonding modes. The N,N′-bis(aryl)formamidinate ligands can form stable 
and structurally interesting mono/trivalent antimony and trivalent aluminium species 
using metathesis route, due to their ease of steric variability. In addition, this thesis 
demonstrates the ability of N,N-dimethyl-N'-2,3,5,6-tetrafluorophenylethane-1,2-
diaminate ligand to stabilise antimony in its most common and stable oxidation state 
(III). Many of these compounds, particularly the compounds with M-X bonds, are now 
well set for potential reduction to low valent species. Reaction with KC8 should form 
isolable low valent Sb or Al complexes and this work could be performed in future 
work. There are also many other formamidinate, guanidinate and amidinate ligands that 
could be used to extend this work.  
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CHAPTER ONE 
INTRODUCTION TO ANTIMONY (III) 
AND ALUMINIUM (III) AMIDINATE, 
DIAMINATE AND PHENOLATE 
COMPLEXES 
 
 
CHAPTER ONE: INTRODUCTION 
 
1 
 
 
Outline 
 
 Each chapter in this thesis presents a diverse compilation of antimony and/or 
aluminium N,N'˗bis(aryl)formamidinate, N,N-dialkyl-N′-(2,3,5,6-tetrafluorophenyl) 
ethane-1,2-di-aminate or phenolate chemistry, and begins with an introduction. This 
preliminary chapter provides an overview of the properties of antimony and aluminium 
chemistry, a brief summary of cyclopentadienyl (Cp) antimony and aluminium 
chemistry as a basis for nitrogen based Cp replacement ligands, and a review of the 
current literature regarding antimony and aluminium amides and phenolate complexes.  
 
1.1       Introduction 
 
1.1.1 Antimony: General Aspects 
 
Antimony is a metal located between arsenic and bismuth in group 15 of the periodic 
table, and is well-known for its relatively high toxicity. There are some health concerns, 
but elemental antimony metal has rather low toxicity. It is the 63rd most abundant 
element in the earth's crust and is mainly found as a sulfide ore (Sb2S3) or combined 
with other metal ores such as copper, silver as dicrasite (Ag2Sb) or pyrargyrite 
(Ag3SbS3), nickel as breithauptite (NiSb) or ullmanite (NiSbS) and lead ores.1  
Elemental antimony adopts five allotropes but the α allotropic form is the most stable.2 
Antimony has two stable isotopes: 121Sb and 123Sb, in addition to 35 radioisotopes, 
including the longest-lived 125Sb with a half-life of 2.75 years.3 Sb being a metalloid 
and therefore a semiconductor has low electrical and thermal conductivities compared 
with those of metallic elements.1 To date, atomic absorption spectrometry is the most 
commonly used method for detecting antimony with atomisation in a graphite tube and 
with generation of hydrides.4,5 However, the most recent used technique is hydride 
generation inductively coupled plasma optical emission spectrometry (HG-ICP-OES).6 
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Not much attention has been given to antimony chemistry compared to its lighter 
congeners. Over the past two decades, various interesting studies and novel inorganic 
and organometallic chemistry of antimony have been performed. This consideration 
can mainly be attributed to the following myriad of applications: (a) biological 
importance i.e.: treatment against leishmaniasis,7 anti-tumour,8 and anti-bacterial 
activity 9,10,11,12,13; (b) industrial uses as precursors for the chemical vapour deposition 
(CVD) techniques for generating antimony oxide thin films, 14 which have potential 
applications in electronic ceramics components and catalysis; 15,16,17,18,19,20,21,22,23,24,25 26 
(c) superconductors; and (d) ferroelectrics.   
Compounds of antimony normally contain the element in either the (+III) or (+V) 
oxidation states, with the latter being the most common, and can occur in oxidation 
states (‒III), (+IV) and the very rare form (+I).27 According to Pearson’s hard soft acid 
base theory, Sb(III) can be classified as a borderline metal ion,28 and has a high capacity 
to bind with nitrogen and sulfohydryl-containing ligands. Many compounds of Sb(III) 
are analogous to those of P, As and Bi compounds. The majority of SbX3 molecules 
such as SbPh3 and SbCl3 in the valence state three show three pyramidally directed 
single bonds, with a lone pair occupying the fourth tetrahedral position (Figure 1.1).  
 
 
 
 
Figure 1.1 
 
The general coordination number of Sb ranges between 3 and 6.29 The antimony atom 
has empty d orbitals of fairly low energy. Compounds of Sb in oxidation states (III) or 
(V) are strong Lewis acids (Lewis acceptors) that accept electron pairs from donors. 
There are uncommon compounds in which antimony in the (I) oxidation state forms 
trigonal planar geometry at the Sb center (Figure 1.2), and this may be attributed to dπ-
pπ interactions.29  
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Figure 1.2 
 
Although the chloride ion affinity of SbCl5 has been shown by the Gutmann group to 
be stronger than BCl3,30 utilising antimony penta-halide derivatives is problematic 
because they have extreme reactivity and an inconvenient corrosive nature; specifically, 
both SbF5 and SbCl5 react severely with water, releasing the corresponding hydrohalic 
acid. This property has discouraged many from investigating the synthesis of such 
derivatives.  
 
1.1.2 Aluminium: General Aspects 
 
Aluminium is a silvery-white metal of main Group 13 of the periodic table. Aluminium 
is the third most abundant element in the earth's crust (7.4 %) behind oxygen and 
silicon, and all the earth's aluminium has combined with other elements to form 
compounds such as alumina Al2O3 and cryolite Na3AlF6.1 It is an excellent electrical 
and thermal conductor. The only stable isotope of aluminium is 27Al. Al metal is 
stabilised by almost instantaneously formation of an oxide coating allowing the metal 
to be used in construction…etc. The vast majority of aluminium compounds are found 
in the oxidation state (III) for the aluminium atom with varied coordination numbers 
ranging between 3-6 that can be attributed to the high stability of (III) oxidation state;31 
however, a substantial increase in the synthesis of low valent aluminium compounds 
like AlH, Al2O, Al2S, Al2Se and AlX (X = F, Cl, Br, and I) has been noticed in the past 
two decades.32,33,34 Aaluminium (I) complexes have found wide applications in 
materials and agrochemicals. The efficacy of aluminium as Lewis acid lay in its ability 
to attract and coordinate the electrons of neighbouring atoms and molecules. 
Aluminium reacts strongly with hydrochloric acid and caustic soda. The reaction with 
sulfuric acid is weaker, whereas it is inactive towards cold nitric acid. 
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1.2  Applications of antimony and its compounds and aluminium and its compounds 
   
1.2.1 Commercial applications of antimony and its compounds 
 
Antimony and its complexes have had many uses dating back centuries; in fact, certain 
products were initially used for cosmetic purposes in ancient Egypt thousands of years 
ago. That usage was to darken the eyelashes and as an eyeliner that it is still used for 
this purpose in many countries. In the past two decades, antimony has been used in 
industry in the form of fire-retardant chemicals added to textiles, rubber, paper, etc. 
(e.g. bromine-based flame retardants are often used with an antimony synergist 
Sb2O3).35,36,37,38  
Today the most common use of antimony is as an alloy with lead to harden the 
material,39 which can be used then for electrical storage batteries, sheathing for 
electrical and TV cables, semiconductor and infrared devices, matches, glassware, 
ceramics, enamels, paints, pottery, fireworks and lacquers.40 Along with many other 
metals, such as barium-cadmium, tin, lead, calcium-zinc, antimony is used as a heat 
stabiliser in the plastics industry; a disadvantages being its presence in plastic 
containers, which could lead to increased oral exposure in humans, as Sb has a strong 
affinity towards the materials.40 Recently, addition of antimony oxide to polyvinyl 
chloride (PVC pipe) to act as a flame retardant was a valuable innovation.41 
 
1.2.2     Commercial applications of aluminium and its compounds 
 
Aluminium has very versatile properties with wide industrial uses, the most common 
of which are in construction (including sheets, tubes, castings, windows, doors, sidings, 
building wire, sheathing and roofing), as well used in the aviation-space and automobile 
industries.42,43 Alloying the natural soft aluminium with small amounts of copper or 
magnesium prominently increase its strength.44 In addition, the strength of the 
aluminium Lewis acid can be controlled by halides having different electronegativities.  
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While an aluminium is a very reactive metal, it is strong and light and can be used as a 
building material that is protected from corrosion by the incorporation of a thin 
protective oxide layer. Aluminium features by its fundamental role in a large scope of 
chemical transformations. It is now the most commonly used material in the home food 
and drinks cans and beverage containers,45 also for other home cooking utensils and in 
common household aluminium foils in its elemental form, as well in large power 
transmission lines (not in household wiring). Another popular use of aluminium 
represented in its ability to transfer hydrides to electron deficient atoms. It can be used 
also in pyrotechnics, to manufacture die casting auto engine blocks and parts, for 
incendiary bombs, and for all types of alloys with other metals.  
Recycling an aluminium scrap is less expensive than extracting the metal from its 
bauxite ore. Corundum, a pure oxide crystals of aluminium, is used as an abrasive for 
sandpaper and grinding wheels. As this material resists heat, therefore it is used for 
lining high-temperature ovens, and to form a protective coating on many electronic 
devices such a transistors. Synthetic rubies and sapphires that used for lasers beams are 
made from aluminium oxide.  
For more than 70 years, aluminium compounds have been used extensively as adjuvants 
in both human and veterinary practical inoculations, such as boehmite and aluminium 
hydroxyphosphate.46 Aluminium compounds have also various pharmaceutical uses, 
for example in ointments, toothpaste, deodorants and shaving creams. 
 
1.2.3    Biological application of antimony compounds 
 
Despite their heavy metal nature, antimony compounds are considered to be less 
mutagenic, teratogenic and carcinogenic than many other heavy metals, such as arsenic, 
chromium, or nickel, among others, although they are more toxic than bismuth and its 
compounds.40 Antimony’s therapeutic activity has been known for centuries. Thus, its 
compounds have found applications in metabolic and biochemical studies. The major 
clinical use of organoantimonials during the twentieth century was to treat 
leishmaniasis.7 Leishmaniasis is a human infective parasitic disease that is widespread 
in the world but mainly localised to the tropics and subtropics. 
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Some studies have cited that Old World cutaneous disease was recognised by the 
second millennium B.C. in Iraq,47 and this is why the disease was formerly known as 
Baghdad boil. The Leishmaniasis parasites have been detected in Australia, which 
could lead to growth of the disease in Australia’s tropical regions.48 The parasite is 
transmitted to humans via the bite of sand flies, and the illness manifests as cutaneous, 
muco-cutaneous and visceral lesions that may be fatal if untreated.47 Gaspar Vianna, in 
1912, reported the first use of the internal administration of antimony(III) potassium 
tartrate (tartar emetic), K2[Sb(d-C4O6H2)]2.3H2O, in the treatment of muco-cutaneous 
leishmaniasis.49  
Later, tartar emetic was found to be a valuable anthelmintic agent for the control of 
Schistosomal blood flukes.50,51 In the late nineteenth century, tartar emetic was used for 
fever and pneumonia, but its clinical use slowly diminished because of severe side-
effects. 
Since 1940, the less toxic Sb(V) complexes have continued as the frontline drugs in the 
treatment of leishmaniasis.52 However, their uses have several limitations, such as high 
cost and toxicity, difficult route of administration and lack of efficacy in endemic 
areas.53,54 Typically, local pain has accompanied antimony therapy through 
intramuscular injections and also systemic side effects, necessitating superfluous 
medical control. Furthermore, drug resistance is the second key problem for treating 
this disease.55 Whether Sb(III) or Sb(V) is the active form remains an interesting 
question.   
Recently pentavalent antimonials such as N-methyl-D-glucamine (meglumine 
antimoniate/commercialised as Glucantime) (Fig. 1.3 a) and sodium gluconate (sodium 
stibogluconate/Pentostam)56 (Fig. 1.3 b) have proven highly effective in cancer, 
hepatitis C virus (HCV) and AIDS experimental models,57 emphasising revived interest 
in the chemistry and biochemistry of these old drugs, as well as in developing more 
effective pharmaceutical formulations.  
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Figure 1.3    a: Meglumine Antimoniate 56     b: Sodium Stibogluconate 56 
 
Pro-drug Sb5+ compounds are non-covalent chelates and are bioreduced or activated to 
the active form Sb3+ intracellularly,58 to have antileishmanial activity against 
extracellular promastigotes.59 Antimony binds to biomolecules such as glutathione, 
trypanothione, and nucleotides, and forms binary and ternary complexes that may allow 
it to be trafficked in cells.  
In 2006, Wyllie and Fairlamb showed that trivalent antimonial compounds (SbIII) are 
extremely effective in treating acute promyelocytic leukemia (APL) when examined on 
glutathione homeostasis, oxidative stress and apoptosis in the human leukemia 
monocyte cell line, THP-1 macrophages.60 They also showed that antimony might 
induce apoptosis and kill through DNA fragmentation and externalisation of 
phosphatidylserine.61 
Guéguéniat et al. introduced the role of the radioisotope 125Sb as an excellent tracer 
material for identifying pathways and transit times for the waste derived from the 
nuclear fuel reprocessing plant. The importance of the 125Sb tool can be attributed to its 
conventional behaviour in the environment within the water mass, which is 
characteristic of releases from La Hague, France.62  
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1.2.4  Aluminium compounds in organic synthesis 
 
Aluminium is employed in a wide arrange of applications. Jordan, Teuben and their co-
workers have achieved an extensive set of mono-amidinate, bis-amidinate, and 
dinuclear cationic aluminium complexes that have significant function as catalysts. 
These catalysts can be utilised in olefin polymerisation, polymerisation of ethylene as 
new transition-metal-free homogeneous Al catalysts 63 and C–H bond activation.64  
Since 1964, alkylaluminium and alkylaluminium hydride compounds have gained 
considerable attention as reagents in organic synthesis. Diisobutylaluminium hydride 
and triisobutylaluminium have been presented as excellent options for reducing 
agents.65 An amide moiety of acyclic and macrocyclic amidoketals was best selectively 
reduced in the presence of lithium aluminium hydride LiAlH4 with drops of 
triethylamine.66 
The use of methylaluminoxane (MAO) as co-catalyst was the latest discovery of the 
tailored synthesis in polyolefins industry, which was performed at the chemical 
department of the University of Hamburg and is probably the biggest use in organic 
synthesis.67,68 Consequently, Metallocences or other transition metal complexes in 
combination with the conventional aluminum alkyl co-catalysts used in Ziegler–Natta 
systems have expanded the possibility to design the microstructure of polyolefins in a 
manner wasn’t reachable in years before, playing a crucial part in the olefin 
polymerisation.69  
A series of organic aluminium compounds were introduced as new polycondensation 
catalysts in poly(ethylene terephthalate) (PET) synthesis. These compounds including 
aluminium alkoxide, β-diketones, β-ketoesters and ethylene glycol.70 
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1.3       Antimony and Aluminium amidinate complexes 
 
In 1858, Gerhardt prepared amidines (R2N=C(R1)–NHR3) (Fig. 1.4) for the first time 
through the reaction of aniline with N-phenylbenzimidyl chloride.71 More specifically, 
when R1= H in an amidine, the ligand is classified as formamidine (Fig. 1.5).72  
 
 
 
 
 
Figure 1.4 The overall configuration of an amidine. 
 
 
 
 
                                                  
  Figure 1.5 N,Nʹ-bis(aryl)formamidine. 
 
These ligands are valuable principally because they can be prepared in high yields, 
crystallise without difficulty and offer different coordination modes. The steric 
requirements of these ligands can help to realise low valent metal complexes. 
Furthermore, it can be simple to modify their steric and electronic properties by 
variation of the organic substituent R1, R2 and R3 groups attached to the carbon and 
nitrogen atoms of the ligand backbone.73,74 In particular, amidinate (N-H deprotonated 
amidines) products have proven to be useful precursors for chemical vapour deposition 
(CVD)75,76,77,78,79,80,81,82,83 and atomic layer deposition (ALD),84,85,86,87 as well as 
organic-inorganic hybrids. In addition, the proficiency of such ligands to flexibly 
coordinate the metal centre has enabled them to be very valuable materials in catalysis 
88,89,90,91 and material sciences.92,93,94,95 
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Notably, amidines are important organic compounds for use as starting materials and 
fundamental intermediates in synthetic chemistry.96,97,98,99,100,101,102 Due to their 
biochemical activities, they have been employed in some valuable drugs.102 In 2012, 
some therapeutically effective natural products containing amidine components, such 
as noformycin were isolated as a metabolite from actinobacteria, and pentamidine was 
found to have two amidine units which are used to treat  protozoan infections.103 In 
addition, beside their assistive roles in asymmetric synthesis,104 amidines have 
extensive capacity to actively form complexes with metals.105,106  
For over ten years, a number of small amidine and guanidine molecules containing 
basic functional groups have been revealed as effective nucleophilic catalysts in organic 
synthesis, despite the likely problems associated with their high basicity. Moreover, 
their derived catalysts have proven to be efficient in catalysing aldol reactions, Morita–
Baylis–Hillman reactions, conjugate additions, carbonylations, methylations, 
silylations and brominations.107 
Amidines and amidinates can bind to metals, forming a diversity of possible binding 
modes, such as monodentate (Fig. 1.6, i), bidentate chelating (Fig. 1.6, ii) and bimetallic 
bridging monodentate (Fig. 1.6, iii) modes. As well, the monodentate (i) has two 
potential types of four-electron donation (Fig. 1.6, iv and v). There are also the types of 
bridging–chelating mode (Fig. 1.6, vi, vii, viii and ix).71, 108 
 
 
 
 
 
 
 
 
 
Figure 1.6 Distinctive binding modes of amidinate metal complexes.71, 108 
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Jordan, et al. assert that the diverse structural products of the amidinate ligand are 
dependent on steric influences, such as the ideally amidinate structure (Fig. 1.6 ii) with 
120° angles at the C and N centers that enables nitrogen sp2 orbitals to project in parallel 
directions.63,64  These types of ligands have π-bonds allowing the negative charge to be 
located across the N–C–N backbone.109 Amidines are classified based on the number 
and distribution of the substituents into five general structures (Fig. 1.7).110 
 
 
 
 
 
 
                    
     
     
Figure 1.7 General categories of the amidine. 
 
According to Cole, et al. 108,111,112,113 amidinates coordinated to metal centres can have 
different binding modes, with their classification based on the stereoisomer form of the 
amidine (R2N=C(R1)–NHR3), such as E-syn, E-anti, Z-syn and Z-anti. These binding 
dissimilarities depend on the position of the substituents relative to each other with 
respect to the single bond (C–N) and double bond (C=N) (Fig. 1.8).  
 
 
 
 
 
 
Figure 1.8 Possible isomeric classes of amidinate employed in metal amidinate 
complexes. 
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N,N'-chelating organic ligands have attracted growing attention in organometallic 
chemistry over the past decade due to their ability to flexibly coordinate a large variety 
of main-group f-block and transition metal centres. More specifically, β-diketiminate 
I,114 guanidinate II115 and amidinate anions III 71,108,116,111 (Fig. 1.9) are becoming 
increasingly common because their steric and electronic properties can easily be tuned 
by varying the organic substituents R and R'. Amidinates act as four-electron nitrogen 
σ-donors via the more basic and less sterically crowded imino lone pair to form simple 
adducts.  
 
 
 
 
 
 
 
      
Figure 1.9 The more increasingly common types of N,N'-chelating ligands. 
 
Over the past 40 years, the amidinate (R2N=C(R1)–NR3)- family of ligands has 
motivated different investigations into the synthesis of main-group metal amidinate 
complexes, such as Group 1,109,117 Group 2,118 Group 13,119 Group 14,120 and Group 15 
element complexes.121 These stimulating syntheses generate rather unusual oxidation 
states and a significant number of structurally-characterised metal complexes. For 
example, mono-substituted complexes of the general type LMX2 (M = Al, Ga, In; X = 
halide, alkyl) function as suitable starting components in olefin polymerisation 
reactions and synthesis of low-valent (oxidation state +1) group 13 metal complexes 
LM.122,123,124,125 A series of very bulky guanidinate ligands, [(ArN)2CNR2]- [Ar = 
C6H3iPr2-2,6; R = cyclohexyl (Giso-), R = iPr (Priso- )], have been developed for use in 
stabilising low oxidation-state group 13 complexes such as [:MI(κ2-N,N′-Giso)] (M = 
Ga or In).126 The trisubstituted guanidine ligand has a chelating angle at the metal (N–
Sb–N), which typically is required to be 90 °.127  
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Various forms of ArFormH pro-ligands N,N′-bis(aryl)formamidines (ArN=CH-NHAr 
(Ar = aryl)) (Fig. 1.5) can be readily synthesised in high yields by heating to reflux one 
equivalent of triethylorthoformate with two equivalents of the appropriately substituted 
aniline in the presence of acetic acid (eqn. 1.1).128 This method can readily provide 
formamidines with differing electronic effects and varying steric bulk.  
 
 
 
       
 
 
 
 
 
Equation 1.1 Synthesis of various N,N′-diphenylformamidines catalysed by glacial 
acetic acid (FormH abbreviations shown). 
 
Syntheses of compounds introducing group 15 elements have attracted many 
researchers for a range of reasons. First, examples of low valent antimony complexes 
are very rare compared with the corresponding phosphorus analogues.129 Second, the 
prospective applications of group 15 heterocyclic compounds can lead to valuable 
studies in various industrial and medical fields.130 Third, researchers can further explore 
the chemistry in this field through investigating the potential role of these compounds 
as precursors in organometallic syntheses.  
Despite the ability of ArForm ligands to adopt a variety of coordination modes, ArForm 
coordination to the heavier group 15 elements is comparatively new, and to the best of 
our knowledge prefers this type of chelation (Fig. 1.6, ii). Regarding the work presented 
in this thesis, there have not been many reported examples.131,132,133 The field of 
antimony N,N'-chelating chemistry is still largely unexplored, opening the possibility 
for further exciting discoveries.  
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Chemistry of the Lewis base coordinated dipnictenes is still limited and only a few 
types have been synthesised and structurally characterised such as α-(tBuN)4P4 (Fig. 
1.10).134 Further, Green and his team prepared [As2{μ-(ArN)2CR}2] (Ar = C6H3iPr2-
2,6; R = N(C6H11)2, NiPr2, or tBu) as a dimeric complexes (Fig. 1.11).121  
 
 
 
 
 
 
 
 
Figure 1.10 Structure of α-(tBuN)4P4. 
 
 
 
 
 
 
 
Figure 1.11 Structures of [As2{μ-(ArN)2CR}2] (Ar = C6H3iPr2-2,6; R = N(C6H11)2, 
NiPr2, tBu). 
 
Recently, Hinz and co-workers reported different complexes of the Lewis base–
stabilised dipnictenes such as [Sb2-{µ-(TerN)2P}2] ((TerN)2P = 
bis(terphenylimino)phosphide), which were obtained in high yield by a simple 
metathesis reaction (Fig. 1.12).135 These types of complexes and publications are 
relevant to work described in this thesis and are introduced in more detail in Chapter2. 
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Figure 1.12 Structure of [Sb2-{µ-(TerN)2P}2] ((TerN)2P = 
bis(terphenylimino)phosphide). 
 
1.4       Polyfluorophenyletheylenediamidate complexes 
 
In 1988, Buxton first reported the in situ composition of 
polyfluorophenyletheylenediamidato ligands, N-dialkyl-N'-2,3,5,6-
tetrafluorophenylethane-1,2-di-aminate LMe/Et, through synthesis of 
polyfluorophenylaminatoplatinum (II) complexes [Pt(LMe/Et)X(py)] (X=Cl, Br, I) (eqn. 
1.2, i and ii). The procedure combined decarboxylation reactions between (N,N-
dialkylethane-1,2-diamine)(dihalogeno)platinum(II) or dichloro(ethane-1,2-
diamine)platinum(II) complexes and thallium(I) polyfluorobenzoates with added 
polyfluorobenzene in pyridine (nucleophilic substitutions).136,137,138,139 
 
 
 
 
 
 
 
 
 
Equation 1.2 Initial synthesis of polyfluorophenyletheylenediaminato ligands LMe/Et. 
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Overall, reaction of the appropriate N,N-dialkylethane-1,2-diamine with C6F5H by 
heating to reflux in EtOH (eqn. 1.3) can readily produce the two types of substituted 
ligands LMe/EtH.140  
 
 
 
 
 
 
 
Equation 1.3 Synthesis of N,N-dialkyl-N'-2,3,5,6-tetrafluorophenylethane-1,2-di 
amine ligands HLMe/Et. 
 
The coordination mode of polyfluorophenylethylenediamidate to a metal can vary either 
by fluorine and nitrogen or most commonly N,N'-chelating as in the  
tetrafluorophenylethylenediamidate complexes.141,142,143  
Tetrafluorophenylethylenediamidato metal complexes are accessible via a wide array of 
synthetic strategies. For example, [Yb(LMe/Et)2(thf)2] complexes were prepared by 
metathesis, by protolysis of [Yb{N(SiMe3)2}2(thf)2] with LMe/EtH, and by redox 
transmetallation/protolysis (RTP) between Yb metal, Hg(C6F5)2 and LMe,EtH.144 
By using the former route in tetrahydrofuran, a new class of homoleptic organoaminato 
rare earth complexes [Ln(LMe or LEt)3] (Ln = La, Ce, Nd; LMe/Et = p-
HC6F4N(CH2)2NMe2/Et2) has been isolated, demonstrating (Ar)CF–Ln interactions.145 
The structures of these complexes feature eight-coordinate Ln metals with two 
tridentate (N,N′,F) aminate ligands including (Ar)CF–Ln bonds, and either a bidentate 
(N,F) ligand (Ln = La, Ce, Nd; LEt) or a bidentate (N,N′) ligand (Ln = Nd; LMe) showing 
a rare case of connection variation. Recently, divalent europium complexes, 
[Eu(LMe/Et)2(thf)2] and [Eu(LEt)2(dme)] have been achieved using the same method; 
they are thermally robust but experience C–F activation upon exposure to light.146 
Synthesis of metal tetrafluorophenylethylenediaminate complexes are detailed in 
Chapter 3 of this thesis. 
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1.5        Antimony aryloxidate/alkoxidate complexes 
 
Aromatic rings with a hydroxyl functional group are known as phenols and are shown 
in (Fig. 1.13). These are also called carbolic acids and are naturally derived from coal 
tar. Aryloxidates are the anionic forms of the hydroxyl groups upon deprotonation.147 
Figure 1.13 displays some widely used aryloxide ligands that have attracted much 
attention.   
 
 
 
 
 
Figure 1.13 some common aryloxide ligands. 
 
Phenols are weak acids; however, they are more acidic compared with aliphatic alcohols, 
which can be attributed to aryloxide ion stability by resonance, along with the 
delocalisation of the negative charge at the ortho and para positions (Fig. 1.14).148 
Notably, phenol proton acidity can be positively or negatively affected by adding 
substituents. For example, a fluorine substituent might be able to increase the acidity of 
the phenolic residue by enhancing the resonance that has been brought from the electron 
withdrawing group. In contrast, alkyl substituents, which exist as an electron donating 
group, can decrease acidity by obstructing resonance.149  
  
   
 
 
   
Figure 1.14 Charge delocalisation in the phenoxide ion 
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Moreover, despite the fact that alkyl substituents in the para position of the aryloxides 
might increase solubility and change the spectroscopic properties, they usually have 
little steric effect in coordination with the metal ion. However, alkyl ortho-phenyl 
substituents can have a distinct influence on the structural properties and metal 
reactivity in the complex. Meta substituents greatly affect the steric aspects of the 
ligands through hampering the confirmed flexibility of nearby substituents employed 
in the ortho position.150,151  
The pro-ligand 2,6-di-tert-butyl-p-cresol, commercialised as butylated hydroxy toluene 
(BHT), is widely used in the production of phenolic resins as antioxidants152 and 
polymerisation inhibitors.153 The alkoxide/aryloxide chemistry of antimony complexes 
has been known for over half a century and remains the subject of much interest,154 due 
to the myriad of applications in organic and oxidation catalysis, medicine and 
biochemistry, superconductors, ferroelectrics, and many other oxide based materials.  
The two structures of Sb(V) and Sb(III) alkoxide, [Sb(OCH3)5]155 and 
[Sb{OCH(CH3)2}3],156 respectively, have been crystallographically authenticated, 
adopting a dinuclear motif including alkoxide bridges and forming distinct 
centrosymmetric dimers in the solid state by Sb–O–Sb interactions (Fig. 1.15).  
 
 
 
 
 
 
 
 
Figure 1.15 Two types of Sb(V) and Sb(III) alkoxides. 
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Antimony phenolate complexes are reachable by common synthetic methods. For 
example, the two diantimony calix-4-arene complexes, ButC4(SbCl)2, have been 
synthesised by the direct reaction at room temperature between SbCl3 with the 
monosodium salt of p-tert-butylcalix-4-arene (ButC4), ButC4Na, and the tetralithium 
salt of p-tert-butylcalix-4-arene, ButC4Li4. Another reaction of SbCl3 with RC4·Li4 (R 
= But, H, or allyl) in a 2:1 molar ratio in THF led to producing a range of diantimony 
chlorides of calix-4-arene and p-allylcalix-4-arene such as (HC4(SbCl)2, AC4(SbCl)2. 
These complexes feature on central planar Sb2(µ-O)2 four-membered rings (eqn. 1.4).24 
 
 
 
 
 
 
 
 
 
Equation 1.4 
 
Later, Espinosa and Hanna reported a chain of calix[5]arene Sb+3 mono complexes 
[Sb{ButC5(H)2}] from either the reaction of p-tert-butylcalix[5]arene (ButC5(H)5) 
trianionic salts M'3·ButC5(H)2 (M' = Li, Na, K) with SbCl3 or by reacting ButC5(H)5 in 
a 1:1 ratio with M(OBut)3 in lower yield. [ButC5(Bn)(H)4] reacts with Sb(NMe2)3 or 
Sb(OBut)3 in a 1:2 ratio to produce the bimetallic complex [Sb2O{ButC5(Bn)}]. 
Treatment of calix[5]arene [HC5(H)5] with ¾ equivalents of Sb(NMe2)3 yielded the  
bimetallic complex [Sb2O{HC5(H)}]. The reaction of [Sb{ButC5(H)2}] with 
Sb(OBut)3 in a 1:1 ratio yields [Sb2O{ButC5(H)}].154  
In 1998, a room temperature metathesis reaction of SbCl3 with a solution of 
Li[OC6H2But3-2,4,6] in THF led to the production of colourless block crystals of 
SbCl2(OC6H2But 3-2,4,6).157 
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The first monomeric Sb+3 aryloxide Sb(OC6H3Me2)3 that adopts a trigonal pyramidal 
geometry, has been synthesised by a direct reaction between 2,6-Me2C6H3OH with 
Sb(NMe2)3 in hexane, which was redissolved in toluene from which colourless crystals 
were obtained.23 This complex is important as a precursor for the chemical vapour 
deposition (CVD) of Sb2O3 and Sb6O13 thin films,14 which have many potential 
applications, including parts of electronic ceramics and catalysis.158,159 Phenol has an 
affinity with electropositive metals, forming a protective surface oxide layer.  
Homoleptic [Sb(Odpp)3]·C6H12; HOdpp = 2,6-diphenylphenol) has been synthesised 
by direct reaction of anhydrous SbCl3 with LiOdpp in THF having a mononuclear 
distorted trigonal pyramidal geometry in the solid state (eqn. 1.5).22 
 
 
 
 
 
 
 
 
 
 
Equation 1.5 
 
A few years ago, Tanski et al. prepared a mixture of antimony compounds involving 
multidentate aryloxide ligands, N(o-C6H4OH)3 and PhN(o-C6H4OH)2. These 
complexes are [η4–N(o-C6H4O)3]Sb(OSMe2), {{[η3-N(o-C6H4OH)(o-
C6H4O)2]Sb}2(µ2-O)}2 and {[η3-PhN(o-C6H4O)2]Sb}4 (µ3-O)2, in addition to [η4-N(o-
C6H4O)3]Sb(OSMe2), which present as a discrete mononuclear species and 
multinuclear oxo complexes {{[η3-N(o-C6H4OH)(o-C6H4O)2]Sb}2(µ2-O)}2 and {[η3-
PhN(o-C6H4O)2]Sb}4(µ3-O)2.160 Syntheses of antimony and aluminium phenolate 
complexes is presented in detail in Appendix 1 and Appendix 2 of this thesis. 
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1.6       The Current Study 
 
 This thesis presents work done, including the formation and characterisation of 
a range of varied ArForm antimony and aluminium complexes using two ArForm 
ligands with different functionalities (Figure 1.16). In addition, the chemistry of 
antimony N,N-dialkyl-N'-2,3,5,6-tetrafluorophenylethane-1,2-di-aminate complexes is 
discussed, and the thesis further explores the phenolate complexes. The ligands shown 
in (Fig. 1.16) were selected, firstly, to study the possible coordination modes of the 
amidates and phenolate functional group. Secondly, these ligands contain electron 
donating substituents (NH, OH) in different positions, which can have an impact on the 
properties and final composition of the antimony complex.    
 
Figure 1.16 Substituted formamidinate, polyfluorophenylethylenediaminate and 
phenolate ligand used in this work. 
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Salt metathesis in THF/PhMe was the method used to synthesise the majority of 
trivalent antimony and aluminium ArForm complexes. Chapter 2 describes the 
successful use of the N,N′-bis(2,6-diisopropylphenyl)formamidinate DippForm ligand 
for stabilisation of both Sb(III) and Sb(I) compounds presenting the synthesis, 
characterisation and structural features of these complexes with the general formula 
[Sb(DippForm)3-nXn] (n = 2,1) {X = Cl, Br, I}. Initially, complexes were generated by 
the reaction of M(DippForm) with SbX3 through the metathesis method utilising three 
different solvent media (THF, PhMe, and hexane) and four different reagents (M = n-
BuLi, LiN(SiMe3)2, NaN(SiMe3)2, KN(SiMe3)2), where the oxidation state of one 
resulting complex was reliant on the reagent used. Indeed, this technique proved to be 
an effective synthetic route to trivalent antimony DippForm complexes. Additionally, 
treatment of haloformamidinatoantimony with tetramethylethylendiamine (TMEDA), 
has been investigated to increase the scope of the haloorganoantimony system that 
unpredictably led to the creation of µ-oxygen bridged dinuclear antimony 
[(Dipp)ClSb-µ-OSbCl2(Me2NC2H4NMe2)]2.C6D6. This result can open exciting novel 
investigations into the coordination manner that occurs in this reaction. However, when 
Hg(C6F5)2, the material usually used as a reagent in the redox transmetallation/ 
protolysis (RTP) protocol, was employed in a reaction of the bulky DippForm ligand 
system with SbX3, the result was unforeseen. Formation of the dimeric compound, 
[Sb(DippForm)(NSiMe3)]2, is also discussed in this chapter. 
Chapter 3 discusses the use of N,N-dimethyl-N'-2,3,5,6-tetrafluorophenylethane-1,2-
di-aminate in metathesis reactions. A series of mononuclear heteroleptic and 
homoleptic [Sb(p-HC6F4NC2H4NMe2)3-nCln] (n = 2, 1, 0) complexes has been obtained 
by this method, and showed interesting structures. More specifically, an antimony (III) 
in [Sb(p-HC6F4NC2H4NMe2)3-nCln] (n = 2) was successfully generated by an alternative 
synthetic method, namely direct reaction between p-HC6F4NHC2H4NMe2 and SbCl3 in 
THF. 
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Chapter 4 ventures away from the chemistry of antimony formamidinate and further 
explores the extensive coordination chemistry of aluminium formamidinate complexes 
[Al(ArForm)3-nXn] {(Form (ArNCHNAr)  =  XylForm  (Ar  =  2,6-Me2C6H3),  
DippForm  (Ar  =  2,6-iPr2C6H3); X =  Cl, Br, I} in terms of structures and synthesis, 
where it appears that these complexes preferentially produce monomeric units. 
Diversity of heteroleptic aluminium formamidinates complexes has been demonstrated, 
with new binding modes to aluminium identified, new synthetic methods determined 
using different metal alkyls/amides as reagents, for example, AlMe3, n-BuLi, 
LiN(SiMe3)2, NaN(SiMe3)2 and KN(SiMe3)2 in THF/PhMe. An ionic [Me3Sb-
SbMe2][AlCl4] and [Br4Sb-SbBr3][AlCl2(thf)4] structures consequential from these 
reactions are also discussed. 
 
The appendix section contains the use of (2,6-di–tert-butyl-4-Me) (HOAr) in 
metathesis reactions. A mononuclear [Sb(OAr)3] complex has been prepared by this 
method,  and [Al(OAr)(OH2)Cl(thf)], and structural features are discussed. 
 
By navigating between chapters of this thesis, a wide range of antimony and aluminium 
amidates and phenolate complexes has been demonstrated, showing somewhat new 
binding modes to antimony and aluminium, new synthetic manipulations identified 
along with the known former technic methods, and the outcomes have offered many 
more prospects for further interesting chemistry.   
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Outline 
 
This chapter presents the synthesis and structural characterisation of a range of 
mono- and tri-valent antimony N,N′-bis(2,6-diisopropylphenyl)formamidinate 
complexes. Conventionally, the syntheses were by treatment of the deprotonated 
formamidine ligand with anhydrous SbX3 (X = Cl, Br, I) in THF and/or PhMe under 
varying conditions. Halo- and nonhalo-formamidinatoantimony complexes have been 
successfully gained as monomers or dimers in the solid state featuring a variety of 
coordination geometries and have been comprehensively characterised. Mono- and bis-
substituted formamidinato antimony (III) complexes are expected to have 
stereochemically active lone pairs of electrons, except where the coordination number 
is high. To the best of our knowledge, there have been no formamidinato antimony (III) 
structures reported to date, which have prompted us to further study this field.    
  
2.1 Introduction 
 
Study on the potentially bioactive organometallic compounds revealed that the 
activity of these types of compounds vastly relies on: the nature and number of organic 
groups, nature of ligands, existence of fluoro substituents for hydrophilic and lipophilic 
components and the hydrolytic stability of the metal-carbon bond.1 Nitrogen-based 
systems, such as amides, amidinates and guanidinates are of major importance, 
however the literature cites only a very few examples of mono- and tri-valent group 15 
element complexes that have been isolated and crystallographically authenticated. The 
majority of the produced complexes however, are present in the trivalent oxidation 
state. Therefore, it is of interest to further explore the chemistry of amidinato antimony 
(III) complexes. The first structurally characterised mononuclear amidinato antimony 
(III) dichloride was [Sb{(Me3SiN)2CPh}Cl2] (Scheme 2.1), which was obtained by the 
reaction of N,N,N'-tris(trimethylsilyl)benzamidine, [C6H5-C(NSiMe3)N(SiMe3)2], with 
SbCl3 in CH2C12.2 A guanidinato antimony (III), [Sb{(iPrN)2CN-
(H)iPr}{(iPrN)2CNiPr}], was obtained by the reaction between 1,2,3-
triisopropylguanidine [(iPrNH)2C=NiPr] with antimony tris(dimethylamide) 
[Sb(NMe2)3] in PhMe, which featured the formation of helices through N–H···N 
hydrogen bonding of the single proton in the solid state of the complex.3   
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Scheme 2.1: [Sb{(Me3SiN)2CPh}Cl2]. 
 
A much more practicable route, namely salt metathesis, was adopted by the reaction of 
lithium amidate, [2-(6-methyl)pyridyl]trimethylsilylamido-lithium, with SbCl3 in 
diethyl ether under a nitrogen atmosphere that led to acquisition of colourless prisms of 
the monomeric Sb[{2-(6-Me)C5H3N}NSiMe3]2Cl.4 In 2006, Lesikar and Richards 
reported the novel β-diketiminato antimony crystalline complexes were also achieved 
by salt metathesis reactions between the appropriate lithium β-diketiminate with large 
steric demands, either (DippnacnacLi) (Dippnacnac = [{N(C6H3iPr22,6)C(Me)}2CH]−) 
or (MesnacnacLi) (Mesnacnac =  [{N(Mes)C(Me)}2CH]−, Mes = 2,4,6, trimethyl 
benzene) and antimony (III) halide SbX3 (X = Br, Cl) in THF/PhMe (Scheme 2.2) that 
are dependent on the reaction stoichiometry, the R substituent on the nacnac and 
manipulation of the halide precursor.5 
 
 
 
 
 
 
 
 
 
 
Scheme 2.2: Synthesis of the novel β-diketiminato antimony complexes. 
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The reactions of SbCl3 with (Li2bam) (bam = [PhB(NtBu)2]) (Scheme 2.3) in 
1:1, 1:1.5 and 1:2 molar ratios in diethyl ether led to producing the mono-boraamidinate 
ClSb[PhB(NtBu)2], the novel 2:3 bam complex [PhB(NtBu)2]Sb-μ-
N(tBu)B(Ph)N(tBu)-Sb[PhB(NtBu)2] and the bis-boraamidinate LiSb[PhB(NtBu)2]2 
respectively. In the structurally distinctive 2:3 bam complex, each metal center is 
chelated by the N,N'-bam ligand, and the two [Sb(bam)]+ units are bridged by the third 
[bam]2- ligand.6 
 
 
 
 
 
 
 
Scheme 2.3: bam = [PhB(NtBu)2]2-. 
 
X-ray structural studies are reported for complexes [Sb(L)X2]·(½ thf)·(½ Et2O), 
(X = Cl, Br) and [{SbI(L)(µ-I)}2]·(½ Et2O), which are generated in a good yield from 
reactions between SbCl3, SbBr3 or SbI3 with an equivalent portion of β-
dialdiminatopotassium, K[{N(C6H3iPr2-2,6)C(H)}2CPh] (KL), as described by 
(Scheme 2.4). A feature that differentiates β-dialdiminato from the former β-
diketiminato ligands is that substitution at any of the endocyclic carbon atoms is 
energetically prohibitive.7  
 
 
 
 
 
 
 
Scheme 2.4: Synthesis of [Sb(L)X2]·(½ thf)·(½ Et2O) and [{SbI(L)(µ-I)}2]·(½ Et2O). 
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A set of mono-substituted antimony (III) amidinate complexes [Sb{tBuC(NiPr)2}Cl2], 
[Sb{tBuC(NCy)2}Cl2],  [Sb{tBuC(NDipp)2}Cl2] and [Sb{nBuC(NiPr)2}Cl2] were 
gained in high yields by salt elimination reactions between SbCl3 and Li-amidinates.8  
 
N,N′-bis(aryl)amidinate (RNC(R')NR), more specifically the sterically 
demanding N,N′-bis(aryl)formamidinate (RNC(H)NR) ligands are a very distinct 
class of nitrogen based ligand. That distinction belongs to the ability of their phenyl 
substituents to be readily adjusted in order to achieve synthetic requirements, such 
as increasing steric bulk at the ortho position (H→iPr) or modification of the 
electronic effects. Utilising amidinate ligands of high steric demand could result in 
complexes with uncommon coordination numbers, and also kinetically stabilising 
unusual oxidation states. For example, Brym, et al. have achieved a variety of 
bismuth (III) formamidinate complexes of the form Bi(Form)X2, Bi(Form)2X and 
Bi(Form)3 through metathesis reactions of the alkali metal formamidinates 
M(RNC(H)NR), M = Li or K; R = C6H3-2,6-iPr2 (DippForm), C6H3-2,6-Et2 
(EtForm), C6H2-2,4,6-Me3 (MesForm), C6H3-2,6-Me2 (XylForm) or C6H4-2-Ph (o-
PhForm), with BiX3 (X= Cl, Br or nBu).9 The bulky substitutes affect the ligand’s 
flexibility, and as a consequence, different coordination modes for all of the range 
of formamidinates can be adopted. Moreover, all the reported structures containing 
trivalent bismuth ions and formamidinate ligands have preferring displayed N,N′-
chelation mode.9 Bismuth (III) and antimony (III) are in the same group (group 15 
of the periodic table) and therefore formamidinate ligands will potentially provide 
great opportunities for the appropriate expansion of organoamidoantimony (III) 
complexes. Stepping away from N,N' bidentate structures (Scheme 2.5), the 
monodentate tris(trimethylsilyl)amine N(SiMe3)3 reacted with SbCl3 and produced an 
unusual nitridoantimony complex with a heterocubane framework 
[SbN(SbCl)3(NSbCl2)(NSiMe3)2.SbCl3] in quantitative yield.10 Also, (Me3Si)2N–SbCl2 
reacted with GaCl3 at low temperature to produce a novel amino(chloro)stibenium 
cation, the recommended intermediate in methyl exchange reactions.  
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Scheme 2.5: A nitrogen-based ligand used to stabilise trivalent Sb ion. 
 
In addition, a new type of silylated aminostibane compound of the type 
Ter(Me3Si)N−SbCl2 (Ter = terphenyl = 2,6-bis(2,4,6-trimethyl-phenyl)phenyl) can be 
treated with AgOTf, AgN3, KOtBu, GaCl3, and Me3SiN3/GaCl3 leading to 
triflate/methyl, azide/methyl, and chlorine/methyl exchange reactions at ambient 
temperature (Scheme 2.6).11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.6: Different products gained by triflate/methyl, azide/methyl, and 
chlorine/methyl exchange reactions with a silylated aminostibane. 
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Most of the antimony species discussed above were synthesised by salt 
metathesis protocols between the relevant antimony halide and the group one salt of the 
respective ligands. However, salt metathesis can have some weaknesses such as the 
requirement of two air-sensitive starting materials, as well, this method is practically 
dependent on the solubility of the anticipated product. The potential formation of group 
one “ate” components as side products is another synthetic obstacle, as was observed 
in some cases of the DippForm ligand system.9 The reaction was 1:2 BiBr3 and 
K(DippForm), which gave [Bi(DippForm)Br(µ-Br)(thf)]2 and K(DippForm). 
Treatment of primary amine tris(trimethylsilyl)hydrazine, R−N(SiMe3)H (R = 
Si(SiMe3)3 = Hyp), with PCl3 and base such as n-BuLi is the typical method to prepare 
cyclo-diphosphadiazanes, through formation of R−N(SiMe3)PCl2. A new synthetic 
technique leading to cyclo-diphosph (III)-azanes, [RfOP(μ-NSiMe3)]2, from a one pot 
reaction was simply by adding a mixture of RfOH/base (RfOH = 
hexafluoroisopropanol) to trimethylsilyl-substituted amino(dichloro)phosphanes 
R−N(SiMe3)PCl2 (Scheme 2.7). The difficulties arising from preparation of cyclo-
diphosphadiazanes depend on the preliminary materials, solvents, and bases due to the 
rivalry of different potential reactions.12 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.7: Synthesis of hexafluoroisopropoxy-substituted cyclo-diphosphazanes 
utilising silylated amines. 
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The chemistry of heavier pnictogen (As, Sb, Bi) analogues of this classic 
inorganic ring system (cyclodipnict (III) azanes) has been slower to develop. Initial 
interest for the kinetically stabilised low-coordination Group 15 chemistry occurred in 
1981 when Yoshifuji reported the synthesis and isolation of the first stable 
bis(C6H2tBu3-2,4,6)diphosphene compound,13 with a formal Mes*P=PMes* double 
bond in which steric hindrance marks a significant involvement to the stabilisation. This 
compound prepared from the addition of phosphorus trichloride to the solution of 
Li(2,4,6-tBu3C6H2) in THE at − 78 °C and then refluxed for 1 h. This achievement was 
followed by products of base coordinated heavier dipnictenes, RE=ER (E = P, As, Sb, 
or Bi).14,15  
It has been agreed that the lowest unoccupied molecular orbitals (LUMOs) of 
dipnictenes, including antimony, have the ability to be given electrons from reducing 
agents.16 This was evidenced by achievement of ArSb=SbAr (Ar = Tbt = 2,4,6-
[CH(SiMe3)2]3C6H2), establishing the doubly bonded system of the heavier Group 15 
elements (dipnictenes).17 These species show reversible one-electron reduction couples 
and that the distibene system has the lowest reduction potential among the 
corresponding dipnictenes. 
Reduction of As (III) precursors, (e.g. [Cl2-As{κ2-N,N'-(ArN)2CR}]) by KC8 in 
PhMe led to bulky guanidinato- or amidinato-bridged diarsenes [As2{µ-(ArN)2-CR}2] 
(Ar = C6H3iPr2-2,6; R = N(C6H11)2, NiPr, or tBu), having the coordination mode µ-
N,N' bridging instead of κ2-N,N' chelating mode.18 According to theoretical studies, the 
As‒As bonds forming the dimers have significant double-bond character, the σ and π 
components of which are resultant mainly from As p-orbital overlap. 
A very recent study reported on a different synthetic approach, showing that 
initial treatment of SbCl3 with K[(TerN)2P] (Ter = 2,6-dimesityl-phenyl) led to a 
diazadipnictane, [Ter2N2P(III)Sb(III)Cl2], which was transformed to a cyclic 
diazastibaphosphenium cation [P(µ-NTer)2SbCl]+ by the halide abstraction step using 
GaCl3. A donor-stabilised [Sb2]2+ ion of a dimerised biradical [Sb2-{µ-(TerN)2P}2] was 
obtained from a subsequent reduction process of [Ter2N2PSbCl2] with KC8 in non-polar 
solvent.19 
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Salts of both the [PhSbCl3]– and [PhSbC14]2– anions were obtained from 
reactions between phenylantimony dichloride with ionic chlorides such as Me4NCl or 
HpyCl, while reactions of the latter with the associated diphenylantimony chloride 
afforded [Ph2SbCl2]– salts.20 Since 1970, a number of methods employed in the 
preparation of species analogous to phenyl antimony (III) halides, were not easy, and 
the reactions were low yielding.21 Particularly, those compounds comprising 
pentafluorophenyl groups are very rare and are limited to 
tris(pentafluorophenyl)antimony (V) compounds such as (C6F5)3SbX2 (X = Cl, Br, 
NO3, ClO4, OCH3)22,23 and (C6F5)3SbIY (Y = Cl, Br, N3, NCO).24 In 1989, the first 
combining of pentafluorophenyl and antimony (III) chloride was successfully achieved 
by redistribution reactions between (C6F5)3Sb (prepared as described previously),25 and 
SbCl3 in 2:1 and 1:2 molar ratios giving (C6F5)2SbCl and (C6F5)SbCl2 respectively in 
good yield. Oxidative chlorination of ice cold solutions of these resultant complexes 
led to formation of Sb (V) species, bis(pentafluorophenyl)antimony (V) trichloride 
(C6F5)2SbCl3 and (pentafluorophenyl)antimony (V) tetrachloride (C6F5)SbCl4. While 
bromination of Sb (III) products at ‒178 °C generated mixed halide forms, 
(C6F5)nSbCl3-nBr2 (n = 1, 2) (eqn. 2.1).26 A fluoro based organoantimony compound 
has recently been patented for its biological effectiveness.27  
 
 
 
 
 
 
 
Equation 2.1 
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2.2 The current study 
 
The current study is a prelude to other chapters within this thesis, representing 
the synthetic protocols that have been employed for the other systems discussed in all 
consequent chapters, in addition to the different binding modes that can be obtained 
using formamidinate ligands. Beside one monovalent formamidinatoantimony 
complex, uncharted trivalent haloformamidinatoantimony complexes have been 
synthesised in this chapter. The reaction between antimony (III) halides SbX3 (X = Cl, 
Br, I) and the deprotonated formamidine (DippForm)‾ has been examined to increase 
the scope of the haloorgano(amido)antimony system. Fundamentally, the synthesis of 
antimony (I) and (III) formamidinate complexes was accomplished through 
deprotonation of N,N′-2,6-diisopropylphenylformamidine (DippFormH) by a group of 
metal alkyl/amide reagents (n-BuLi, LiN(SiMe3)2, NaN(SiMe3)2) in a donor solvent THF 
or in PhMe and then combined with SbX3 in THF and/or PhMe. The major products 
obtained were bis-substituted complexes; for example, [Sb(DippForm)2Cl] (2.2), 
[Sb(DippForm)2Br] (2.3),  [Sb(DippForm)2I] (2.4), and mono-substituted complexes 
of [Sb(DippForm)Br2] (2.5), [Sb(DippForm)I2] (2.6). Whereas unpredictable products 
with differing binding modes are described, such as [Li2I(DippForm)(µ-thf)(thf)2] (2.7),  
[Sb(DippForm)(NSiMe3)]2 (2.8), [SiMe3(DippForm)] (2.9) and 
[SbCl3(Me2NC2H4NMe2)] (2.10). Work-up for synthesis of a tri-substituted complex of 
the type [Sb(DippForm)3] was unsuccessful, due to steric complications. The reduction 
reaction of Sb+3 to Sb+1 occurred through treatment of DippFormH with NaN(SiMe3)2 in 
THF, then added to SbCl3 producing the formamidinato-bridged distibane [Sb2{µ-
(DippForm}2].(THF)8 (2.1), which is discussed along with the difficulties associated 
with the synthesis of a monovalent antimony complex as a further comparison. After 
retreatment of [SbCl3(Me2NC2H4NMe2)] (2.10) with DippFormH in THF, an attempt 
to recrystallise the product from C6D6 is described, unexpectedly affording an antimony 
complex [(DippForm)ClSb(µ-O)SbCl2(Me2NC2H4NMe2)]2.(C6D6) (2.11), and it was 
the only type of halogenated hetero dinuclear complex isolated in this study. Reaction of 
DippFormH in THF with Hg(C6F5)2, as a source of the  pentafluorophenyl group, 
followed by its combination with SbCl3 gave the unexpected product 
[Sb(DippForm)Cl(C6F5)]2.(THF)2 (2.12) in low yield.  
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Different studies have been implemented to explore the nature of the 
formamidinatoantimony derivatives in the solid state and in solution. Structures of all 
the complexes were obtained using single crystal X–ray structure 
determination/analysis and further characterised by 1H-, 7Li-(2.7) and 13C-NMR 
spectroscopy, IR spectra, elemental analysis as well as melting points (to complete 
characterisation providing thermal stability information). Structural elucidation 
revealed that some of the isolated complexes showed somewhat infrequent Dippform 
coordination modes with the antimony. 
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GLOSSARY OF COMPOUNDS AND CODES 
 
The following structures are a summary of the antimony complexes discussed 
throughout this chapter, together with respective codes. These structures show 
antimony atoms in different colours representing the colours of the compounds 
observed in the solid state.  
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2.3 Results and discussion  
  
2.3.1 Synthesis by metathesis reactions in THF/PhMe 
 
In this chapter, we started to investigate the synthesis of a variety of antimony 
(III) formamidinate complexes by means of metathesis reactions in THF/PhMe. The 
reaction yields were relatively dependent on stoichiometric and synthetic techniques 
used for preparing the complexes, although some unpredicted results were gained. 
Scheme 2.13 ( outlined below) shows the reagents and conditions used within this 
study.  
A range of synthetic routes seeking the formation of haloformamidinatoantimony 
(I)/(III) complexes have been investigated as outlined in (Scheme 2.8). 
 
Scheme 2.8: Synthetic routes to formamidinato antimony (I)/(III) complexes. 
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The methods described above have been used to prepare antimony 
formamidinates as moisture sensitive compounds, and all of the procedures required 
utilising the common organic solvents, either THF or PhMe, under varying conditions. 
The standard metathetical reaction (Scheme 2.8) can produce more complicated 
products by contamination from salt formation. The reaction of SbX3 with alkali metal 
formamidinate M(DippForm) can yield Sb(DippForm)X2, Sb(DippForm)2X and 
Sb(DippForm)3 (due to the steric demands of DippForm, it is improbable) (see later), 
depending on the molar ratio of the SbX3 vs. (DippFormH) used. It was noticed that the 
reaction of the deprotonated N,N′-2,6-diisopropylphenylformamidinate with SbX3 in THF 
at any ratio (1:1, 2:1, 3:1) can provide both the mono- and bis-substituted complex 
(Scheme 2.9).  
 
 
 
 
 
 
Scheme 2.9: Synthesis of mono- and bis-substituted complexes. 
 
Sb(DippForm)2Br (2.3) reacted as starting material instead of using DippFormH 
ligand in one of the reactions, which represents other synthetic technique proving 
successfully synthesis of Sb(DippForm)Br2 through it (Scheme 2.8, eqn. 6). Several 
coordination modes have been gained, including the three most common ones as shown 
in (Scheme 2.10). 
 
 
 
 
 
Scheme 2.10: Three common coordination modes for substituted formamidinate with 
antimony. 
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An adequate amount of very shiny orange block-shaped crystals of [Sb2{µ-
(DippForm}].(THF)8 (2.1) (Fig. 2.1) were gained. The processed reaction was between 
NaN(SiMe3)2 and DippFormH, and then combination with the anhydrous SbCl3 in THF 
in 3:1 molar ratio. The reaction pathway is proposed in (Scheme 2.11). The dimeric 
crystalline complex (2.1) was isolated instead of an expected Sb+3 complex [SbL3-nCln] (n 
= 2, 1, 0) due to an unanticipated reduction reaction, reducing Sb+3 to Sb+1. NaCl was 
displaced and Sb (I) sat in the C–N pocket forming a bridged Sb+1 compound. In this 
chapter, we attempted reduction reactions of SbX3 (X = Cl, Br, I) combined with 
DippFormH and several reducing agents (Na, K, Mg), as well as reactions with hydride 
transfer reagents (NaH, KH, LiAlH4) in different solvents (THF, PhMe, hexane), with 
the aim of forming low valent Sb species. However, the reduction reaction results were 
generally unsuccessful and only gave dark, insoluble precipitates.  
 
 
Scheme 2.11: A proposed route to the synthesis of complex (2.1). 
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2.3.1.1 Mono-formamidinato antimony (III) complexes  
 
DippFormH was stirred at room temperature in THF/PhMe and deprotonated 
by dropwise addition of LiN(SiMe3)2. This was followed by the addition of 
Li(Dippform) to anhydrous SbX3 (X = Br, I) pre-dissolved in THF/PhMe in 1:1 molar 
ratios to produce the new antimony formamidinate species. A colour change was 
observed in the solution (after ~10 minutes). Consequently, crystalline complexes 
containing examples of the corresponding mono-substituted formamidinate complexes 
of the general type [Sb(DippForm)X2], (X = Br (2.5), I (2.6)) have been generated. Both 
of the complexes were obtained in almost quantitative yields (Scheme 2.12).  
 
 
 
 
 
 
 
 
 
Scheme 2.12: Synthesis of mono-substituted formamidinate complexes (2.5 and 2.6). 
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2.3.1.2 Bis-formamidinato antimony (III) complexes 
 
[Sb(DippForm)2Cl] (2.2), [Sb(DippForm)2Br] (2.3) and [Sb(DippForm)2I] (2.4) 
were synthesised by treating SbX3 with Li(Dippform) in a 1:3 molar ratio (Scheme 
2.13). However, reactions of different metal alkyls/amides such as (n-BuLi, 
LiN(SiMe3)2 and NaN(SiMe3)2) with DippFormH, followed by combination with the 
corresponding SbX3 in 3:1 molar ratio in different solvents failed to give the tri-
substituted stibines Sb(DippForm)3, in spite of comparable findings having previously 
been described for organobismuth complexes.9 This implies that the Dippform ligand 
is too sterically demanding to form the tris-substituted product with the antimony (ionic 
radius 0.76 Å), which is smaller than bismuth (ionic radius 0.96 Å). A ratio of 1:2 was 
therefore used to synthesise the bis-substituted antimony (III) complexes in THF or 
PhMe under variant conditions in good yield. The general equation of the reaction is 
given below (eqn. 2.2): 
 
 
 
 
 
Equation 2.2: Overall synthesis of bis-substituted Sb+3 complexes in THF/PhMe. 
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Scheme 2.13. Synthesis of halo- and nonhalo-formamidinatoantimony complexes, 
reagents and under different conditions: (i) NaN(SiMe3)2, SbCl3, _78 0C, 3:1 molar ratio 
in THF. Note: compound (2.1) crystallised as a dimer with eight THF molecules in the 
crystallographic asymmetric unit. (ii) LiN(SiMe3)2, SbCl3, r.t, 1:2 molar ratio in 
THF/PhMe. (iii) LiN(SiMe3)2, SbBr3, _ 78 0C, 1:2 molar ratio in THF/PhMe and hexane. 
(iv) LiN(SiMe3)2, SbI3, _ 78 0C, 1:2 molar ratio in THF/PhMe. (v) (2.3) + SbBr3 in 1:1 
molar ratio, r.t, THF. (vi) LiN(SiMe3)2, SbI3, r.t, 1:1 molar ratio in THF/PhMe. The 
metathesis reactions described in (Scheme 2.13) generally produce Sb in (III) valence 
complexes (except for 2.1 with monovalent Sb).  
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[Li2I(DippForm)(µ-thf)(thf)2] was obtained unexpectedly as a primary 
product in very reasonable yield from the reaction of Li(DippForm) (prepared in situ) 
with SbI3 in 3:1 molar ratio (Scheme 2.14). Storage of the reaction mixture in PhMe at 
room temperature gave off white-yellow crystals of (2.7) suitable for single-crystal X-
ray diffraction studies.  
 
 
 
Scheme 2.14 The proposed mechanism for the formation of complex (2.7). 
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A reaction between Li(DippForm) and SbBr3 in the presence of THF and PhMe at room 
temperature produced an unanticipated components [Sb(DippForm)(NSiMe3)]2 (2.8) 
and [SiMe3(DippForm)] (2.9), suggesting an interaction activation process occurred 
according to the proposed route (eqn. 2.3):   
 
 
 
 
 
 
 
Equation 2.3 
 
Addition of N,N,N′,N′-tetramethyl-1,2-ethanediamine (TMEDA) to SbCl3 pre-
dissolved in THF and pre-treated with Li(DippForm) gave the crystallisable complex 
[SbCl3(Me2NC2H4NMe2)] (2.10). An attempt to deliberately synthesise this complex 
was achieved by the reaction of SbCl3 with an equivalent of (TMEDA) in THF          
(eqn. 2.4).  
 
 
 
 
 
Equation 2.4 
 
On the basis of an NMR-spectroscopic-scale recrystallisation experiment in C6D6 at 
ambient temperature, an attempted synthesis of (2.10) was performed by treating 
(DippFormH) with LiN(SiMe3)2 in THF and (TMEDA), followed by unintentional 
exposure to small amounts of H2O, resulted in the formation of an unexpected new 
heterocyclic cage [(DippForm)ClSb(µ-O)SbCl2(Me2NC2H4NMe2)]2.C6D6 (2.11) 
(Scheme 2.15). 
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   Scheme 2.15. Synthesis of complex (2.10) and (2.11). 
 
Complex [Sb(DippForm)Cl(C6F5)]2.(THF)2 (2.12) was obtained in low yield 
from one pot reaction of DippFormH with Hg(C6F5)2 and SbCl3 in THF (eqn. 2.5). 
 
 
 
Equation 2.5 
 
In an attempt to co-crystallise M(DippForm), an intractable combination formed 
when the alkali metal formamidinate combined with SbX3, which can be attributed to the 
extremely air sensitivity of the starting materials. To illustrate that, the 2:1 reaction of 
Li(DippForm) with SbI3 gave [Sb(DippForm)2I] (2.4) and Li(DippForm). It is not 
unexpected, where no pure material was observed.9 Therefore, it was recommended to 
perform the reaction in situ to minimise the potential mixed materials. Overall, Sb-
including product could be entirely distinguishable.  
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Some of the products presented within this chapter were isolated from the 
reaction mixture by filtration from the unwanted precipitate MX (M = Li, Na, Hg; X = 
Cl, Br) as shown in (eqn. 2.6), followed by fractional crystallisation from THF (2.1, 2.5, 
2.9, 2.10, 2.12). Whereas the others were evaporated to the point of dryness under 
vacuum, due to the high solubility of the precipitate in THF, and recrystallisation from 
PhMe after filtration from MX (M = Li; X = Cl, I) (2.2, 2.4, 2.6, 2.7, 2.8) (eqn. 2.6). 
Experiment (2.3) was performed in a mixture of THF/PhMe and for further purification 
were required hexane. Only [(DippForm)ClSb(µ-O)SbCl2(Me2NC2H4NMe2)]2.(C6D6) 
(2.11) was isolated from the reaction mixture in THF/TMEDA by filtration from LiCl 
and recrystallised from C6D6. Complex [Sb(DippForm)2Br] (2.3) was gained with the 
highest yield of (80 %). 
 
 
 
 
Equation 2.6 
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2.3.2 Characterisation 
 
Characterisation was primarily authenticated through single crystal X-ray 
structure identification of the isolated crystalline samples [Sb(DippForm)3-nXn] (n = 1, 
2; X = Cl, Br, I) displayed in (scheme 2.13) using the MX1 beamline at the Australian 
Synchrotron. To develop an understanding of the bonding and structural diversity, the 
experimental observations were interpreted with additional characterisation by IR 
spectroscopic techniques (Table 2.1), 1H-NMR (Table 2.2), 13C-NMR (Table 2.3), 7Li-
NMR (2.7) spectroscopy, elemental analyses and melting point determination (with the 
exception of (2.12), which was obtained only in very poor yield).  
 
The 1H-NMR spectra for some of the complexes such as (2.1, 2.7) revealed that 
the ratios of solvent to ligand are not consistent with the composition identified in the 
solid state X-ray crystal structure. Loss of some THF of solvation occurred during 
drying the product under vacuum. To illustrate this, the 1H-NMR spectrum of [Sb2{µ-
(DippForm}2].(THF)8 (2.1) revealed the loss of 2 THF molecules, shown by the 
integration of two resonances at δ = 3.64 and 1.34, where a DippForm methyl (48 1H, 
CH(CH3)2):THF (24 1H, OCH2-thf) ratio was found to be 2 to 1.  
 
In the 1H-NMR spectra of the DippFormH proligand, the methine proton NCHN 
resonance on the backbone typically occurred at δ = 7.05 ppm, while upon 
deprotonation of the NH group on the formamidine and coordination with antimony, 
the methine proton resonances occurred at δ = 10.60, 10.93, 8.04, 8.31 and 8.29 ppm 
for the corresponding (2.1), (2.2), (2.3), (2.6) and (2.8) compounds respectively, 
representing one NCHN enviroment shifted to higher frequencies when compared with 
the neutral ligand. The 13C-NMR spectrum of the compounds displayed the predictable 
resonances and were identifiable, however the only resonances were amassed together 
in (2.10) restricting full resolution of the signals. 
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The IR spectra of all antimony compounds (except 2.10) revealed 
comprehensive deprotonation of the N–H group of the formamidine ligand upon 
formation of the antimony complex. This was evident by absence of the ν (N–H) 
absorption band typically observed at 3300-3100 cm-1. This indication was combined 
with the absence of a N–H resonance in the 1H-NMR spectra of the bulk vacuum 
dried materials. The only one case was observed in (2.8) when N–H band showed very 
weak resonance at the region of 5.31 ppm in the 1H-NMR spectrum. This was coupled 
with the presence of a very weak band analogous to the formamidine in the IR spectrum 
of (2.8), suggesting high intensity of the ν (N=C) band for the NCHN vibrational mode, 
which could be attributed to the extreme sensitivity of the DippForm complex to air. 
More specifically, the potential slight decomposition on movement from the glovebox 
to the infrared spectrometer could have occurred even when the sample was protected 
in a Nujol mull (dried over sodium) between NaCl plates. Complexes (2.1 - 2.9 and 
2.11) had absorptions at 1644-1698 cm-1 through N–C stretching (Table 2.1), which 
belonged to a metal (Sb, Li, Si)-coordinated formamidinate ligand.  
 
Analysis of the bulk material provided a satisfactory elemental analysis (C, H, 
N), which is consistent with the formation of the compounds (2.2, 2.3, 2.5, 2.8, 2.9, 
2.10). The acceptable range of error in C, H, and N is ± 0.50 % from the calculated value. 
Attempts to gain satisfactory carbon and nitrogen analysis data for compound (2.1) 
were unsuccessful, most likely because of the product contamination or possibly from 
the high air and/or moisture sensitivity and extreme ease of solvent loss or even 
potential decomposition in transit.  
The existence of TMEDA in [SbCl3(Me2NC2H4NMe2)] and [(DippForm)ClSb-µ-O-
SbCl2(Me2NC2H4NMe2)]2.(C6D6) complexes was confirmed by the 1H-NMR spectra 
with resonances at ppm = 2.15 (CH3-(TMEDA)), 2.31 (CH2-(TMEDA)) and 2.05 (CH3-
(TMEDA)), 2.10 (CH2-(TMEDA)), respectively, although the elemental analyses were 
repeatedly showing slightly low in the C percentage for (2.11). This could be attributed 
to loss of C6D6 solvation upon standing.  
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Table 2.1 N–C Stretching in IR spectra for antimony formamidinate complexes 
                                               2.1 - 2.9 and 2.11 (υ 4000 - 400 cm-1) 
 Compound                                N–C stretching vibration (cm-1) 
[Sb2{µ-(DippForm}2].(THF)8                                                (2.1) 1668 
[Sb(DippForm)2Cl]                                                                (2.2) 1666 
[Sb(DippForm)2Br]                                                               (2.3) 1662 
[Sb(DippForm)2I]                                                                  (2.4) 1651 
[Sb(DippForm)Br2]                                                               (2.5) 1644 
[Sb(DippForm)I2]                                                                  (2.6) 1667 
[Li2I(DippForm)(µ-thf)(thf)2]                                                (2.7) 1698 
[Sb(DippForm)(NSiMe3)]2                                                    (2.8) 1670 
[SiMe3(DippForm)] (2.9) 1661 
[(DippForm)ClSb(µ-O)SbCl2(Me2NC2H4NMe2)]2.(C6D6)   (2.11) 1662 
DippFormH  1600 
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Table 2.2 1H-NMR chemical shift data in ppm for antimony formamidinate complexes 2.1 - 2.9 and 2.11 in C6D6 
        
1H-NMR 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.11 
NCHN 10.60 10.93 8.04 7.86 7.56 8.31        7.86        8.29         7.21        7.77 
Aromatic H 6.98-7.06 6.91-7.03 6.99-7.03 6.98-7.06 6.88-7.08 6.76-6.99  6.99-7.06   6.95-7.08   6.96-7.04   6.92-7.09
CH(CH3)2 3.42 3.44 3.45 3.42 3.33 3.22        3.43        3.46         3.43        3.41 
OCH2, thf 3.64 – – –    – – 3.55        – – – 
CH2, thf 1.34 – – – – – 2.10 – – – 
CH(CH3)2 1.12 1.13 1.15 1.15 1.21 1.11        1.16        1.16         1.10 1.22 
CH2-(TMEDA)   – – – – – – – – – 2.10 
CH3-(TMEDA) – – – – – – – – – 2.05      
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Table 2.3 13C-NMR chemical shift data in ppm for antimony formamidinate complexes 2.1 - 2.9 and 2.11 in C6D6 
 
13C-NMR 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.11 
NCN 157.39 155.62 161.27 155.54 159.80 158.89 146.47 152.60 147.00 163.22 
Aromatic C 123.3-143.1 123.4-143.6 123.9-145.6 123.4-145.8 123.5-145.5 123.9-145.5 123.6-144.1 123.3-145.9 123.0-127.1 122.9-146.0 
CH(CH3)2 28.51 28.17 29.60 28.39 29.13 29.21 28.40 28.25 28.43 28.41 
OCH2, thf 66.50 – – – – – 68.63 – – – 
CH2, thf 25.12 – – – – – 25.35 – – – 
CH(CH3)2 23.84 23.47 25.58 23.71 24.60 25.43 24.16 23.86 24.09 23.91 
CH2-(TMEDA)  – – – – – – – – – 54.62 
CH3-(TMEDA) – – – – – – – – – 41.62 
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2.3.3 Crystal structure determinations 
 
[Sb2{µ-(DippForm}2].(THF)8 (2.1)  
 
By means of metathesis in THF, the monovalent antimony complex [Sb2{µ-
(DippForm}2].(THF)8 (2.1) was synthesised (Scheme 2.11). The Lewis base–stabilised 
diantimony (2.1) complex was achieved in low to moderate yield as light orange block-
shaped crystals, while the X-ray data was established only in moderate quality but the 
connectivity has been established and is unambiguous. Compound (2.1) crystallised in the 
monoclinic space group P21/c (Table 2.5), with one dinuclear molecule within the 
asymmetric unit. As it can be seen from the crystal structure depicted in (Figure 2.1), 
antimony is tri-coordinate with the coordination sphere involving two bridging 
DippForm ligands that symmetrically link between Sb‒Sb. Eight uncoordinated THF 
molecules per dimer are present in the lattice. The overall geometry of the Sb (I) 
complex displays a planar structure of the central structural motif. [Sb2{µ-
(DippForm}2].(THF)8 dimerises via Sb=Sb double bond formation, and this double 
bond has two contributions, a σ bond and a substantial degree of π bonding, both of 
them are predominantly formed by interactions of p atomic orbitals located at each Sb 
centre. The molecular structure shows there is no stereochemically active lone pair of 
electrons at the antimony centres (Scheme 2.16).    
 
 
 
 
 
 
 
 
 
Scheme 2.16. Diagram of dinuclear antimony (I) compound (2.1). 
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Figure 2.1. Molecular structure of dimeric [Sb2{µ-(DippForm}2].(THF)8 (2.1) (left 
view: along the Sb–Sb bond, right: top view) with the atom numbering system; thermal 
ellipsoids are drawn at the 50 % probability level, and hydrogen atoms and lattice THF 
have been omitted for clarity. Selected bond lengths (Å) and angles (°): Sb(1)–Sb(2): 
2.6806(11), Sb(1)–N(1): 2.302(9), Sb(1)–N(4): 2.307(9), Sb(2)–N(3): 2.290(8), Sb(2)–
N(2): 2.288(10), N(3)–C(38): 1.311(14), N(1)–C(1): 1.421(14), N(1)–C(13): 
1.344(13), N(4)–C(38): 1.307(14), N(4)–C(26): 1.412(14), N(2)–C(14): 1.434(13), 
N(2)–C(13): 1.330(13), N(1)–Sb(1)–Sb(2): 85.5(2), N(4)–Sb(1)–Sb(2): 85.4(2), N(3)–
Sb(2)–Sb(1): 85.3(2), N(2)–Sb(2)–Sb(1): 85.9(2), C(39)–N(3)–Sb(2): 117.7(7), C(38)–
N(3)–Sb(2): 123.2(7), C(1)–N(1)–Sb(1): 119.1(6), C(13)–N(1)–Sb(1): 123.3(7), 
C(38)–N(4)–Sb(1): 122.2(7), C(13)–N(2)–Sb(2): 123.8(7).  
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The most prominent structural feature is the highly symmetric, a novel planar 
eight-membered N4C2Sb2 heterocycle, also described as two condensed five-membered 
rings, highlighting a relatively short Sb(1)–Sb(2) bond length of 2.6806(11) Å, (∑rcov 
(Sb–Sb) = 2.8 vs. ∑rcov (Sb=Sb) = 2.66 Å).28 A Sb=Sb bond length in (2.1) is slightly 
longer than the bond lengths measured for the formerly established of 2.6438(4) Å for 
[Sb2-{μ-(TerN)2P}2],19 2.642(1) for Tbt2Sb2, 2.6558(5) for Ter2Sb2, but shorter than the 
bond length of 2.7104(5) for [Ar*N(SiiPr3)]2Sb2 (Ar* = 2,6-bis(diphenylmethyl)-4-
isopropyl-phenyl), where these compounds also had a Sb=Sb double bond with Sb in 
the +1 oxidation state.16, 29,30,31,32,28,33 
 
Complex (2.1) is the first structurally characterised formamidinate/amidinate-
substituted distibine, and is also considered as one of the series of Lewis base-
coordinated dipnictenes, with a Sb–N bond length range of 2.288(10)‒2.307(9) Å, 
which is slightly shorter than the Sb–N bond length range of 2.372(2) Å reported for 
[Sb2‒{μ‒(TerN)2P}2],19 and significantly longer than the sum of covalent radii (∑rcov 
(Sb–N) = 2.11 Å).28 In addition, the short C–N distances of N1/3–C13/38 
1.344(13)/1.311(14), N2/4–C13/38 1.330(13)/1.307(14) Å are in the midway between 
the typical range of CN double bonds ((C=N) =1.25 Å) and the CN single bonds ((C–
N) =1.47 Å), establishing the delocalisation of the anionic charge across the N-C-N 
moiety. Thus, the symmetrically bridging NCN ligand retains its anionic nature within 
the bridging mode, as assigned by the carbon–nitrogen bond lengths above. In contrast, 
an example of related structures having μ-N,N′ bridging mode that have been recently 
reported by Jones and co-workers, each Sb centre is being coordinated by an amide 
centre of one ligand, and the imine arm from the other ligand constructing a dative 
interaction (by view of the ligand geometry). In these structures, an average C–N 
distances 1.340 Å in the planar [As2{μ‒(ArN)2CR}2] bicyclic fragment (Ar = C6H3iPr2‒
2,6; R = N(C6H11)2, N(iPr)2, tBu).18 This geometry is also comparable to the planar 
amidinato-bridged copper (I) dimers.34 By obtaining complex (2.1), the sterically bulky 
formamidinate ligand (DippForm), synthesised and developed in our laboratory, further 
highlights its ability to stabilise low oxidation state p-block compounds with unusual 
coordination mode.     
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[Sb(DippForm)2X] (X = Cl (2.2), Br (2.3) and I (2.4))   
 
The trivalent antimony complexes [Sb(DippForm)2X] (X= Cl (2.2), Br (2.3) and 
I (2.4)) were synthesised (Scheme 2.10). These complexes crystallised in the monoclinic 
space group P21/c (Table 2.5), with one mononuclear molecule within the asymmetric 
unit. The three complexes (2.2, 2.3 and 2.4) are the first reported five coordinate 
antimony formamidinate/amidinate compounds, with an Sb-N bond length range: 
2.112(4) – 2.646(3) Å showing asymmetric formamidinate chelation. Complexes (2.2, 
2.3 and 2.4) are isostructural, including the very similar coordination environment 
observed for the Sb atoms in the three structures, where the iodide or bromide ligand 
was placed instead of chloride ligand. The Sb+3 metal centre in each of the three 
structures is five coordinate, bounded by two of η2(N,N') DippForm ligands through the 
nitrogen donor atoms, and one terminal halide ligand (Figures 2.2, 2.3 and 2.4). The 
antimony atom shares a plane with a halide atom and two nitrogen from both of the two 
ligands in equatorial position, while the other two nitrogen atoms from both of the 
ligands above and below the plane (axial or apical position).  
 
The coordination geometry of (2.2, 2.3 and 2.4) was very symmetrical and most 
probably distorted as a consequence of the steric effect of the ligand–ligand dislikes 
compressed by the bulky aryl substituents and the acute bite angle of the Dippform 
ligand N(3)–Sb(1)–N(4) 55.54(5), 54.96(11) and 54.833(11)° respectively. The ligands 
are asymmetrically bound to Sb, with the four N atoms forming an estimated trapezium, 
such as in (2.2) (N(2)–Sb(1)–N(3) 86.56(5)°, N(1)–Sb(1)–N(4) 154.63(5)°) (Figure 
2.2). In the three complexes, the two DippForm ligands attached to Sb atom were 
positioned by the NCN planes approximately perpendicular to each other (interplanar 
angles average between 86.56(5)–88.194(11)°), these positions were generally blocked 
by the bulky pendant aryl groups of the formamidinate ligand inhibiting additional 
coordination of potential donor groups. On the other hand, the steric bulk of the 
DippForm ligand does not allow for a dinuclear arrangement formed by bridging 
halides. 
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The crystallographic analysis for (2.2) revealed normal Sb–Cl of 2.3980(6) Å, 
Sb–N1/N2/N3/N4 of 2.5634(15)/2.1131(14)/2.6044(13)/2.1624(15) Å distances, 
average NCN bond angle of 117.29(13)° and other bond angles.5,35,36,37,38 The bond 
angles in (2.2): N(3)–Sb(1)–Cl(1) 139.43(3), N(1)–Sb(1)–Cl(1) 78.84(3) and N(3)–
Sb(1)–N(1) 132.04(4)° indicate the formation of a rather distorted trigonal bipyramid 
geometry, which is the same as for (2.3 and 2.4) (Scheme 2.17).  
The N(4)–Sb(1)–N(1) bond angles of 154.63(5)/156.24(11)/156.06(15)°, show 
a high distortion from the expected 180° that may due to the rather acute bite angles of 
56.80(5)/55.54(5), 56.31(11)/54.96(5) and 55.85(15)/54.83(5)° for N1–Sb1–N2/N3–
Sb1–N4, respectively. The unsymmetrical C–N bond lengths (Figure 2.2) of NCN 
(N1/N2–C13 of 1.282(2)/1.363(2) Å, N3/N4–C38 of 1.291(19)/1.349(19) Å; 
DippFormH:1.311(17) and 1.310(16) Å), suggest limited delocalisation of the anionic 
charge across the backbone.39,40 
 
 
 
 
 
 
 
 
Scheme 2.17. Diagram of a typical trigonal bipyramid with bond angles shown for a 
rather disordered trigonal bipyramid geometry formed by (2.2, 2.3 and 2.4). 
 
The Sb–Cl bond length in (2.2) 2.3980(6) Å is approximately in agreement with 
the Sb–Cl 2.366(8) and 2.398(6) Å of [Sb{tBuC(NR)2}Cl2] (R = Cy and Dipp)8, and is 
much shorter than the sum of the van der Waals radii of (∑ vdw (Sb–Cl)= 3.81 Å.28  
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In the formamidinate compounds, the sum of the three bond angles around the 
backbone C is normally 360°, resulting in a trigonal planar geometry consistent with 
the expected sp2 geometry. However, the 120° N(1)-C(13)-N(2) and N(3)-C(38)-N(4) 
angle in the formamidine is reduced to a slightly tight 117.37(14)/117.29(13)° in the 
formamidinate of (2.2) due to the existence of the four-membered rings (Scheme 2.18), 
which is the same observation in the other two structures (2.3 and 2.4). Unsurprisingly, 
the C(13)-N(1)-C(1), C(13)-N(2)-C(14), H-C(13)-N(1) and H-C(13)-N(2) angles are 
increased in comparison to the angles of the free formamidine.  
 
 
 
 
 
 
 
Scheme 2.18. Diagram of a trigonal planar geometry around NCHN in complex (2.2). 
 
As expected, it can be noticed the decrease in the values of the bond angles of 
(2.2), C(13)–N(1)–Sb(1), C(13)–N(2)–Sb(1), C(38)–N(3)–Sb(1) and C(38)–N(4)–
Sb(1) that found to be 83.88(10), 101.94(10), 82.79(8) and 100.94(10)° respectively; 
whereas in the free formamidine ligand such C–N–H bond angles are typically 
calculated 120°.  
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Figure 2.2. Molecular structure of monomeric [Sb(DippForm)2Cl] (2.2) with the atom 
numbering system; thermal ellipsoids are drawn at the 50 % probability level, and 
hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and angles 
(°): Sb(1)–N(1): 2.5634(15), Sb(1)–N(2): 2.1131(14), Sb(1)–N(3): 2.6044(13), Sb(1)–
N(4): 2.1624(15), Sb(1)–Cl(1): 2.3980(6), N(3)–C(38): 1.2911(19), N(3)–C(26): 
1.4260(18), N(2)–C(13): 1.363(2), N(2)–C(14): 1.434(2), N(4)–C(38): 1.3497(19), 
N(4)–C(39): 1.438(2), N(1)–C(13): 1.282(2), N(1)–C(1): 1.413(2), N(1)–Sb(1)–Cl(1): 
78.84(3), N(2)–Sb(1)–Cl(1): 94.67(4), N(3)–Sb(1)–Cl(1): 139.43(3), N(4)–Sb(1)–
Cl(1): 85.44(4), N(2)–Sb(1)–N(3): 86.56(5), N(2)–Sb(1)–N(4): 105.46(6), N(1)–
Sb(1)–N(3): 132.04(4), N(1)–Sb(1)–N(2): 56.80(5), N(3)–Sb(1)–N(4): 55.54(5), N(1)–
Sb(1)–N(4): 154.63(5), C(38)–N(3)–Sb(1): 82.79(8), C(26)–N(3)–Sb(1): 152.72(9), 
C(38)–N(3)–C(26): 119.24(12), C(13)–N(2)–Sb(1): 101.94(10), C(14)–N(2)–Sb(1): 
138.00(11), C(14)–N(2)–C(13): 116.98(14), C(13)–N(1)–Sb(1): 83.88(10), C(1)–
N(1)–Sb(1): 152.95(11), C(1)–N(1)–C(13): 123.11(14), C(39)–N(4)–Sb(1): 
126.88(11), C(38)–N(4)–Sb(1): 100.94(10), C(38)–N(4)–C(39): 117.81(13), N(4)–
C(38)–N(3): 117.29(13), N(1)–C(13)–N(2): 117.37(14).  
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An Sb-N bond length range in (2.3) was found to be 2.576(3)-2.113(3) Å (Figure 
2.3), which has as expected slightly shorter than the Bi-N bond length range: 
2.643(7)_2.323(6) Å for the bulky formamidinate coordinated to Group 15 (analogous 
angles and bond lengths for [Bi(DippForm)2(Bun)]) (Table 2.4),9 due to the metal size 
differences. The variance in the Sb–N bond lengths in (2.3) (0.463, 0.488 Å) is slightly 
different to those (0.320, 0.243 Å) reported for the [Bi(DippForm)2Br] complex.9 The 
position of Sb–Cl bond is almost vertical with the SbN4 plane and 2,6-diisopropyl 
groups involved above and below the plane. The Sb–Br bond length 2.5576(6) Å is 
between those of 2.446 Å for Sb(1)–Br(1) and 2.98 Å for Sb(2)–Br(2) noted in 
[({N(C6H3iPr22,6)C(Me)}2CH)2Sb2(µ-Br)2Br2].5 These values are not unusual for Sb–
Br bonds,41 and this dissimilarity appears to be a common characteristic in the 32 stated 
Sb–Br bridged structures.42 
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Figure 2.3. Molecular structure of monomeric [Sb(DippForm)2Br] (2.3) with the atom 
numbering system; thermal ellipsoids are drawn at the 50 % probability level, and 
hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and angles 
(°): Sb(1)–N(1): 2.576(3), Sb(1)–N(2): 2.113(3), Sb(1)–N(3): 2.646(3), Sb(1)–N(4): 
2.158(3), Sb(1)–Br(1): 2.5576(6), N(3)–C(38): 1.280(4), N(3)–C(26): 1.414(4), N(2)–
C(13): 1.362(5), N(2)–C(14): 1.450(5), N(4)–C(38): 1.343(4), N(4)–C(39): 1.452(5), 
N(1)–C(13): 1.262(5), N(1)–C(1): 1.429(5), N(2)–Sb(1)–Br(1): 95.39(8), N(3)–Sb(1)–
Br(1): 139.570(8), N(4)–Sb(1)–Br(1): 85.80(8), N(2)–Sb(1)–N(3): 88.142(11), N(2)–
Sb(1)–N(4): 106.91(11), N(1)–Sb(1)–N(2): 56.31(11), N(3)–Sb(1)–N(4): 54.963(11), 
N(4)–Sb(1)–N(1): 156.24(11), C(38)–N(3)–Sb(1): 81.487(2), C(26)–N(3)–Sb(1): 
153.080(2), C(38)–N(3)–C(26): 121.7(3), C(13)–N(2)–Sb(1): 102.0(2), C(13)–N(1)–
Sb(1): 83.7(2), C(14)–N(2)–Sb(1): 138.4(2), C(14)–N(2)–C(13): 117.0(3), C(1)–N(1)–
C(13): 123.6(3), C(39)–N(4)–Sb(1): 127.6(2), C(38)–N(4)–Sb(1): 101.7(2), C(38)–
N(4)–C(39): 117.1(3), N(4)–C(38)–N(3): 118.8(3), N(1)–C(13)–N(2): 118.0(4).  
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An average Sb-N bond length of (2.4) was found to be 2.291 Å, range: 2.112(4) 
-2.634(3) Å (Figure 2.4). Despite the same coordination number in (2.4), the Sb–I bond 
distance was found to be 2.7725(6) Å, which is longer, as expected, than the Sb–Cl 
distance in (2.2) of 2.3972(7) Å and the Sb–Br distance in (2.3) of 2.5576(6) Å, due to 
the differing halide at sizes in the three compounds. The coordination environment for 
the Sb atom in (2.2, 2.3 and 2.4) is similar with the Bi literature complexes 
[Bi(XylForm)2Br] and [Bi(2-PhForm)2Br], where XylForm and 2-PhForm ligands were 
involved instead of the bulky DippForm ligand.9    
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Figure 2.4. Molecular structure of monomeric [Sb(DippForm)2I] (2.4) with the atom 
numbering system; thermal ellipsoids are drawn at the 50 % probability level, and 
hydrogen atoms and lattice PhMe have been omitted for clarity. Selected bond lengths 
(Å) and angles (°): Sb(1)–N(1): 2.597(4), Sb(1)–N(2): 2.112(4), Sb(1)–N(3): 2.634(3), 
Sb(1)–N(4): 2.165(4), Sb(1)–I(1): 2.7725(6), N(3)–C(38): 1.283(6), N(3)–C(26): 
1.433(6), N(2)–C(13): 1.350(6), N(2)–C(14): 1.454(6), N(4)–C(38): 1.346(6), N(4)–
C(39): 1.449(7), N(1)–C(13): 1.264(6), N(1)–C(1): 1.410(7), N(2)–Sb(1)–I(1): 
96.58(11), N(3)–Sb(1)–I(1): 140.329(8), N(4)–Sb(1)–I(1): 86.40(10), N(2)–Sb(1)–
N(3): 88.194(11), N(2)–Sb(1)–N(4): 106.94(16), N(4)–Sb(1)–N(1): 156.06(15), N(3)–
Sb(1)–N(4): 54.833(11), N(1)–Sb(1)–N(2): 55.85(15), C(38)–N(3)–Sb(1): 82.556(2), 
C(26)–N(3)–Sb(1): 154.133(2), C(38)–N(3)–C(26): 119.6(4), C(13)–N(2)–Sb(1): 
102.6(3), C(13)–N(1)–Sb(1): 83.9(3), C(14)–N(2)–Sb(1): 137.9(3), C(14)–N(2)–
C(13): 117.4(4), C(1)–N(1)–C(13): 124.4(5), C(39)–N(4)–Sb(1): 127.0(3), C(38)–
N(4)–Sb(1): 102.0(3), C(38)–N(4)–C(39): 116.9(4), N(4)–C(38)–N(3): 117.6(5), N(1)–
C(13)–N(2): 118.6(5).  
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 2.2 2.3 2.4 [Bi(DippForm)2(Bun)] 
Sb-N1 2.563(15) 2.576(3) 2.597(4) Bi-N1 2.323(6) 
Sb-N2 2.113(14) 2.113(3) 2.112(4) Bi-N2 2.643(7) 
Sb-N3 2.604(13) 2.646(3) 2.634(3) Bi-N3 2.333(7) 
Sb-N4 2.162(15) 2.158(3) 2.165(4) Bi-N4 2.576(7) 
 
Table 2.4 Selected Sb-N bond lengths (Å) for complexes: [Sb(DippForm)2Cl] (2.2), 
[Sb(DippForm)2Br] (2.3), [Sb(DippForm)2I] (2.4) and [Bi(DippForm)2(Bun)].9   
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Table 2.5 Crystallographic data for compounds 2.1 - 2.4 
 
Compound 2.1 2.2 2.3 2.4 
Formula C82H134N4O8Sb2 C50H70ClN4Sb C50H70BrN4Sb C50H70IN4Sb 
Fw 1547.51 884.32 928.80 975.79 
crystal system monoclinic monoclinic monoclinic monoclinic 
space group P21/c P21/c P21/c P21/c 
a, Å 21.243(4) 18.443(4) 18.7239(14) 18.616(2) 
b, Å 18.997(4) 20.455(4) 20.5497(17) 20.713(2) 
c, Å 21.743(4) 12.817(3) 12.9785(10) 12.9942(13) 
α, deg 90 90 90 90 
β, deg 118.60(3) 97.46(3) 96.886(4) 96.750(5) 
γ, deg 90 90 90 90 
V, Å3 7704(3) 4794.3(17) 4957.7(7) 4975.8(9) 
Z 2 4 4 4 
T, K 173.15 100.15 296(2) 296.15 
no. of rflns collected 71852 87850 63608 63063 
no. of indep rflns 21388 12579 8732 8728 
Rint 0.0697 0.0406 0.1091 0.0889 
Final R1 values (I > 2σ(I)) 0.1352 0.0359 0.0402 0.0468 
Final wR(F2) values (I >2σ(I)) 0.3964 0.1280 0.0876 0.1220 
Final R1 values (all data) 0.1556 0.0381 0.0825 0.0923 
Final wR(F2) values (all data) 0.4021 0.1321 0.1061 0.1580 
GooF (on F2) 1.198 1.194 1.009 0.869 
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[Sb(DippForm)X2] (X= Br in 2.5, I in 2.6) 
  
The crystalline monomeric complexes [Sb(DippForm)Br2] (2.5) and 
[Sb(DippForm)I2] (2.6) are isostructural and crystallised in the triclinic space group 
P-1 (Table 2.8), with one molecule within the asymmetric unit. Single crystals were 
obtained from solution in THF (2.5) after storage at 15 0C for 1 day or in PhMe (2.6) 
after storage at ‒ 30 0C for 12 hours. The formamidinate moiety in (2.5) and (2.6) again 
adopted the N,N′-chelating coordination mode, with four–electron donor ligands as 
observed for the literature corresponding mono-substituted amidinate dichloride 
complexes [Sb{RC(NR')2}Cl2] (R = tBu, R' = iPr, Cy, 2,6-iPr2C6H3; R = nBu, R' = 
iPr).8 The antimony atom is coordinated by a bidentate (N,N') DippForm ligand and two 
bromide ligands in (2.5) or two iodide ligands in (2.6), giving a coordination number 
of four for the antimony atom. The molecular structure of the crystalline compound 
(2.5) is depicted in (Fig. 2.5). Both of (2.5) and (2.6) complexes have average Sb-N 
bond lengths 2.27 Å, which is significantly longer than the very short average of the 
Sb-N bond lengths (1.17 Å) reported for [Sb(ArNRNAr)I2] (Ar = 2,6-iPrC6H3; R = 
NCy2) due to the ligand size differences.18 The structures of (2.5) and (2.6) were 
comparable somewhat with that of [Sb({N(2,4,6-Me3C6H2)C(Me)}2CH)Cl2] (Scheme 
2.16), in which π-delocalisation was much more noticeable, with Sb-N and N-C 
endocyclic bond lengths of 2.088/2.083 and  1.334/1.334 Å, respectively.5  
 
 
 
 
 
 
 
 
 
Scheme 2.16. Structure of [Sb({N(2,4,6-Me3C6H2)C(Me)}2CH)Cl2].5 
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Figure 2.5. Molecular structure of monomeric [Sb(DippForm)Br2] (2.5) with the atom 
numbering system; thermal ellipsoids are drawn at the 50 % probability level, and 
hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and angles 
(°):Sb(1)–N(1): 2.091(2), Sb(1)–N(2): 2.435(2), Sb(1)–Br(1): 2.5989(13), Sb(1)–Br(2): 
2.5172(7), N(2)–C(13): 1.295(3), N(1)–C(13): 1.348(3), Br(2)–Sb(1)–Br(1): 94.98(3), 
Br(1)–Sb(1)–N(1): 90.13(6), N(1)–Sb(1)–Br(2): 98.92(5), N(2)–Sb(1)–Br(1): 
148.10(5), N(2)–Sb(1)–Br(2): 87.08(5), N(2)–Sb(1)–N(1): 58.20(7), C(1)–N(1)–Sb(1): 
137.39(15), C(13)–N(1)–Sb(1): 100.51(14), C(13)–N(2)–Sb(1): 86.43(14), C(14)–
N(2)–Sb(1): 149.66(15), N(1)–C(13)–N(2): 114.4(2). 
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The N1–Sb1–N2 bond angles of 58.20(7)° (2.5) and 57.6(3)° (2.6) were normal 
as for metal amidinate complexes. The N1–C13–N2 bond angles of 114.5(11)° (2.5) 
and 114.4(2)° (2.6) were virtually identical. Even though the endocyclic bond lengths 
show that there is substantial π-delocalisation over the N1C13N2 moiety, the pairs of 
Sb_N1/Sb_N2 bond lengths vary by ca. 0.34, 2.091(2)_2.435(2) Å in (2.5), which is 
exactly the same difference for 2.457(9)_2.111(11) Å in (2.6). On the other hand, the 
dissimilar N1/N2–C13 bond lengths of 1.348(3)/1.295(3) Å (2.5) and 
1.360(14)/1.281(15) Å (2.6) confirmed the limited delocalisation of the π-electrons in 
the amidinate backbone.  
 
The overall coordination environment observed for the central Sb atoms in (2.5 
and 2.6) was similar, where iodide ligands replace bromide ligands, and could possibly 
be described as a heavily distorted tetrahedral geometry. In contrast, the solid state 
structures of Group 15 tetra-coordinated bismuth (III) formamidinate complexes of the 
general formula [Bi(Form)X2] have previously observed, forming symmetrical dimers, 
bridged by two bromides and a coordinated thf molecule on each Bi atom, namely 
[Bi(Form)Br(µ-Br)(thf)]2 (Form = 2,6-iPr2C6H3, 2,6-Me2C6H3). Whereas a thf deficient 
species have a weakly associated trinuclear array with two coordinated thf molecules 
per three Bi atoms [{Bi(2,6-iPr2C6H3)Cl2(thf)}2Bi(2,6-iPr2C6H3)Cl2].9 Complexes (2.5) 
and (2.6) are also similar to the structures of [Sb(Form)X2] (X = F, N3; Form = 
tBuC(NiPr)2, tBuC{N(2,6-iPr2C6H3)}2), forming four membered ring NSbNC  
rhomboid.43 The most prominent structural consistency between (2.5) and (2.6) is 
shown by the exocyclic X1–Sb–X2 bond angles (X = Br or I), 94.98(3)° in complex 
(2.5), which is almost identical with that in complex (2.6) 95.80(5)°.  
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Figure 2.6. Molecular structure of monomeric [Sb(DippForm)I2] (2.6) with the atom 
numbering system; thermal ellipsoids are drawn at the 50 % probability level, hydrogen 
atoms have been omitted for clarity. Selected bond lengths (Å) and angles (°): Sb(1)–
N(2): 2.457(9), Sb(1)–N(1): 2.111(11), Sb(1)–I(1): 2.8215(13), Sb(1)–I(2): 2.7287(13), 
N(2)–C(13): 1.281(15), N(1)–C(13): 1.360(14), I(2)–Sb(1)–I(1): 95.80(5), N(2)–
Sb(1)–I(1): 148.5(2), N(1)–Sb(1)–I(1): 91.1(2), N(1)–Sb(1)–I(2): 99.6(3), N(2)–Sb(1)–
I(2): 86.9(2), N(1)–Sb(1)–N(2): 57.6(3), C(13)–N(2)–Sb(1): 87.1(7), C(13)–N(1)–
Sb(1): 100.5(7), C(14)–N(2)–Sb(1): 149.2(8), C(1)–N(1)–Sb(1): 137.9(7), N(1)–
C(13)–N(2): 114.5(11). 
 
A feature of complexes of the form Sb(DippForm)2X and Sb(DippForm)X2 (X = 
Cl, Br, I) (2.2 – 2.6) is that the formation of the monomeric structures was favoured rather 
than a dimeric structures and showed noticeable asymmetry of the formamidinate binding, 
suggesting that they have reached coordination saturation.  
 
 
 
 
CHAPTER TWO: RESULTS AND DISCUSSION  
 
76 
 
 
 
 2.5 2.6 [Sb{tBuC(NiPr)2}Cl2] [Sb{tBuC(NCy)2}Cl2] [Sb{tBuC(NDipp)2}Cl2] [Sb{nBuC(NiPr)2}Cl2] [Sb(ArNRNAr)I2] Ar = C6H3iPr-2,6; R = NCy2 
Sb-N1 2.091(2) 2.111(11) 2.101(16) 2.220(17) 2.104(2) 2.205(3) 2.230(2) 
Sb-N2 2.435(2) 2.457(9) 2.190(17) 2.102(16) 2.305(19) 2.116(2) 2.123(2) 
N1–C13 1.348(3) 1.360(14) 1.352(2) 1.320(3) 1.361(3) 1.319(4) 1.349(3) 
N2–C13 1.295(3) 1.281(15) 1.320(2) 1.366(3) 1.323(3) 1.346(4) 1.374(3) 
Sb-X1 2.598(13) 2.821(13) 2.403(6) 2.611(6) 2.366(8) 2.673(9) 2.907(6) 
Sb-X2 2.517(7) 2.728(13) 2.643(6) 2.398(6) 2.473(7) 2.412(9) 2.743(6) 
N1–Sb–N2 58.20(7) 57.60(3) 60.69(6) 60.41(6) 59.21(8) 60.99(10) 60.85(8) 
N1–C13–N2 114.4(2) 114.5(11) 108.5(16) 108.2(18) 109.0(2) 110.8(3) 108.2(2) 
X1–Sb–X2 94.98(3) 95.80(5) 88.02(2) 87.65(2) 90.27(3) 95.49(7)      87.43(13) 
 
Table 2.6 Selected bond lengths (Å) and angles (°) for complexes: [Sb(DippForm)Br2] (2.5), [Sb(DippForm)I2] (2.6), [Sb{tBuC(NR)2}Cl2] (R = 
iPr, Cy, Dipp),8 [Sb{nBuC(NiPr)2}Cl2]8 and [Sb{NCy2(C6H3iPr-2,6)2}I2].18 
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[Li2I(DippForm)(µ-thf)(thf)2] (2.7)  
 
The lithium iodide adduct [Li2I(DippForm)(µ-thf)(thf)2] crystallised in the 
monoclinic space group P21/n (Table 2.8), with one molecule within the asymmetric 
unit. Examination of the crystal structure in the solid state revealed that the monomeric 
structure of (2.7) featured a six-membered ring made up of one N,N′-formamidinato 
ligand, bridging two lithium centres by bimetallic bridging coordination mode (µ-[κ1-
N: κ1-N']), and to maintain charge balance both lithium atoms pincer a single µ bridged 
iodide anion located between the two adjacent Li ions. The coordination sphere of the 
two lithium centres is accompanied by coordination of a µ bridging thf donor between 
the two lithium centres and a single donating thf molecule is coordinated to each lithium 
cation as shown in (Figure 2.7). An analogous structures were achieved with p-
TolForm44 and MesForm45 ligands, even though with the less steric bulk of the ligand. 
The N,N'–chelating mode is usually observed with Li formamidinate, amidinate, 
guanidinate and β-diketiminate compounds.  
Most of Li(bis(aryl)formamidinate) compounds are synthesised and used in situ during 
salt elimination reactions, and they have widespread synthetic applications.46,47,48 
[Li(DippForm)(THF)2] is an example of these compounds.49 The exact mechanism for 
the formation of (2.7) is illustrated in (Scheme 2.14), and as a result it appears that the 
compound is primary product formed, and it was stable enough to be isolated and 
characterised. There are two relatively short Li-I bond lengths 2.820(8) and 2.783(9) Å 
in [Li2I(DippForm)(µ-thf)(thf)2] comparing with the Li-I bond lengths 2.912(8) and 
2.960(12) Å observed in [(thf)3Li3(µ3-I){(NtBu)3S}].50 The delocalisation of the 
anionic charge across the formamidinate backbone NCN in (2.7) is indicated by 
virtually identical C–N bonds 1.315(5) and 1.313(5) Å (Figure 2.7). The N–C–N bond 
angle of 124.2(4)° was bigger than what is usually stated for Li amidinate complexes 
displaying η2-chelating mode such as the N–C–N bond angle of 122.01(15)° reported 
for [Li(DippForm)(PMDETA)] and 120.0(2)° for [Li(DippForm)(THF)2].49 The Li–N 
distances are found to be 1.971(8) and 2.003(8) Å, which are in the typical range of Li–
N bond lengths.49  
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The Li–I–Li bond angle in (2.7) is 59.2(2)°, which is significantly smaller than 
the Li–I–Li bond angle (83.0(5)°) reported for [2,6-Pmp2C6H3Cd(µ3-I)2{Li(THF)}]2,51 
while it is slightly smaller than the average Li–I–Li bond angle (57.7(1)°) reported for 
[(ad)(SiMe3)N]2Li3(μ3-I)(thf)2 (ad = adamantyl).52 The formation of formamidinate 
bridged monomers have been commonly observed for lithium complexes involving 
formamidinate ligands (Scheme 2.17).49    
 
 
 
 
 
 
 
 
 
Scheme 2.17. Molecular structure of a: [Li2(p-TolForm)2(µ-THF)(THF)2] and b: 
[Li2(p-TolForm)3]‾.49 
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Figure 2.7. Molecular structure of monomeric [Li2I(DippForm)(µ-thf)(thf)2] (2.7) 
with the atom numbering system; thermal ellipsoids are drawn at the 50 % probability 
level, and hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and 
angles (°): Li(1)–N(1): 1.971(8), Li(2)–N(2): 2.003(8), Li(1)–I(1): 2.820(8), Li(2)–I(1): 
2.783(9), N(2)–C(13): 1.315(5), N(2)–C(14): 1.432(5), N(1)–C(13): 1.313(5), N(1)–
C(1): 1.427(5), O(2)–Li(2): 2.128(9), O(2)–Li(1): 2.105(8), O(1)–Li(1): 1.940(8), 
O(3)–Li(2): 1.901(9), I(1)–Li(1)–N(1): 113.6(3), I(1)–Li(2)–N(2): 112.7(4), N(1)–
C(13)–N(2): 124.2(4), Li(2)–I(1)–Li(1): 59.2(2), Li(1)–O(2)–Li(2): 81.6(3), C(14)–
N(2)–Li(2): 120.3(3),  C(13)–N(2)–Li(2): 122.7(3), C(1)–N(1)–Li(1): 114.4(3), C(13)–
N(1)–Li(1): 125.4(3), O(2)–Li(2)–I(1): 92.5(3), O(3)–Li(2)–I(1): 113.6(4), O(3)–
Li(2)–O(2): 107.2(4), O(3)–Li(2)–N(2): 120.8(4), N(2)–Li(1)–I(1): 92.0(3), O(1)–
Li(1)–I(1): 107.4(4), O(1)–Li(1)–O(2): 114.5(4), O(1)–Li(1)–N(1): 122.1(4), N(1)–
Li(1) –O(2): 103.2(4). 
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[Sb(DippForm)(NSiMe3)]2 (2.8)  
 
The Sb+3 complex [Sb(DippForm)(NSiMe3)]2 (2.8) crystallised as a solvent free 
product in the triclinic space group P-1 (Table 2.8), with one molecule within the 
asymmetric unit. No significant intermolecular contacts were observed. X-ray 
determination for the structure in the solid state revealed that the complex is dimer 
resides on an inversion centre at centre of the Sb2N2 ring, more specifically the 
inversion centre located at the midpoint of the Sb(1)···Sb(1)# vector. The whole 
molecule generated by the symmetry operation 11-X,1-Y,1-Z as depicted in (Figure 
2.8).  
The two [Sb(DippForm)(NSiMe3)] units are joined through N atoms from 
symmetrical bridging silyl amide moieties and one nitrogen bridging terminal 
DippForm ligand, giving the antimony atom a coordination number of three and a 
stereochemistry best described as distorted trigonal pyramidal with a stereochemically 
active lone pair residing in a fourth coordination site (Scheme. 2.18). Generally, the 
cationic charge of +3, from each Sb3+ ion in the dimer is balanced by a (‒1) charge 
detected for terminal formamidinate ligand, and a (‒2) charge for bridged silyl amide 
moiety [N(SiMe3)]2-.Thus, the Sb2N2 ring in (2.8) is planar with a slight difference 
between bond lengths of Sb1-N3 2.057(12) and Sb1-N3# 2.071(12) Å, adopting the 
trans configuration with respect to the capped monodentate DippForm ligand. The 
N3−Sb1−N3# bond angle of 81.7(5)° was significantly smaller compared with the 
Sb1−N3#−Sb1# angle of 98.3(5)° (Figure 2.8). The N1−Sb1−N3 and N1#−Sb1#−N3# 
angles were found between 98.2(4) and 103.0(5)°, which is similar to the angles N−P−O 
(97.6 and 103.7°) reported in the structure of [RfOP(μ-NSiMe3)]2.12  
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Scheme 2.18 Diagram of the dinuclear antimony (III) complex (2.8). 
 
The Sb-N bond length associated with the DippForm of (2.8) was found to be 
2.150(12) Å, while Sb-N bond length that belongs to the SiMe3 moiety was 2.057(12) 
Å, which is slightly longer than the Sb–N bond length (2.033 Å) reported for 
[Ter(Me3Si)N-SbCl2] (Ter = terphenyl = 2,6-bis(2,4,6-trimethyl-phenyl)phenyl),11 
presumably due to steric demand differences. Whereas, it is not surprisingly almost the 
same as the Sb–N bond length (2.059(2) Å) reported for [Mes*{Me2(Cl)Si}N-
Sb(Cl)Me] (Mes* = supermesityl = 2,4,6-tri-tert-butylphenyl).11 The Sb–N bond 
distance 2.057(12) Å in respect to the SiMe3 moiety of (2.8) was in close proximity into 
the Ga–N bond distance 1.989(5) Å in a known four-coordinate Ga of 
[(Me3Si)2NSbCl][(Me3Si)2N(GaCl3)2],11 in spite of metals size differences. 
The Sb–N(SiMe3) bond length is found to be 2.057(12) Å, which is in the typical 
range found for Sb–N single bonds. For example, (Sb–N) = 2.056(3) in Mes*N(SiMe3)–
SbCl2,53 2.092(2) in [tBuC(iPrN)2]Sb(N3)2,54 ((∑rcov (Sb–N) = 2.11 Å).28  However, the 
N(SiMe3) group in (2.8) is covalently bound to the antimony centre. The Si–N bond 
length found to be 1.715(13) Å ((∑rcov (Si–N) = 1.87 Å).28   
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Figure 2.8. Molecular structure of dimeric [Sb(DippForm)(NSiMe3)]2 (2.8) with the 
atom numbering system; thermal ellipsoids are drawn at the 50 % probability level, and 
hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and angles 
(°): Sb(1)–N(3): 2.057(12), Sb(1)–N(3)#: 2.070(12), Sb(1)–N(1): 2.150(12), N(3)–
Si(1): 1.715(13), Si(1)–C(26): 1.842(17), Si(1)–C(27): 1.838(15), Si(1)–C(28): 
1.866(18), N(2)–C(13): 1.285(18), N(2)–C(14): 1.412(16), N(1)–C(13): 1.359(18), 
N(1)–C(1): 1.420(17), N(1)–Sb(1)–N(3): 103.0(5), N(3)–Sb(1)–N(3)#: 81.705(5), 
N(1)–Sb(1)–N(3)#: 98.2(5), Sb(1)–N(3)–Sb(1)#: 98.295(7), N(3)–Si(1)–C(26): 
110.8(7), N(3)–Si(1)–C(27): 113.7(7), N(3)–Si(1)–C(28): 107.0(7), Si(1)–N(3)–Sb(1): 
132.5(7), C(13)–N(1)–Sb(1): 105.5(9), C(1)–N(1)–Sb(1): 129.1(9), N(2)–C(13)–N(1): 
117.6(13).  
# = Atoms generated by symmetry: 11-X,1-Y,1-Z.  
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 2.8 [Ter(Me3Si)N-SbCl2] Ter(Me3Si)N–Sb(OtBu)2 Ter(Me3Si)N–Sb(N3)2 (Me3Si)2N–SbCl2 [(Me3Si)2NSbCl][(Me3Si)2N(GaCl3)2] 
Sb-N(SiMe3) 2.057 2.033(3) 2.033(1) 2.013(2) 2.002(2) 1.953(5) 
N-Si 1.715(13) 1.783(4) 1.770(1) 1.782(2) 1.767(3) –1.776(3) 1.868(7) –1.715(7) 
Sb–N–Si 132.5(7) 126.1(2) 121.7(6) 125.1(1) 113.5(13) –124.9(14) 109.7(3) –132.3(4), 
 
Table 2.7 Selected bond lengths (Å) and bond angles (°) for [Sb(DippForm)N(SiMe3)]2 (2.8) and literature aminostibane complexes 
[Ter(Me3Si)N-SbCl2], Ter(Me3Si)N–Sb(OtBu)2, Ter(Me3Si)N–Sb(N3)2, (Me3Si)2N–SbCl2, [(Me3Si)2NSbCl][(Me3Si)2N(GaCl3)2].11 
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Table 2.8 Crystallographic data for compounds (2.5 - 2.8). 
 
Compound 2.5 2.6 2.7 2.8 
Formula C25H35Br2N2Sb C25H35I2N2Sb C37H59ILi2N2O3 C56H88N6Sb2Si2 
Fw 645.12 739.12 720.67 1145.05 
crystal system triclinic triclinic monoclinic triclinic 
space group P-1 P-1 P21/n P-1 
a, Å 10.105(2) 10.4137(4) 9.7157(7) 9.7000(19) 
b, Å 10.332(2) 10.5559(4) 18.4703(13) 11.793(2) 
c, Å 14.240(3) 14.6097(5) 22.9728(15) 14.246(3) 
α, deg 96.69(3) 95.876(2) 90 74.24(3) 
β, deg 103.93(3) 104.946(2) 94.165(4) 70.22(3) 
γ, deg 111.72(3) 111.754(2) 90 73.62(3) 
V, Å3 1305.2(5) 1405.64(9) 4111.6(5) 1443.0(6) 
Z 2 2 4 2 
T, K 293(2) 296(2) 296.15 100.15 
no. of rflns collected 23525 35754 75506 12213 
no. of indep rflns 6299 6393 12018 4429 
Rint 0.0324 0.0773 0.1342 0.0234 
Final R1 values (I > 2σ(I)) 0.0283 0.0710 0.0698 0.0950 
Final wR(F2) values (I >2σ(I)) 0.0755 0.2050 0.1614 0.2892 
Final R1 values (all data) 0.0291 0.0884 0.2143 0.0954 
Final wR(F2) values (all data) 0.0760 0.2263 0.2284 0.2892 
GooF (on F2) 1.077 1.039 0.910 1.255 
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[SiMe3(DippForm)] (2.9)  
 
Si+4 complex [SiMe3(DippForm)] (2.9) was isolated by fractional crystallisation 
from the mother liquor of (2.8) as another component of the Schlenk equilibrium involving 
Dippform ligand. Compound (2.9) crystallised in the monoclinic space group P21/c (Table 
2.9), with one molecule within the asymmetric unit. The monomeric unit of the four-
coordinate Si metal centre displays tetrahedral geometry and is coordinated by one 
monodentate Dippform ligands through the nitrogen donor atom and the other three sites are 
occupied by three methyl groups. Selected bond lengths and angles of (2.9) are showed in 
(Figure 2.9).  
 
Figure 2.9. Molecular structure of a monomeric unit of [SiMe3(DippForm)] (2.9) with 
the atom numbering system; thermal ellipsoids are drawn at the 50 % probability level, 
and hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and angles 
(°):Si(1)–N(1): 1.783(2), Si(1)–C(26): 1.856(3), Si(1)–C(27): 1.860(3), Si(1)–C(28): 
1.860(3), N(2)–C(13): 1.275(3), N(2)–C(14): 1.426(3), N(1)–C(13): 1.373(3), N(1)–
C(1): 1.451(3), N(1)–Si(1)–C(26): 110.30(12), N(1)–Si(1)–C(27): 111.35(12), N(1)–
Si(1)–C(28): 104.90(12), C(13)–N(1)–Si(1): 120.48(17), C(1)–N(1)–Si(1): 124.15(16), 
N(2)–C(13)–N(1): 122.9(2). 
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[SbCl3(Me2NC2H4NMe2)] (2.10)  
 
The incorporation of N,N,N',N'-tetramethylethylenediamine (TMEDA) into 
antinmony chemistry provided typical N-donor binding modes. In the solid state, 
[SbCl3(Me2NC2H4NMe2)] a mononuclear monomeric complex is formed using the 
usually chelating TMEDA ligand. Complex (2.10) crystallised in the monoclinic space 
group P21/c (Table 2.9), with one molecule within the asymmetric unit. The central 
antimony atom is surrounded by the two nitrogens of a chelating (TMEDA) ligand and 
three chloride ligands. The overall geometry of the pentacoordinated Sb metal centre 
can be assigned as distorted square-pyramidal arrangement. An average Sb-N bond 
length: 2.45 Å, range: 2.436(3) – 2.471(4) Å. The Sb atom in (2.10) is bonded to a 
bidentate TMEDA ligand Sb–N 2.436(3) and 2.471(4) Å and three chloride ligands Sb–
Cl 2.5349(11), 2.5859(10) and 2.3956(11) Å with N1–Sb1–N2 bond angle found to be 
74.42(15)°. Slightly longer Sb–N bond distances 2.490(3) and 2.595(3)° with somewhat 
smaller N1–Sb1–N2 71.96(9) bond angle were observed in [Sb(CO2Ph-o-
CO2Me)2(OMe)(tmeda)] complex.55 
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Figure 2.10. Molecular structure of monomeric [SbCl3(Me2NC2H4NMe2)] (2.10) with 
the atom numbering system; thermal ellipsoids are drawn at the 50 % probability level, 
and hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and angles 
(°): Sb(1)–N(1): 2.436(3), Sb(1)–N(2): 2.471(4), Sb(1)–Cl(3): 2.5349(11), Sb(1) –
Cl(2): 2.5859(10), Sb(1)–Cl(1): 2.3956(11), N(1)–C(1): 1.516(7), N(1)–C(2): 1.477(5), 
N(1)–C(3): 1.414(6), N(2)–C(4): 1.572(8), N(2)–C(5): 1.457(6), N(2)–C(6): 1.451(7), 
N(1)–Sb(1)–N(2): 74.42(15), Cl(2)–Sb(1)–Cl(1): 86.55(4), Cl(2)–Sb(1)–Cl(3): 
100.72(4), Cl(1)–Sb(1)–Cl(3): 87.77(4), N(1)–Sb(1)–Cl(1): 83.13(9), N(1)–Sb(1)–
Cl(2): 163.62(10), N(1)–Sb(1)–Cl(3): 91.58(10), N(2)–Sb(1)–Cl(1): 85.27(10), N(2)–
Sb(1)–Cl(2): 92.11(12), N(2)–Sb(1)–Cl(3): 165.00(11), C(1)–N(1)–Sb(1): 113.8(3), 
C(2)–N(1)–Sb(1): 104.5(2), C(3)–N(1)–Sb(1): 109.3(3), C(4)–N(2)–Sb(1): 103.7(3), 
C(5)–N(2)–Sb(1): 104.3(3), C(6)–N(2)–Sb(1): 116.9(3).       
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[(DippForm)ClSb(µ-O)SbCl2(Me2NC2H4NMe2)]2.C6D6 (2.11)  
 
The obtained small offwhite single crystals grown in C6D6 were suitable for 
identification by X-ray diffraction studies, illuminating the establishment of a dinuclear 
oxide complex [(DippForm)ClSb-µ-OSbCl2(Me2NC2H4NMe2)]2.(C6D6). The Sb+3 
complex crystallised in the monoclinic space group P21/c (Table 2.9). Two 
crystallographically independent molecules with similar core coordination geometries 
were present within the asymmetric unit. 
Overall, the molecular structure of the dineclear (2.11) complex was 
undoubtedly asymmetrical, showing an oxygen associated as a bridge between the two 
antimony atom centres. One of the Sb metal centre chelated by terminal η2 (N,N') 
DippForm ligand through the nitrogen donor atoms Sb–N (2.153(11) and 2.570(10) Å), 
with one apical chlorine atom Sb–Cl (2.346(5) Å) and a µ oxygen atom with Sb–O 
distance of 1.979(9) Å giving the Sb a coordination number of four and geometry best 
described as a distorted tetrahedron (considering DippForm to occupy a single 
coordination site at the mid-point of the N–N vector). While the other Sb atom 
in (2.11) is bonded to a bidentate TMEDA ligand Sb–N (2.259(13) and 2.535(15) Å), 
two chloride ligands Sb–Cl (2.795(4) and 2.484(5) Å) and a µ oxygen atom with Sb–O 
distance of 1.923(9) Å (Fig. 2.11), giving the Sb a coordination number of five, and 
stereochemistry best described as a distorted trigonal bipyramid. Complex (2.11) had 
one C6D6 molecule filling the space in the X-ray crystal structure lattice. Furthermore, 
the structure had two transoid angles of Cl(2)–Sb(2)–Cl(3) 96.24(18)◦ and Cl(1)–
Sb(1)–N(2) 95.47(3)◦. Slightly longer Sb–N bond distances of 2.490(3) and 2.595(3), 
with a smaller N–Sb–N 71.96(9) bond angle and a similar Sb–O bond distance of 
1.951(2) were observed in [Sb(CO2Ph-o-CO2Me)2(OMe)(tmeda)] complex,55 In fact, 
attempt to deliberate synthesise (2.11) was impossible, as only starting materials 
isolated and could be identified by 1H-NMR spectra. However, the obtained complex 
showed how the steric protection offered by DippForm ligand governs the nuclearity of 
the product and affords monomers. The average Sb–N bond lengths in (2.10) and (2.11) 
were found to be 2.45 Å, 2.37 Å respectively. The average N–Sb–N bond angles of 
(Me2NC2H4NMe2) in (2.10) and (2.11) were found to be 74.4 °, 75.8(6)° respectively.  
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Figure 2.11. Molecular structure of monomeric [(DippForm)ClSb(µ-
O)SbCl2(Me2NC2H4NMe2)]2.(C6D6) (2.11) with the atom numbering system; thermal 
ellipsoids are drawn at the 50 % probability level, and hydrogen atoms and lattice C6D6 
have been omitted for clarity. This is one of the two molecules in the asymmetric unit 
and the other molecule is essentially the same. Selected bond lengths (Å) and angles 
(°): Sb(1)–N(2): 2.153(11), Sb(1)–N(1): 2.570(10), Sb(2)–N(3): 2.259(13), Sb(2)–N(4): 
2.535(15), Sb(1)–Cl(1): 2.346(5), Sb(2)–Cl(2): 2.795(4), Sb(2)–Cl(3): 2.484(5), Sb(2)–
O(1): 1.923(9), Sb(1)–O(1): 1.979(9), N(2)–C(13): 1.363(18), N(1)–C(13): 1.371(16), 
N(1)–C(1): 1.451(16), N(2)–C(14): 1.516(17), N(1)–Sb(1)–N(2): 58.29(4), N(3)–
Sb(2)–N(4): 75.84(6), N(2)–C(13)–N(1): 116.79(11), Sb(2)–O(1)–Sb(1): 119.35(5), 
Cl(1)–Sb(1)–N(1): 77.80(3), O(1)–Sb(1)–Cl(1): 98.97(3), N(2)–Sb(1)–Cl(1): 95.47(3), 
Cl(3)–Sb(2)–Cl(2): 96.24(18), Cl(3)–Sb(2)–N(4): 95.18(5), O(1)–Sb(2)–Cl(3): 
85.06(3), N(3)–Sb(2)–Cl(3): 165.66(4), O(1)–Sb(2)–Cl(2): 86.94(3), N(4)–Sb(2)–
Cl(2): 165.42(5), N(3)–Sb(2)–Cl(2): 91.11(4), O(1)–Sb(2)–N(4): 85.05(4), O(1)–
Sb(2)–N(3): 83.05(4), C(13)–N(1)–Sb(1): 83.54(7), C(13)–N(2)–Sb(1): 101.35(8), 
C(1)–N(1)–Sb(1): 153.65(9), C(14)–N(2)–Sb(1): 136.23(8), O(1)–Sb(1)–N(1): 
143.4(4), O(1)–Sb(1)–N(2): 86.17(4).  
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[Sb(DippForm)Cl(C6F5)]2.(THF)2  (2.12)  
 
In a simple one–pot synthesis, antimony trichloride, Hg(C6F5)2 and one 
equivalent of DippFormH were stirred in THF for several days. During this, the reaction 
mixture became cloudy as elemental mercury is liberated. A small number of single 
crystals of [Sb(DippForm)Cl(C6F5)]2.(THF)2 were isolated from the filtered reaction 
mixture; thus, the very poor yield disallowed additional characterisation. The antimony 
complex (2.12) crystallised in the triclinic space group P-1 (Table 2.9), with two 
molecules within the asymmetric unit. Compound (2.12) is a centrosymmetric dimer 
species (Scheme 2.19), composed of two [Sb(DippForm)Cl(C6F5)] units. The X-ray 
crystal structure of (2.12) showed a pair of chloro ligands are symmetrically bridging 
between the two antimony centres with the complex coordination sphere consisting of 
one κ1-bound DippForm ligand and one pentafluorophenyl ligand coordinated to each 
Sb metal centre, in addition to two uncoordinated THF molecules per dimer. The 
stereochemistry around each four-coordinate Sb metal centre in the dimer can be best 
described as distorted tetrahedral. Half of the structure was generated by symmetry 
through an inversion centre located at the midpoint of the Sb(1)···Sb(1)# vector.  
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.19 Diagram of dinuclear antimony complex (2.12). 
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Figure 2.12. Molecular structure of dimeric [Sb(DippForm)Cl(C6F5)]2.(THF)2 (2.12) 
with the atom numbering system; thermal ellipsoids are drawn at the 50 % probability 
level, and hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and 
angles (°): Sb(1)–N(1): 2.189(6), Sb(1)–Cl(1): 2.705(16), Sb(1)–Cl(1)#: 2.757(17), 
Sb(1)–C(26): 2.097(7), N(1)–C(13): 1.281(8), N(2)–C(13): 1.314(8), N(1)–Sb(1)–
Cl(1): 91.93(16), N(1)–Sb(1)–Cl(1)#: 91.83(15), N(1)–Sb(1)–C(26): 146.3(2), C(26)–
Sb(1)–Cl(1): 113.6(2), C(26)–Sb(1)–Cl(1)#: 111.0(2), N(1)–C(13)–N(2): 126.3(6).  
# = Atoms generated by symmetry: 12-X,1-Y,-Z; 21-X,1-Y,1-Z 
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Complex (2.12) was the first reported pentafluorophenyl antimony 
formamidinate/amidinate complex, with the Sb–N bond length found to be 2.189(6) Å. 
Antimony (III) complexes containing an aryl ligand such as (2.12) are uncommon, and 
only three structures have been described previously in the literature; (C6F5)3Sb,25 
(C6F5)SbCl2,26 and a carboxylato complex [CH3CO2SbPh4].56  
Replacement of one or more of the chlorine atoms by phenyl groups will give 
[Sb(DippForm)Cl(C6F5)]2.(THF)2, with potential change in antimony Lewis acidity. 
This subject has been little examined, and compounds previously described were very 
hard making sensitive samples of the related antimony (III) species. Because of the lack 
of data in this area, we have systematically examined reaction of SbCl3 with the 
formamidine ligand and bis-pentafluorophenyl mercury, the latter as the source of 
pentafluorophenyl ions, in order to assess the ability of antimony to coordinate variety 
of an inions. The Sb–C distance in (2.12) is value of 2.097 Å, which is shorter than the 
Sb–C bond lengths (2.196 Å) reported for [CH3CO2SbPh4],56 and was also shorter than 
the average value of Sb–C bond lengths (2.170 Å) reported for the well compared 
tris(pentafluorophenyl)stibine Sb(C6F5)3.57  
The Sb–Cl bond lengths of [Sb(DippForm)Cl(C6F5)]2.(THF)2 were found to 
be 2.705(16), 2.757(17) Å for Sb1–Cl1 and Sb1–Cl1# respectively, which are shorter 
than the Sb–Cl bond lengths 2.817(3) and 2.859(3) Å reported for an asymmetric 
chloride bridged dimer [H2L]2[Sb2OCI6]Cl2.58  
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The formation of halide bridged dimers (Figure 2.13) have been more commonly detected 
for haloorganoantimony complexes. Figure 2.13 shows some known halide-bridged dimeric 
and non-dimeric haloorgano Sb+3 and Sb+5 complexes. 5,7,20 
 
 
 
Figure 2.13 Some halide-bridged dimeric and non-dimeric haloorgano Sb+3 and Sb+5 
complexes.5,7,20 
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Table 2.9 Crystallographic data for compounds 2.9 - 2.12 
 
Compound  2.9 2.10 2.11 2.12 
Formula  C28H44N2Si C6H16Cl3N2Sb C34H54Cl3N4OSb2 C70H88Cl2F10N4O2Sb2 
Fw 436.74 344.31 884.70 1520.90 
crystal system monoclinic monoclinic monoclinic triclinic 
space group P21/c P21/c P21/c P-1 
a, Å 13.873(3) 11.140(2) 12.741(3) 12.043(2) 
b, Å 10.859(2) 7.1720(14) 20.780(4) 16.684(3) 
c, Å 18.874(4) 16.159(3) 29.811(6) 19.801(4) 
α, deg 90 90 90 103.49(3) 
β, deg 105.06(3) 106.70(3) 93.53(3) 105.17(3) 
γ, deg 90 90 90 103.72(3) 
V, Å3 2745.6(10) 1236.6(5) 7878(3) 3540.5(15) 
Z 4 4 8 2 
T, K 293(2) 173.15 173.15 293(2) 
no. of rflns collected 29911 14797 96844 58194 
no. of indep rflns 7723 3118 13206 15192 
Rint 0.0936 0.0465 0.2557 0.0243 
Final R1 values (I > 2σ(I)) 0.0779 0.0388 0.0920 0.0712 
Final wR(F2) values (I >2σ(I)) 0.1951 0.0952 0.2311 0.2768 
Final R1 values (all data) 0.1329 0.0395 0.1676 0.0829 
Final wR(F2) values (all data) 0.2280 0.0956 0.2837 0.2834 
GooF (on F2) 1.083 1.050 1.021 2.452 
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Table (2.10) is a summary of all the selected bond lengths for each of the 
obtained mono- and tri-valent antimony compounds. These Sb-N bond lengths are very 
asymmetric. The shortest Sb-N bond length for the trivalent species is observed in the 
four-coordinate [Sb(DippForm)Br2] (2.5) (2.091 Å), while the longest Sb-N bond 
length was observed for the five-coordinate [Sb(DippForm)2Br] (2.3) (2.646 Å).  
In addition to the monomeric forms of the DippForm antimony (III) complexes 
described in this chapter, the bulky steric demand on the ortho-positions of the 
DippForm ligand has showed its ability to adopt a bridging coordination mode forming 
dimers and thus, low and high coordination numbers were achieved.      
  
 2.1 2.2 2.3 2.4 2.5 2.6 2.8 2.11 2.12 
Sb-N1 2.301(9) 2.563(15) 2.576(3) 2.597(4) 2.091(2) 2.111(11) 2.150(12) 2.153(11) 2.168(5) 
Sb-N2 - 2.113(14) 2.113(3) 2.112(4) 2.435(2) 2.457(9) - 2.570(10) - 
Sb-N3 - 2.604(13) 2.646(3) 2.634(3) - - 2.057(12) - - 
Sb-N4 - 2.162(15) 2.158(3) 2.165(4) - - - - - 
 
Table 2.10 Selected bond lengths (Å) for complexes: [Sb2{µ-(DippForm}].(THF)8 
(2.1), [Sb(DippForm)2Cl] (2.2), [Sb(DippForm)2Br] (2.3), [Sb(DippForm)2I] (2.4), 
[Sb(DippForm)Br2] (2.5), [Sb(DippForm)I2] (2.6), [Sb(DippForm)(NSiMe3)]2 (2.8), 
[(DippForm)ClSb(µ-O)SbCl2(Me2NC2H4NMe2)]2.(C6D6) (2.11) and 
[Sb(DippForm)Cl(C6F5)]2.(THF)2 (2.12). 
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2.4 Conclusion 
 
This work is the first contribution to formamidinato-based mono and trivalent 
antimony chemistry. This chapter reported the results of metathesis reactions, which 
produced monomeric structures with the generic formula [Sb(DippForm)3-nXn] (n = 1, 
X = Cl 2.2, Br 2.3, I 2.4; n = 2, X = Br 2.5, I 2.6). Initially, these complexes were 
synthesised by the addition of N,N′-bis(2,6-diisopropylphenyl)formamidine 
(DippFormH), pre-treated with various metal alkyl/halide reagents (n-BuLi, 
LiN(SiMe3)2, NaN(SiMe3)2), to the appropriate SbX3 (X = Cl, Br, I) compounds. 
Reactions using Li(DippForm), in particular with SbCl3, SbBr3 and SbI3 proceeded 
rapidly. In several instances, despite the use of a 3:1 ratio of (DippFormH) to SbX3, only 
mono- and bis-substituted complexes were obtained, which prompted us to deliberately 
synthesise the mono- and bis-substituted complexes. Isolation of an Sb+1 dimeric 
structure of [Sb2{µ-(DippForm}2].(THF)8 was the alternative to an expected Sb+3 
monomeric structure and a deliberate synthesis remains elusive; nevertheless, could be 
corroborated by treatment of DippFormH with NaN(SiMe3)2 followed by the addition 
of the result from this step to the solution of SbCl3 in THF. The dimeric compound 
[Sb(DippForm)(NSiMe3)]2 (2.8) was prepared in an attempt to achieve 
[Sb(DippForm)Br2] (2.5) deliberately using LiN(SiMe3)2 for (DippFormH) 
deprotonation and then combined with SbBr3 and leaving the mixture stirring for 36 h 
at room temperature. The TMEDA solvated monomeric compound 
[SbCl3(Me2NC2H4NMe2)] (2.10) was prepared by performing the reaction in TMEDA 
and isolated as a main product instead of isolation of the anticipated product [Sb 
(DippForm)Cl2] owing to a shift in the Schlenk equilibrium. A shifts in the Schlenk 
equilibrium for most complexes could certainly contribute to isolate low yields. 
Consequently, existent yields in solution are hard determinable since we depended on 
the isolated crystal yields. The dinuclear [(DippForm)ClSb(µ-
O)SbCl2(Me2NC2H4NMe2)]2.(C6D6) (2.11) was isolated by fractional crystallisation 
of [SbCl3(Me2NC2H4NMe2)] (2.10) from C6D6, after retreatment with DippFormH in 
THF. 
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The (µ-Cl)2-bridged dimeric four-coordinate antimony complex 
[Sb(DippForm)Cl(C6F5)]2.(THF)2 (2.12) was gained in an attempt to examine the 
ability of antimony to coordinate variety of an anions by using Hg(C6F5)2 as the source 
of pentafluorophenyl group. Overall, the described results add to the large field of main 
group metal N,N'-chelated compounds by introducing new ligands to antimony 
chemistry. Compounds (2.1 – 2.12), (except 2.7, 2.9 and 2.10) are novel formamidinato 
antimony complexes and show that through manipulation of the halide precursor, 
reaction stoichiometry and reaction conditions diverse reaction products have been 
achieved and much more information has been obtained regarding their structures and 
bonding modes.  
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2.5 Experimental  
 
General Considerations/Air Sensitive Techniques 
 
Antimony complexes described herein are extremely air and/or moisture 
sensitive, thus all manipulations, including synthesis, were performed under oxygen- 
and moisture-free conditions requiring Schlenk-type glassware (flask), using both 
conventional standard Schlenk techniques interfaced to a high vacuum (10−2 Torr) line, 
under an inert atmosphere of dry nitrogen in a glovebox. All glassware were dried at 
120 0C for no less than of 12 h before use, then used immediately from the oven to 
avoid exposure to moisture. 
 Hexane and PhMe were dried and deoxygenated by an LC solvent purification 
system, whereas tetrahydrofuran was purified and deoxygenated by refluxing over and 
fresh distilled from sodium wire/benzophenone ketyl under nitrogen. After distillation 
solvents were stored in vacuum Schlenk flasks and degassed prior to use. The syntheses 
of the formamidine proligand, DippFormH = N,N′-2,6-
diisopropylphenylformamidine,59,60 and Hg(C6F5)261 were according to published 
procedures. Anhydrous SbCl3 and other starting materials such as n-BuLi, LiN(SiMe3)2, 
and NaN(SiMe3)2 were commercially available from Aldrich and were freshly used as 
supplied and unless stated otherwise, without further purification.  
Multinuclear 1H- and 13C-NMR spectra of air and moisture sensitive compounds 
were recorded by J.Young valve inert atmosphere NMR tubes protecting the sample 
from air at 25 0C on a Bruker AVANCE III HD 400 MHz spectrometer instrument. The 
chemical shifts were expressed in parts per million (ppm). 1H-NMR resonances were 
referenced against residual H in C6D6 (δ = 7.15), while 13C-NMR resonances were 
referenced to the deuterated C6D6 solvent (δ = 128.39). Perdeutero-benzene (C6D6) (all 
≥ 99 atom % D) as solvent for NMR spectroscopy was obtained from Sigma-Aldrich, 
and was degassed, pre-dried over sodium metal for 24 h, then distilled under an 
atmosphere of nitrogen before being stored in a resealable greaseless Schlenk flask 
prior to use.  
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Infrared spectra were obtained from samples in Nujol mulls between NaCl 
plates, with a Nicolet-Nexus FTIR spectrophotometer within the range (ύ = 4000 - 400 
cm-1). Samples were sent in sealed glass pipettes under nitrogen to the Microanalytical 
Laboratory service, Science Centre, London Metropolitan University, England, for 
elemental analyses (C,H,N) on the bulk material. Melting points were determined in 
sealed glass capillaries under nitrogen and were uncalibrated.  
 
Synthesis by metalation reactions in THF/PhMe or hexane 
[Sb2{µ-(DippForm}2].(THF)8 (2.1)   
 
A solution of Na(DippForm), prepared from DippFormH (1.08 g, 3.0 mmol) and 
NaN(SiMe3)2 (0.6 M solution in PhMe, 1.8 ml, 3.0 mmol) in THF (5 ml), was added 
dropwise through a cannula to a solution of SbCl3 (0.22 g, 1.0 mmol) in THF (10 ml) 
at _ 78 0C while stirring. The solution adopted a dark green colour after 5 minutes. To 
ensure completion of the reaction, the suspension was stirred for 5 h and allowed to 
warm to ambient temperature, and continued to be stirred for 18 h. The solution was 
filtrated and concentrated under vacuum to the point of crystallisation ca.5 ml, then 
slow cooling to _ 30 0C overnight gave light orange block - shaped crystals of (2.1). The 
crystals were dried in vacuo after separation from the mother solution via syringe. Yield 
= 0.66 g (62 %).  
2.1: M.P. 210-212 0C. 1H-NMR (400 MHz, C6D6, 25 0C) for [Sb2{µ-
(DippForm}].(THF)8 losing 2(THF): δ (ppm) = 1.12 (d, J = 6.7 Hz, 48H, CH(CH3)2), 
1.34 (m, 24H, CH2-thf), 3.42 (sept, 8H, CH(CH3)2), 3.64 (m, 24H, OCH2-thf), 6.98 (m, 
4H, p-ArH), 7.06 (m, 8H, m-ArH), 10.60 (s, 2H, NC(H)N); 13C-NMR (101 MHz, C6D6, 
25 0C): δ (ppm) = 23.84 (CH3-iPr), 25.12 (CH2-thf) 28.51 (CH-iPr), 66.50 (OCH2-thf), 
123.37 (p-C), 126.20 (m-C), 127.70 (o-C), 143.16 (N-C), 157.39 (NCN); Elemental 
analysis calcd. (%) for C82H134N4O8Sb2 (M = 1547.51 g/mol): C 63.64, H 8.72, N 3.62. 
Calcd (%) for C50H70N4Sb2 (970.65 g/mol after loss of all THF solvation): C 61.87, H 
7.26, N 5.77; found: C 58.61, H 7.22, N 3.57, showing low carbon and nitrogen 
percentage. IR (υ/cm-1, Nujol mull): 2923 (s), 2728 (w), 2364 (m), 2183 (m), 1926 (s), 
1861 (s), 1792 (s), 1668 (m), 1581 (m), 1462 (s), 1377 (s), 1257 (m), 1182 (m), 1093 
(m), 930 (s), 823 (w), 721 (s), 672 (m).  
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[Sb(DippForm)2Cl] (2.2)   
 
A solution of Li(DippForm), prepared from DippFormH (0.72 g, 2.0 mmol) and 
LiN(SiMe3)2 (1 M solution in thf, 2.0 ml, 2.0 mmol) in THF (20 ml), was added 
dropwise through a cannula to a solution of SbCl3 (0.22 g, 1.0 mmol) in THF (10 ml) 
at room temperature with stirring. The reaction progressed smoothly, changing the 
colour of the solution to a pale yellow within seconds of combination between 
Li(DippForm) and SbCl3 in THF. The reaction mixture continued to be stirred for two 
days at ambient temperature. The solvent was evaporated under vacuum to the point of 
dryness and PhMe (20 ml) added. The mixture was then filtered to remove LiCl. The 
solvent was then concentrated under reduced pressure, then slowly cooled at ‒ 30 0C, 
whereupon light colourless block crystals deposited. The composition was determined 
as [Sb(DippForm)2Cl] (2.2) by X-ray crystallography. Yield = 0.43 g (60 %).  
2.2: M.P. 198-200 0C. 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 1.13 (d, J = 6.8, 
48H, CH(CH3)2), 3.44 (sept, 8H, CH(CH3)2), 6.91 (m, 4H, p-ArH), 7.03 (m, 8H, m-
ArH), 10.93 (s, 2H, NC(H)N); 13C-NMR (101 MHz, C6D6, 25 0C): δ (ppm) = 23.47 
(CH3-iPr), 28.17 (CH-iPr), 123.47 (p-C), 126.12 (m-C), 139.29 (o-C), 143.65 (N-C), 
155.62 (NCN); Elemental analysis calcd. (%) for C50H70ClN4Sb (M = 884.32 g/mol): 
C 67.91, H 7.98, N 6.34; found: C 67.49, H 7.83, N 6.20. IR (υ/cm-1, Nujol mull): 2922 
(m), 2727 (w), 2166 (w), 2097 (m), 2060 (m), 2008 (vs), 1926 (s), 1862 (s), 1796 (s), 
1734 (vs), 1666 (s), 1640 (w), 1586 (s), 1464 (vs), 1454 (vs), 1377 (s), 1294 (w), 1232 
(m), 1184 (m), 1156 (m), 1097 (s), 1057 (s), 1011 (s), 956 (s), 934 (s), 881 (m), 821 (s), 
798 (s), 721 (s), 672 (s), 474 (w).  
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[Sb(DippForm)2Br] (2.3)   
 
Following the same method to that employed for synthesis (2.2), LiN(SiMe3)2 (1 M 
solution in thf, 6.0 ml, 6.0 mmol) was added to DippFormH (2.16 g, 6.0 mmol) in THF 
(20 ml) and the solution stirred at room temperature for 2 h, then added dropwise to 
SbBr3 (1.8 g, 3.0 mmol) in PhMe (10 ml) at _ 78 0C. After warming to room temperature, 
the mixture was stirred for 36 h to yield a yellow-brown solution with a white 
precipitate. Volatiles were removed under reduced pressure, and the residue extracted 
with hexane (30 ml). Filtration and concentration followed by slowly cooling to _ 30 0C 
overnight led to isolation of Sb+3 mononuclear structure [Sb(DippForm)2Br]. Large 
yellow crystals of (2.3) were grown upon standing for one week. Yield = 1.73 g (80 %). 
2.3: M.P. 168-170 0C. 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 1.15 (d, J = 6.8 
Hz, 48H, CH(CH3)2), 3.45 (sept, 8H, CH(CH3)2), 6.99 (m, 4H, p-ArH), 7.03 (m, 8H, 
m-ArH), 8.04 (s, 2H, NC(H)N); 13C-NMR (101 MHz, C6D6, 25 0C): δ (ppm) = 25.58 
(CH3-iPr), 29.60 (CH-iPr), 123.98 (p-C), 124.37 (m-C), 141.16 (o-C), 145.66 (N-C), 
161.27 (NCN); Elemental analysis calcd. (%) for C50H70BrN4Sb (M = 928.80 g/mol): C 
64.60, H 7.64, N 6.02; found: C 64.85, H 7.79, N 5.97. IR (υ/cm-1, Nujol mull): 2922 
(m), 2722 (vs), 2665 (m), 2599 (vs), 2482 (vs), 2359 (s), 2290 (s), 2193 (s), 2122 (vs), 
2060 (vs), 2001 (s), 1976 (s), 1929 (s), 1864 (s), 1793 (s), 1776 (vs), 1699 (vs), 1587 
(w), 1454 (m), 1380 (m), 1259 (m), 1097 (m), 1056 (s), 987 (s), 797 (s), 694 (s), 608 
(s), 590 (s), 537 (s). A reaction stoichiometry of 2:1 (Li-DippForm:Sb) gave (2.3) as 
the sole identifiable Sb-containing product. 
 
[Sb(DippForm)2I] (2.4)   
 
LiN(SiMe3)2 (1 M solution in thf, 2.0 ml, 2.0 mmol) was added to DippFormH (0.72 g, 
2.0 mmol) in THF (20 ml) and the solution stirred at room temperature for 2 h, then 
added dropwise to SbI3 (0.50 g, 1.0 mmol) in THF (10 ml) at _ 78 0C. After warming to 
room temperature, the mixture was stirred for 36 h to yield a yellow solution. The 
solvent was removed under reduced pressure and PhMe (20 ml) added until a white 
precipitate composed. The mixture was then filtered to remove LiCl.  
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The solvent was then concentrated, and storage at ‒ 30 0C for 12 hour, whereupon small 
yellow-white crystals of (2.4) separated from the brown solution and grew upon 
standing after two days. Yield = 0.54 g (75 %).  
2.4: M.P. 188-190 0C. 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 1.15 (d, J = 6.6 Hz, 
48H, CH(CH3)2), 3.42 (sept, 8H, CH(CH3)2), 6.98 (m, 4H, p-ArH), 7.06 (m, 8H, m-
ArH), 7.86 (s, 2H, NC(H)N); 13C-NMR (101 MHz, C6D6, 25 0C): δ (ppm) = 23.71 (CH3-
iPr), 28.39 (CH-iPr), 123.47 (p-C), 123.55 (m-C), 144.20 (o-C), 145.84 (N-C), 155.54 
(NCN); Elemental analysis calcd. (%) for C50H70IN4Sb (M = 975.79 g/mol): C 61.56, 
H 7.18, N 5.74; found: C 53.03, H 6.32, N 4.94 (significantly low in the C percentage). 
IR (υ/cm-1, Nujol mull): 2915 (w), 2722 (vs), 2665 (m), 2594 (vs), 2544 (m), 2487 (m), 
2460 (vs), 2398 (m), 2287 (m), 2187 (s), 2127 (w), 2082 (vs), 2001 (s), 1971 (s), 1928 
(s), 1865 (s), 1793 (s), 1736 (w), 1704 (s), 1583 (w), 1462 (m), 1378 (m), 1043 (m), 
987 (m), 820 (m), 723 (s), 694 (s), 607 (s), 590 (s), 537 (s), 411 (w). A reaction 
stoichiometry of 2:1 (Li(DippForm):Sb) gave (2.4) and Li(DippForm). 
 
[Sb(DippForm)Br2] (2.5)  
 
[Sb(Dipp)2Br] (2.3) prepared previously (0.92 g, 1.0 mmol) was reacted with SbBr3 
(0.36 g, 1.0 mmol) in THF (20 ml) at room temperature with stirring. The reaction was 
continued for 8 h at room temperature; volatiles were removed under vacuum. The 
orange solution was concentrated to ca. 10 ml and set aside for 1 day at 15 0C, yielding 
cubic shiny yellow crystals of (2.5). Yield = 0.30 g (32 %).  
2.5: M.P. 170-172 0C. 1 H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 1.21 (d, J = 6.9 
Hz, 24H, CH(CH3)2), 3.33 (sept, 4H, CH(CH3)2), 6.88 (m, 2H, p-ArH), 7.08 (m, 4H, 
m-ArH), 7.56 (s, 1H, NC(H)N); 13C-NMR (101 MHz, C6D6, 25 0C): δ (ppm) = 24.60 
(CH3-iPr), 29.13 (CH-iPr), 123.52 (p-C), 127.49 (m-C), 137.96 (o-C), 145.53 (N-C), 
159.80 (NCN); Elemental analysis calcd. (%) for C25H35Br2N2Sb (M = 645.12 g/mol): 
C 46.54, H 5.43, N 4.34; found: C 43.13, H 5.19, N 4.22 (low in the C percentage only). 
IR (υ/cm-1, Nujol mull): 2962 (s), 2923 (vs), 2732 (m), 2581 (w), 2393 (s), 2253 (m), 
2166 (w), 2020 (m), 1978 (s), 1949 (s), 1877 (s), 1800 (s), 1731 (m), 1644 (vs), 1593 
(s), 1511 (s), 1462 (s), 1376 (s), 1311 (m), 1257 (s), 1121 (m), 1042 (s), 969 (m), 802 
(m), 763 (s), 676 (w), 627 (w), 426 (w). A reaction stoichiometry of 2:1 (DippForm:Sb) 
gave (2.5) as the sole identifiable Sb-containing product. 
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[Sb(DippForm)I2] (2.6)   
 
LiN(SiMe3)2 (1 M solution in thf, 1.0 ml, 1.0 mmol) was added to DippFormH (0.36 g, 
1.0 mmol) in THF (20 ml) and the solution stirred at room temperature for 2 h, then 
added dropwise to SbI3 (0.5 g, 1.0 mmol) in THF (10 ml) at room temperature. The 
mixture was stirred for 36 h to yield a yellow brown solution. The solution evaporated 
to the point of dryness under vacuum and PhMe (10 ml) added until a white precipitate 
appeared. Volatiles were removed under reduced pressure. Filtration and concentration 
following slow cooling to _ 30 0C overnight yielded shiny brown-orange crystals of the 
expected (2.6). Yield = 0.21 g (58 %).  
2.6: M.P. 156-158 0C. 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 1.11 (d, J = 6.9 
Hz, 24H, CH(CH3)2), 3.22 (sept, 4H, CH(CH3)2), 6.76 (m, 2H, p-ArH), 6.99 (m, 4H, 
m-ArH), 8.31 (s, 1H, NC(H)N); 13C-NMR (101 MHz, C6D6, 25 0C): δ (ppm) = 25.43 
(CH3-iPr), 29.21 (CH-iPr), 123.95 (p-C), 124.38 (m-C), 137.98 (o-C), 145.50 (N-C), 
158.89 (NCN); Elemental analysis calcd. (%) for C25H35I2N2Sb (M = 739.12 g/mol): C 
40.61, H 4.73, N 3.79; found: C 27.47, H 4.92, N 2.91 (low in C and N percentage). IR 
(υ/cm-1, Nujol mull): 2923 (s), 2853 (vs), 2727 (m), 2663 (w), 2411 (m), 2356 (s), 2290 
(m), 1936 (s), 1870 (vs), 1632 (m), 1588 (vs), 1462 (vs), 1376 (s), 1260 (vs), 1168 (vs), 
1074 (m), 911 (s), 885 (m), 849 (s), 722 (s), 666 (s). A reaction stoichiometry of 1:1 
(LH: Sb) gave (2.6) as the sole identifiable Sb-containing product. 
 
[Li2I(DippForm)(µ-thf)(thf)2] (2.7)  
 
Complex (2.7) was prepared through attempting to gain [Sb(DippForm)3] by 
recrystalisation from PhMe. LiN(SiMe3)2 (1 M solution in thf, 3.0 ml, 3.0 mmol) was 
added to DippFormH (1.08 g, 3.0 mmol) in THF (20 ml) and the solution stirred at room 
temperature for 2 h, then added dropwise to SbI3 (0.50 g, 1.0 mmol) in THF (10 ml) at 
room temperature. The mixture was stirred for 16 h to yield a yellow-brown solution. 
The solution evaporated to the point of dryness under vacuum and PhMe (10 ml) added, 
whereupon a white precipitate formed. Filtration and the solvent was then concentrated 
under vacuum to ca.5 ml and left overnight at room temperature.  
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Big white yellow crystals of [Li2I(DippForm)(thf)3] were grown upon standing for 1 
day. Yield = 0.85 g (78 %).  
2.7: M.P. 220-222 0C. 1H-NMR (400 MHz, C6D6, 25 0C ): δ (ppm) = 1.16 (d, J = 6.7 
Hz, 24H, CH(CH3)2), 2.10 (m, 4H, CH2-thf), 3.43 (sept, 4H, CH(CH3)2), 3.55 (m, 4H, 
OCH2-thf), 6.99 (m, 2H, p-ArH), 7.6 (m, 4H, m-ArH), 7.86 (s, 1H, NC(H)N); 13C-NMR 
(101 MHz, C6D6, 25 0C): δ (ppm) = 24.16 (CH3-iPr), 25.35 (CH2-thf), 28.40 (CH-iPr), 
68.63 (OCH2-thf), 123.61 (p-C), 124.06 (m-C), 140.18 (o-C), 144.19 (N-C), 146.47 
(NCN); 7Li-NMR (156 MHz, C6D6): δ 1.15; Elemental analysis calcd. (%) for 
C37H59ILi2N2O3 (M = 720.67 g/mol): C 61.71, H 8.20, N 3.89; found: C 16.52, H 3.35, 
N 0.1 (significantly low in C,H,N percentage). IR (υ/cm-1, Nujol mull): 2790 (w), 2722 
(m), 2601 (m), 2497 (s), 2415 (s), 2360 (s), 2312 (s), 2270 (s), 2178 (vs), 2109 (w), 
2055 (s),1998 (s), 1973 (s),1921 (vs), 1860 (vs), 1751 (m), 1724 (m),1701 (vs), 1038 
(vs), 988 (s), 673 (m), 506 (s), 405 (m).  
 
[Sb(DippForm)(NSiMe3)]2 (2.8)  
 
LiN(SiMe3)2 (1 M solution in thf, 2.0 ml, 2.0 mmol) was added to DippFormH (0.72 g, 
2.0 mmol) in THF (20 ml) and the solution stirred at room temperature for 2 h, then 
added dropwise to SbBr3 (0.36 g, 1.0 mmol) in THF (10 ml) at room temperature. The 
mixture was stirred for 36 h to yield a yellow brown solution with a white precipitate. 
Volatiles were removed under reduced pressure. Filtration and concentration following 
slow cooling to _ 30 0C overnight yielded slightly unexpected off white crystals of (2.8). 
Yield = 0.32 g (44 %).  
2.8: M.P. 180-182 0C (dec). 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 0.32 (s, 18H, 
Si(CH3)3), 1.16 (d, J = 6.5 Hz, 48H, CH(CH3)2), 3.46 (sept, 8H, CH(CH3)2), 6.95 (m, 
4H, p-ArH), 7.08 (m, 8H, m-ArH), 8.29 (s, 2H, NC(H)N); 13C-NMR (101 MHz, C6D6, 
25 0C): δ (ppm) = _ 0.018 (Si(CH3)3), 23.86 (CH3-iPr), 28.25 (CH-iPr), 123.31 (p-C), 
123.47 (m-C), 143.53 (o-C), 145.95 (N-C), 152.60 (NCN); Elemental analysis calcd. 
(%) for C56H88N6Sb2Si2 (M = 1145.05 g/mol): C 58.77, H 7.69, N 7.34; found: C 59.36, 
H 7.63, N 7.04. IR (υ/cm-1, Nujol mull): 2922 (m), 2729 (vs), 2426 (m), 2290 (m), 2092 
(m), 2010 (m), 1929 (s), 1875 (vs), 1808 (vs), 1731 (s), 1670 (m), 1628 (vs), 1586 (s), 
1462 (vs),1377 (s), 1259 (m), 1179 (s), 1097 (vs), 1043 (vs), 958 (m), 934 (s),842 (s), 
799 (s), 753 (s), 722 (s), 672 (s) 622 (m).  
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[SiMe3(DippForm)] (2.9)  
 
LiN(SiMe3)2 (1 M solution in thf, 1.0 ml, 1.0 mmol) was added to DippFormH (0.36 g, 
1.0 mmol) in THF (20 ml)  and the solution stirred at room temperature for 2 h, then 
added dropwise to SbBr3 (0.36 g, 1.0 mmol) in PhMe (10 ml) at room temperature. The 
mixture was stirred for 36 h to yield a colourless solution with a white precipitate. 
Volatiles were removed under reduced pressure, and the residue extracted with hexane 
(30 ml). Filtration and concentration following slow cooling to _ 30 0C overnight 
yielded an unexpected white crystals of (2.9). Yield = 0.10 g (27 %).  
2.9: M.P. 138-140 0C. 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 0.41 (s, 9H, 
Si(CH3)3), 1.10 (d, J = 6.9 Hz, 24H, CH(CH3)2), 3.43 (sept, 4H, CH(CH3)2), 6.96 (m, 
2H, p-ArH), 7.04 (m, 4H, m-ArH), 7.21 (s, 1H, NC(H)N); 13C-NMR (101 MHz, C6D6, 
25 0C): δ (ppm) = 0.14 (Si(CH3)3), 24.09 (CH3-iPr), 28.43 (CH-iPr), 123.02, 124.12, 
127.11 (ArC), 147.00 (NCN); Elemental analysis calcd. (%) for C28H44N2Si (M = 
436.74 g/mol): C 77.06, H 10.09, N 6.42; found: C 77.17, H 9.91, N 6.43. IR (υ/cm-1, 
Nujol mull): 2923 (s), 2799 (w), 2658 (w), 2547 (s), 2497 (s), 2384 (s), 2282 (s), 2104 
(m), 2010 (vs), 1971 (vs), 1877 (vs), 1754 (s), 1661 (w), 1590 (m), 1457 (s), 1377 (s), 
1185 (m), 1044 (s), 976 (s), 802 (m), 753 (s), 654 (s), 542 (m), 424 (w).  
 
 
 
[SbCl3(Me2NC2H4NMe2)] (2.10)  
 
n-BuLi (2 M solution in cyclohexane, 1.0 mmol) was added to DippFormH (0.36 g, 1.0 
mmol) in THF (20 ml) and the solution stirred at room temperature for 2 h, then added 
dropwise to a solution of SbCl3 (0.22 g, 1.0 mmol) dissolved in mixture of THF (10 ml) 
and TMEDA (10 ml) at room temperature. The mixture was stirred for 36 h to yield a 
purple solution with a white precipitate. Volatiles were removed under reduced 
pressure. Filtration and concentration following slow cooling to _ 30 0C overnight 
yielded purple crystals of (2.10) suitable for X-ray diffraction. Yield = 0.70 g (60 %).  
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2.10: M.P. 208-210 0C. 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 2.15 (m, 12H, 
CH3-(TMEDA)), 2.31 (m, 4H, CH2-(TMEDA)); 13C-NMR (101 MHz, C6D6, 25 0C): δ 
(ppm) = 45.47 (NCH3-(TMEDA)), 57.55 (NCH2-(TMEDA)); Elemental analysis calcd. 
(%) for C6H16Cl3N2Sb (M = 344.31 g/mol): C 20.93, H 4.65, N 8.14; found: C 20.91, 
H 4.69, N 8.03. IR (υ/cm-1, Nujol mull): 2727 (s), 2667 (w), 2453 (w), 2359 (w), 2025 
(w), 1933 (s), 1851 (m), 1772 (m), 1650 (s), 1591 (s), 1466 (m),1398 (m), 1262 (s), 
1185 (s), 1091 (s), 1039 (C–N) (s), 990 (m), 942 (s),843 (m), 773 (s), 664 (s) 518 (w), 
446 (m), 400 (w).   
 
[(DippForm)ClSb(µ-O)SbCl2(Me2NC2H4NMe2)]2.C6D6 (2.11)  
 
LiN(SiMe3)2 (1 M solution in thf, 1.0 ml, 1.0 mmol) was added to DippFormH (0.36 g, 
1.0 mmol) in THF (20 ml) and the solution stirred at room temperature for 2 h, then 
added dropwise to SbCl3 (0.22 g, 1.0 mmol) dissolved in mixture of THF (10 ml) and 
TMEDA (10 ml) at room temperature. The mixture was stirred for 24 h to yield an off-
white solution with a white precipitate. Volatiles were removed under reduced pressure. 
Filtration and concentration followed slow cooling to _ 30 0C overnight. On the basis of 
NMR spectroscopy scale, experiment in dry C6D6 resulted in growing unexpected off-
white brown crystals of (2.11). Yield = 0.07 g (20 %).  
2.11: M.P. 232-234 0C (dec). 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 1.22 (d, J 
= 6.9 Hz, 24H, CH(CH3)), 2.05 (m, 12H, CH3-(TMEDA)), 2.10 (m, 4H, CH2-
(TMEDA)), 3.41 (sept, 4H, CH(CH3)), 6.92 (m, 2H, p-ArH), 7.09 (m, 4H, m-ArH), 
7.77 (s, 1H, NC(H)N); 13C-NMR (101 MHz, C6D6, 25 0C): δ (ppm) = 23.91 (CH3-iPr), 
28.41 (CH-iPr), 41.62 (NCH3-(TMEDA)), 54.62 (NCH2-(TMEDA)), 122.99 (p-C), 
123.64 (m-C), 140.38 (o-C), 146.03 (N-C), 163.22 (NCN); Elemental analysis calcd. 
(%) for C34H54Cl3N4OSb2 (M = 884.70 g/mol): C 46.15, H 6.15, N 6.33. Calcd (%) for 
C31H51Cl3N4OSb2 (845.64 g/mol after loss of ½ C6D6 solvation upon standing): C 
44.03, H 6.07, N 6.62; found: C 39.75, H 5.96, N 5.85 (low in C percentage). IR (υ/cm 
-1, Nujol mull): 2923 (s), 2853 (s), 2722 (m), 2678 (m), 2445 (m), 2361 (w), 1936 (vs), 
1872 (s), 1800 (vs), 1736 (m), 1662 (s), 1586 (s), 1456 (s), 1376 (s), 1309 (w), 1284 
(s), 1257 (w), 1235 (s), 1178 (s), 1158 (s), 1099 (vs), 1062 (vs), 1002 (s), 933 (vs), 842 
(s), 822 (s),798 (s), 755 (s), 721 (s), 674 (w).  
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Synthesis using Hg(C6F5)2  in THF 
 
[Sb(DippForm)Cl(C6F5)]2.(THF)2  (2.12)  
 
DippFormH (0.36 g, 1.0 mmol), Hg(C6F5)2 (0.25 g, 0.5 mmol) and SbCl3 (0.22 g, 1.0 
mmol) were stirred in THF (20 ml) at room temperature through one pot reaction. An 
immediate colour change to off-white yellow was observed. Stirring was continued for 
2 days; volatiles were removed under vacuum through reducing pressure. The mixture 
was filtered and the volume of the solution was concentrated under vacuum to ca.3 ml 
and set aside for 2 days at -15 0C, yielding the light white crystals suitable for analysis 
by X-ray crystallography, leaving the composition [Sb(DippForm)Cl(C6F5)].(THF)2   
(2.12). Unfortunately, the titled complex C70H88Cl2F10N4O2Sb2 (M = 1520.90 g/mol) 
achieved in a very low yield (5 %), which was characterised by only X-ray structure 
determination and no other analytical data was obtained.  
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2.6      Single crystal X-ray structure determination/analysis and Refinement model 
           description 
Crystals were initially isolated as suitable single crystals immersed in viscous 
hydrocarbon oil (Paratone-N) and mounted on a glass fibre that was placed on the 
diffractometer under a stream of liquid nitrogen. Crystalline samples were measured 
providing intensity data on either a Bruker APEX II CCD diffractometer for complexes 
(2.2, 2.3, 2.4, 2.6, 2.7), or the Australian Synchrotron diffractometer using the MX1 or 
MX2 macromolecular beam lines for complexes (2.1, 2.5, 2.8, 2.9, 2.10, 2.11, 2.12) at 
173 K by a single wavelength (λ = 0.71073 Å). Structure solutions and refinements 
package were performed using SHELXS-97 and SHELXL-97,62,63 program using 
Direct Methods via the graphical interface X-Seed 64 and OLEX2,65 both of which were 
also used for figures’ generating. Absorption improvements using MULTISCAN were 
applied. All CIF files were checked at www.iucr.org. A summary of crystallographic 
data and collection parameters can be found for each compound below. 
 
[Sb2{µ-(DippForm}2].(THF)8 (2.1)  
1: C82H134N4O8Sb2 (M = 1547.514 g/mol): monoclinic, space group P21/c, a = 
21.243(4) Å, b = 18.997(4) Å, c = 21.743(4) Å, α = 90°, β = 118.60(3)°, γ = 90°, Volume 
= 7704(3) Å3, Z = 2(dimer), T = 173.15 K, Dcalc = 1.280 g/cm3, μ = 0.755 mm‑1, F (000) 
= 3124.0, 2Θmax = 2.184 – 63.66°, 71852 reflections collected, 21388 unique (Rint = 
0.0697, Rsigma = 0.0578), 21388/0/845 parameters, GooF on F2 1.198, The final R1 was 
0.1352 (I>2σ (I)) and wR2 was 0.4021 (all data), Largest diff. peak/hole / e = 9.23 to    
- 4.48 Å-3. 
  
[Sb(DippForm)2Cl] (2.2)   
2: C50H70ClN4Sb (M = 884.322 g/mol): monoclinic, space group P21/c, a = 
18.443(4) Å, b = 20.455(4) Å, c = 12.817(3) Å, α = 90°, β = 97.47(3)°, γ = 90°, 
Volume = 4794.3(17) Å3, Z = 4, T = 100.15 K, μ = 0.663 mm-1, Dcalc = 1.128 g/cm3, F 
(000) = 1585.0, 2Θmax = 2.226 – 63.82, 87850 reflections measured, 12579 unique (Rint = 
0.0406, Rsigma = 0.0229), 12579/0/521 parameters, GooF on F2 1.194, The final R1 was 
0.0359 (I >2σ (I)) and wR2 was 0.1321 (all data), Largest diff. peak/hole / e = 1.17 to   
- 3.21 Å-3.  
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[Sb(DippForm)2Br] (2.3)   
3: C50H70BrN4Sb (M = 928.802 g/mol): monoclinic, space group P21/c, a = 
18.7239(14) Å, b = 20.5497(17) Å, c = 12.9785(10) Å, α = 90°, β = 96.886(4)°, γ = 
90°, Volume = 4957.7(7) Å3, Z = 4, T = 296(2) K, μ = 1.397 mm-1, Dcalc = 1.246 g/cm3, 
F (000) = 1940.0, 2Θmax = 2.19 - 50, 63608 reflections measured, 8732 unique (Rint = 
0.1091, Rsigma = 0.0691), 8732/0/522 parameters, GooF on F2 1.009, The final R1 was 
0.0402 (I >2σ (I)) and wR2 was 0.1061 (all data), Largest diff. peak/hole / e = 0.63 to 
- 0.72  Å-3.  
 
[Sb(DippForm)2I] (2.4)   
4: C50H70IN4Sb (M = 975.798 g/mol): monoclinic, space group P21/c, a = 
18.616(2) Å, b = 20.713(2) Å, c = 12.9942(13) Å, α = 90°, β = 96.750(5)°, γ = 90°, 
Volume = 4975.8(9) Å3, Z = 4, T = 296.15 K, μ = 1.210 mm-1, Dcalc = 1.303 g/cm3, F
(000) = 2008.0, 2Θmax = 2.952 - 50, 63063 reflections measured, 8728 unique (Rint = 
0.0889, Rsigma = 0.0688), 8728/0/521 parameters, GooF on F2 0.869, The final R1 was 
0.0468 (I >2σ (I)) and wR2 was 0.1580 (all data), Largest diff. peak/hole / e = 0.86 to 
- 1.23  Å-3.  
 
[Sb(DippForm)Br2] (2.5)  
5: C25H35Br2N2Sb (M = 645.12 g/mol): triclinic, space group P-1, a = 10.105(2) Å, b = 
10.332(2) Å, c = 14.240(3) Å, α = 96.69(3)°, β = 103.93(3)°, γ = 111.72(3)°, Volume = 
1305.2(5) Å3, Z = 2, T = 293(2) K, μ = 4.133 mm-1, Dcalc = 1.642 g/cm3, F (000) = 640.0, 
2Θmax = 4.706 - 63.84, 23525 reflections measured, 6299 unique (Rint = 0.0324, Rsigma = 
0.0280), 6299/0/279 parameters, GooF on F2 1.077, The final R1 was 0.0283 (I >2σ (I)) 
and wR2 was 0.0760 (all data), Largest diff. peak/hole / e = 0.53 to - 1.26  Å-3. 
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 [Sb(DippForm)I2] (2.6)   
6: C25H35I2N2Sb (M = 739.12 g/mol): triclinic, space group P-1, a = 10.4137(4) Å, b = 
10.5559(4) Å, c = 14.6097(5) Å, α = 95.876(2)°, β = 104.946(2)°, γ = 111.754(2)°, 
Volume = 1405.64(9) Å3, Z = 2, T = 296(2) K, μ = 3.191 mm-1, Dcalc = 1.746 g/cm3, F
(000) = 712.0, 2Θmax = 2.958 - 54.996, 35754 reflections measured, 6393 unique (Rint = 
0.0773, Rsigma = 0.0564), 6393/0/279 parameters, GooF on F2 1.039, The final R1 was 
0.0710 (I >2σ (I)) and wR2 was 0.2263 (all data), Largest diff. peak/hole / e = 2.98 to 
- 2.24  Å-3.  
 
[Li2I(DippForm)(thf)3] (2.7)  
7: C37H59ILi2N2O3 (M = 720.67 g/mol): monoclinic, space group P21/n, a = 
9.7157(7) Å, b = 18.4703(13) Å, c = 22.9728(15) Å, α = 90°, β = 94.165(4)°, γ = 90°, 
Volume = 4111.6(5) Å3, Z = 4, T = 296.15 K, μ = 0.810 mm-1, Dcalc = 1.158 g/cm3, F
(000) = 1496.0, 2Θmax = 2.832 - 60.084, 75506 reflections measured, 12018 unique (Rint = 
0.1342, Rsigma = 0.1301), 12018/0/414 parameters, GooF on F2 0.910, The final R1 was 
0.0698 (I >2σ (I)) and wR2 was 0.2284 (all data), Largest diff. peak/hole / e = 0.36 to 
- 1.40 Å-3. 
 
[Sb(DippForm)(NSiMe3)]2 (2.8)  
8: C56H88N6Sb2Si2 (M = 1145.05 g/mol): triclinic, space group P-1, a = 
9.7000(19) Å, b = 11.793(2) Å, c = 14.246(3) Å, α = 74.24(3)°, β = 70.22(3)°, γ = 
73.62(3)°, Volume = 1443.0(6) Å3, Z = 2(dimer), T = 100.15 K, μ = 1.017 mm-1, Dcalc = 
1.318 g/cm3, F (000) = 596.0, 2Θmax = 6.198 - 49.998, 12213 reflections measured, 4429
unique (Rint = 0.0234, Rsigma = 0.0248), 4429/0/305 parameters, GooF on F2 1.255, The 
final R1 was 0.0950 (I >2σ (I)) and wR2 was 0.2892 (all data), Largest diff. peak/hole / 
e = 5.37 to - 2.22 Å-3.  
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[SiMe3(DippForm)] (2.9)  
9: C28H44N2Si (M = 436.74 g/mol): monoclinic, space group P21/c, a = 
13.873(3) Å, b = 10.859(2) Å, c = 18.874(4) Å, α = 90°, β = 105.06(3)°, γ = 90°, 
Volume = 2745.6(10) Å3, Z = 1, T = 293(2) K, μ = 0.102 mm-1, Dcalc = 1.057  g/cm3, F
(000) = 960.0, 2Θmax = 3.04 - 63.946,  29911 reflections measured, 7723 unique (Rint = 
0.0936, Rsigma = 0.0770), 7723/0/291  parameters, GooF on F2 1.083, The final R1 was 
0.0779 ( I >2σ (I)) and wR2 was 0.2280 (all data), Largest diff. peak/hole / e = 0.59 to 
-0.85Å-3.  
 
[SbCl3(Me2NC2H4NMe2)] (2.10)  
10: C6H16Cl3N2Sb (M = 344.31 g/mol): monoclinic, space group P21/c, a = 
11.140(2) Å, b = 7.1720(14) Å, c = 16.159(3) Å, α = 90°, β = 106.70(3)°, γ = 90°, 
Volume = 1236.6(5) Å3, Z = 4, T = 173.15 K, μ = 2.838 mm-1, Dcalc = 1.849 g/cm3, F
(000) = 672.0, 2Θmax = 7.936 - 63.748, 14797 reflections measured, 3118 unique (Rint = 
0.0465, Rsigma = 0.0349), 3118/0/113 parameters, GooF on F2 1.050, The final R1 was 
0.0388 (I >2σ (I)) and wR2 was 0.0956 (all data), Largest diff. peak/hole / e = 1.89 to 
- 0.88 Å-3.  
 
[(DippForm)ClSb(µ-O)SbCl2(Me2NC2H4NMe2)]2.C6D6 (2.11)  
11: C34H54Cl3N4OSb2 (M = 884.70 g/mol): monoclinic, space group P21/c, a = 
12.741(3) Å, b = 20.780(4) Å, c = 29.811(6) Å, α = 90°, β = 93.53(3)°, γ = 90°, 
Volume = 7878(3) Å3, Z = 8, T = 173.15 K, μ = 1.604 mm-1, Dcalc = 1.461 g/cm3, F 
(000) = 3432.0, 2Θmax = 2.39 - 50,  96844 reflections measured, 13206 unique (Rint = 
0.2557, Rsigma = 0.1178), 13206/0/818 parameters, GooF on F2 1.021, The 
final R1 was 0.0920 (I >2σ (I)) and wR2 was 0.2837 (all data), Largest diff. peak/hole / 
e = 3.77 to - 1.31 Å-3. 
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[Sb(DippForm)Cl(C6F5)]2.(THF)2  (2.12)  
12: C70H88Cl2F10N4O2Sb2 (M = 1520.90 g/mol): triclinic, space group P-1, a = 
12.043(2) Å, b = 16.684(3) Å, c = 19.801(4) Å, α = 103.49(3)°, β = 105.17(3)°, γ = 
103.72(3)°, Volume = 3540.5(15) Å3, Z = 2(dimer), T = 293(2) K, Dcalc = 1.413 g/cm3, 
μ = 0.910 mm‑1, F (000) = 1538.0, 2Θmax = 2.246 - 55.882°, 58194 reflections collected, 
15192 unique (Rint = 0.0243, Rsigma = 0.0209), 15192/0/817  parameters, GooF on F2
2.452, The final R1 was 0.0712 (I >2σ (I)) and wR2 was 0.2834 (all data), Largest diff. 
peak/hole / e = 3.40 to  - 1.80 Å-3. 
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Outline 
 
This chapter discusses the synthesis of a series of tri-valent antimony             
N,N′-bis(polyfluorophenyl)ethane-1,2-diaminate complexes. Halo- and nonhalo-
polyfluorophenylamido antimony (III) complexes have been successfully gained and 
fully characterised as monomers in the solid state highlighting a variety of coordination 
modes. Two antimony (III) tetrafluorophenylethylenediaminate complexes were 
isolated by metathesis reactions between SbCl3 and Li(p-HC6F4N(CH2)2NMe2), Li(LMe), 
a common synthetic route to antimony complexes; while the direct reaction between SbCl3 
and p-HC6F4NH(CH2)2NMe2, HLMe was alternative pathway for one complex in this 
chapter. To the best of our knowledge, no examples of antimony compounds supported by 
a mono-anionic N,N-dimethyl-N'-2,3,5,6-tetrafluorophenylethane-1,2-diaminate ligand 
bound to antimony have been previously reported.    
 
The two types of a pro-ligand used in the metathesis reactions within this 
chapter were (p-HC6F4NH(CH2)2NMe2/Et2) (HLMe/Et) (Fig. 3.1). The substituted ligands 
HLMe/Et can be easily synthesised by a slight modification from the published procedure 
(explained in details in the experimental section of this Chapter).1 Syntheses of 
complexes containing these ligands have been reported previously, but with different 
metals across the periodic table allowing for comparisons in this work. 
 
 
 
 
 
 
 
 
     Figure 3.1 Ligand system used in metathesis syntheses (HLMe/Et). 
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3.1  Introduction 
  
Tri-valent antimonial compounds have shown to be promising in the therapy of 
acute promyelocytic leukemia (APL),2 and could have the potential to be 
antileishmanial drugs, and this has stimulated many researchers, including us, in this 
field. The amido–N atoms have the ability to partly saturate the electronic demands of 
a highly Lewis acidic metal centre, and protect most of the coordination sphere around 
the metal.3  
It is believed that the polyfluorophenyl substituents in the chelating 
organoamide ligands enhance the complexes stability against hydrolysis, which is 
essential for biological examination.4,5 Complexes of the type 
[Pt{N(R)CH2CH2NY2}X(py)] (R = polyfluorophenyl (p-HC6F4 or C6F5); Y = Et 
or Me; X = Cl, Br, I) and [Pt{N(R)CH2}2(py)2],6 which have been prepared previously1 
with trans amine ligands and no H atoms on the N donor atoms feature high biological 
activity against a varied cell lines containing cisplatin resistant variants.7,8 Moreover, 
the integration of fluorine atoms is being widely adopted in drug design.9 This 
stabilising effect is due to a combination of electronic and steric factors of the ligand. 
Furthermore, fluorine atoms in the ligand periphery may act as additional donor 
functions in their bidentate amido complex derivatives. Fluorine-mediated interactions 
between polyfluorocarbon groups and metal atoms, –CF–M,10 across the periodic table 
is a rapidly expanding field due to fundamental interest and also as possible precursors 
for C–F activation reactions,11 as –F–M coordination weakens the C–F bond.12 The 
carbon-fluorine bond is considered as one of the strongest single bonds in organic 
chemistry, with typical bond dissociation energies (BDE) of 105.4 kcal/mol.13 This is 
due to fluorine being the most electronegative element in the periodic table.  
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Usually, activation of the C–F bond is more difficult than activation of similar 
C–H bonds (C-H: normally detected at 98.8 kcal/mol), and affords an important 
challenge because of its characteristic strength that comes from thermal stability and 
highest chemical inertness. These properties have attracted studies in this area, as C–F 
moieties are present already in 30 % of agrochemicals and 20 % of pharmaceuticals.14 
On the other hand, these same properties can also present adverse side effects including 
the role of chlorofluorocarbons in the ozone layer and the role of hydrofluorocarbons 
as strong greenhouse gases.15  
The intensity of C–F bond can be measured by the resultant electrostatic/dipole 
interactions between the electropositive Cδ+ atom and electronegative Fδ- atom, giving 
the polar-covalent bond a further ionic character. This polarity prevents the fluorine 
from donating lone pair, and also fluorine overall is a weak coordinator. Furthermore, 
one of the main difficulties in C-F activation chemistry is the isolation and identification 
of the final organic product produced from activation. More specifically, it could be 
more problematical when activation leads to the complete decomposition of the organic 
molecule.16  
Although not observed for the antimony tetrafluorophenylaminoaminate 
complexes, C-F activation of fluorinated aminoamidate ligands has been previously 
observed for HLMe (HLMe = N,N-dimethyl-N'-2,3,5,6-tetrafluorophenylethane–1,2-
diamine) when coordinated to Na and K.16 In the synthesis of [Na(LMe)] and [K(LMe)], HLMe 
was treated with NaN(SiMe3)2 in THF and KN(SiMe3)2 in PhMe respectively. 
Furthermore, the sodium and potassium complexes [Na(LMe)2Na(tmeda)] and 
[K2(LMe)2(tmeda)2],16 prepared by ligand exchange after treating with the TMEDA 
display o-F-M coordination (Scheme 3.1, a and b), proposing that tridentate N,N',F 
coordination may be the main mode for these ligands with electropositive elements.   
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a: [Na(LMe)2Na(tmeda)] 
 
 
b: [K2(LMe)2(tmeda)2] 
 
Scheme 3.1 Synthesis of a: [Na(LMe)2Na(tmeda)] and b: [K2(LMe)2(tmeda)2] by 
treatment of HLMe with  NaN(SiMe3)2 in THF and KN(SiMe3)2 in PhMe in the presence 
                                                                 of TMEDA.16 
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The initial assembled of N,N-dialkyl-N'-2,3,5,6-tetrafluorophenylethane-1,2-
di-aminate ligands in situ was in a template synthesis of platinum (II) complexes 
[Pt(LMe/Et)X(py)] (X= Cl, Br, I) to give probable ‘rulebreaker’ anticancer drugs.6,8 The 
process was a combination between decarboxylation and nucleophilic substitution.17,18 
 
 
     
 
 
 
 
    
 
 
Scheme 3.2 Potential ligand binding mode to Sb. 
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3.2  The current study 
 
This chapter describes the synthesis and characterisation of the first series of 
halo- and nonhalo-organoantimony (III) complexes of the general type [SbLMe3-nCln] (n 
= 2, 1, 0) incorporating a bulky amido fluorine ligand tethered with an amino pendant 
arm, HLMe = p-HC6F4NH(CH2)2NMe2. Although the other type of polyfluorophenylamide 
ligand: HLEt = p-HC6F4NH(CH2)2NEt2 was involved in the experiments of this chapter, no 
compounds were easily isolate. Metathesis and direct reactions were carried out in non-
coordinating solvents, PhMe and hexane, or in a strong electron donor solvent, THF.  
The HLMe/Et pro-ligands attractively features by the existence of many proton 
environments that can be easily interpreted when conducting 1H-NMR spectra. These 
ligands are also rather sterically demanding and has F and Me or Et groups to enhance 
solubility in organic solvents, whereas the N atoms allow a range of structural variation. 
Furthermore, this type of ligand was chosen to be chelated to Sb either through its two 
nitrogen or one nitrogen, as well as potentially o-F–Sb interactions forming a five-
membered chelate ring by a charged amide nitrogen atom together with an amine 
nitrogen atom chelated with two methyl/ethyl group. Perhaps ephemeral Sb–F 
interactions can mostly occur in solution by the two ortho fluorine atoms, even with 
some rotation around the p-HC6F4–N bond. However, the meta fluorine atoms existence 
further away from the antimony atom and characteristically shifted by the p-H 
substituent, as observed in the 19F{1H}-NMR spectra.  
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER THREE: INTRODUCTION  
 
123 
 
 
GLOSSARY OF COMPOUNDS AND CODES 
 
The following simplified diagrams are a summary of the complexes discussed 
throughout this chapter, together with respective codes. These structures show 
antimony atoms in different colours representing the colours of the compounds 
observed in the solid state.  
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3.3       Results and discussion 
  
3.3.1 Synthesis 
 
Preparation of the amine ligand precursors p-HC6F4N(CH2)2NR2 (R = Me, Et) 
(LMe/Et) became more convenient from nucleophilic substitution based on heating to 
reflux the appropriate N,N-dialkylethane-1,2-diamine and pentafluorobenzene in EtOH 
(eqn. 1.3).1,16 Antimony LMe complexes, [Sb(p-HC6F4NC2H4NMe2)Cl2] (3.1), [Sb(p-
HC6F4NC2H4NMe2)2Cl] (3.2) and [Sb(p-HC6F4NC2H4NMe2)3] (3.3), were synthesised 
by two different methodologies: either direct reaction (DR) between SbCl3 and p-
HC6F4NH(CH2)2NR2 (HLMe ) (Scheme. 3.3, i), or by means of metathesis between Li(LMe) 
and SbCl3 (Scheme. 3.3, ii).  
 
 
 
 
 
 
 
Scheme 3.3 Summary of syntheses of tri-valent antimony LMe complexes by either 
direct reaction (DR) (Scheme. 3.3, i), or by metathesis (Scheme. 3.3, ii). 
 
Bright yellow crystals of the tri-valent antimony complex [Sb(LMe)Cl2] (3.1) 
was synthesised in reasonable yield by a straightforward synthetic approach to this class 
of compound. The reaction was between an equivalent molar amount of SbCl3 and HLMe 
in THF. This antimony complex is thermally stable (M.P = 186-192 0C) and even on 
exposure to light, it is robust keeping the same colour both in solution and in the solid 
state. This complex can also be synthesised in a 1:1 molar ratio by metathesis between 
Li(LMe) dissolved in hexane and SbCl3 dissolved in PhMe (Scheme 3.4). 
 
 
 
 
CHAPTER THREE: RESULTS AND DISCUSSION  
 
125 
 
 
 
 
Scheme 3.4 Two routes to synthesise (Sb(LMe)Cl2) (3.1), a: through the formation of 
an intermediate compound Li(LMe) and b: direct path. 
 
Both synthetic approaches gave the desired complexes in reasonable yield 
(Direct: 31%; Metathesis: 35%), but one of the key advantages of DR reactions over 
metathesis is that the synthesis does not require preparation of the air/moisture sensitive 
[Li(LMe)]2 compound, which are often isolated in low yield and impact the purity of the final 
product. On the other hand, although direct reaction was the faster route to (3.1) than the 
metathesis route, it appears that metathesis is the more effective route for other 
antimony complexes (e.g. 3.2, 3.3). It is possible to monitor reactions by 1H-, 7Li- or 
19F{1H}-NMR spectroscopy. [Li(LMe)]2 is synthesised via deprotonation of the HLMe by n-
BuLi in hexane at ‾ 78 0C (Scheme 3.5). The salt metathesis reaction between SbCl3 in 
PhMe and [Li(LMe)]2 in hexane, readily yielded the analogous metal complexes [SbLMe3-
nCln] (n = 2, 1, 0) (Scheme 3.5).  
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Scheme 3.5 Synthesis of [Li(LMe)]2 and subsequently [SbLMe3-nCln] (n = 2, 1, 0). 
 
Following the same technique, the parent amine ligand was first lithiated by n-
BuLi in hexane at low temperature (‾ 78 °C) and the observed lithium precursor Li(LMe) 
was in situ treated with ⅓ molar equivalent of anhydrous SbCl3 in PhMe and stirred for 
several days. The reaction result was the trivalent antimony complex, [Sb(LMe)3] (3.3) 
(Scheme 3.6). Because such complexes would have crowded coordination spheres, it is 
hard to predict their coordination number and whether N,N',F-ligation or even –CF–Sb 
bonding can potentially occur for some or all ligands. In this complex, the metathesis 
reaction appeared complete within 2-3 hours, but the precipitate was required approximately 
two days to settle, and after filtration the solution was immediately left to crystalise. Isolation 
and characterisation required careful handling as the product was very sensitive to moisture 
and easily decomposed. 
 
 
 
 
 
 
 
 
 
Scheme 3.6: Synthesis of complex (3.3). 
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With the challenge to structurally characterise the more crowded antimony N,N-
diethyl- N′-2,3,5,6-tetrafluorophenylethane–1,2-diamine complexes, many attempts were 
made under varying conditions to examine the possibility of the LEt to be coordinated 
with antimony (III), namely to synthesise [SbLEt3-nCln] (n = 2,1,0). Although the 
reactions appeared to be successful with a colour change to deep brown, attempted 
crystallisation of the trivalent species were met with synthetic difficulties and rapid 
decomposition. Antimony (III) diethyl substituted complexes have not been 
synthesised; though, their isolation should be possible, as ytterbium (III) 
polyfluorophenylamidate complex of the type, [Yb(Lᴱᵗ)₃] that has been previously 
isolated.19 [Yb(Lᴱᵗ)₃] displays remarkable structural variances from reported [Ln(Lᴱᵗ)₃] 
(Ln = La, Ce, Nd) complexes,20 and highlights an incomplete shift towards N,N′ 
chelation to the much smaller Yb ion. 
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3.3.2 Characterisation 
 
Two of the products obtained within this chapter (3.2, 3.3) were isolated from 
the reaction mixture by filtration from LiCl, followed by fractional crystallisation from 
PhMe/hexane solution as unsolvated heteroleptic and homoleptic species respectively. 
Compound (3.1) was prepared in THF and for further purification required hexane. All 
the three complexes experience limited solubility in C6D6. Although the 
polyfluorophenylamide ligands can feature tridentate N,N',F chelation, the 
spectroscopic data and structural considerations indicate that none of the four F-donors 
are coordinated to Sb. Where possible, all these isolated compounds (3.1, 3.2 and 3.3) 
were crystallised and characterised by standard analytical techniques. The main 
characterisation was authenticated by X-ray crystallography in the solid state using the 
MX1 beamline at the Australian Synchrotron. Crystal data and refinement details are 
given in (Table 3.5), and in the experimental section. Further characterisation included 
IR spectroscopic (Table 3.1), 1H-NMR (Table 3.2), 19F{1H}-NMR spectroscopy (Table 
3.3), elemental analyses and melting points determination. 
The 19F{1H}-NMR chemical shifts in the N,N-dimethyl-N'-2,3,5,6-
tetrafluorophenylethane-1,2-di-aminate antimony complexes are indicative of the 
coordinative engagement of the ligand; thus, the 19F{1H}-NMR spectra of diamagnetic 
Sb-LMe complexes at a slightly elevated temperature 60 0C showed only two almost equal 
intensity multiple resonances for the ortho (δ = −147.26 – 148.20 ppm) reasonably 
attributable to F2,6; and a signal for the meta F atoms (δ = −140.11−140.95 ppm) 
reasonably attributable to F3,5. The 1H-NMR spectra of diamagnetic Sb LMe complexes 
at room temperature show an absence of a N-H resonance and simple multiple signals 
for the CH2NMe and CH2NAr proton resonances consistent with the single crystal 
compositions in the solid-state structure. For the 1H-NMR spectra, the very low 
solubility required use of slightly elevated temperatures to obtain satisfactory NMR 
spectra. The 1H-NMR spectra were consistent with the proposed composition from X-
ray data without PhMe/hexane or THF of crystallisation. NMR scale studies of the 
decomposition of freshly isolated and pure (3.1-3.3) (in C6D6), showed complete shifts 
of resonances of the 19F{1H}-NMR signals for these compounds over time.  
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The reactions containing Li(p-HC6F4NC2H4NMe2), were monitored by 
19F{1H}-NMR spectroscopy, which indicated the formation of Li-containing products, 
with chemical shifts different from the free ligand over 2 days, none of which could be 
isolated to be identified by X-ray diffraction. It has been noticed that complex [Sb(p-
HC6F4NC2H4NMe2)2Cl] (3.2) has been gained with the highest yield (70 %).  
The 1H-spectrum of [Sb(LMe)Cl2] at room temperature shows signals over the 
range 1.63 to − 6.24 ppm. The 19F{1H}-NMR spectrum of (3.1), two multiple are seen 
at −140.91 (F3,5) and −147.26 (F2,6) ppm. The 19F{1H}-NMR spectrum for 
[Sb(LMe)2Cl] is almost similar to that of [Sb(LMe)Cl2] and it shows resonances at 
−140.95 ppm attributable to the (F3,5), which is closely comparable to the resonance 
−140.8 ppm refers to (F3,5) that reported for [N-(4-bromo-2,3,5,6-tetrafluorophenyl)-
N’-(2,3,5,6-tetrafluorophenyl)ethane-1,2-diaminato(2-)] dipyridineplatinum(II)-
ether,21 and another signal at −147.28 ppm, attributable to the (F2,6) atoms.  
Although a poorly soluble brown crystalline solid of (3.3) was obtained from 
the filtered reaction mixture, the compound was isolated in 30 % yield as small crystals 
adequate for X-ray identification, allowing only 1H- and 19F{1H}-NMR as further 
characterisation. The 1H NMR spectrum revealed that [Sb(LMe)3] is the major product 
of the synthesis process, but also detected the existence of other material recognised 
from the reaction mixture as minor product, which is an uncoordinated HLMe. The 
substitution patterns of polyfluorophenylamide groups have been confirmed by 
comparison of observed and calculated 1H- and 19F{1H}-NMR chemical shifts. An 
attempt to prepare the product in bulk failed. 
The IR spectra of the three complexes are similar to those of reported LMe 
complexes,20 and they show loss of v (N-H) bands of the reactant p-
HC6F4NH(CH2)2NM2 upon complexation, consistent with deprotonation of LMe and 
coordination to the respective metal (Li and then Sb). Characteristic υ (C-F) absorptions 
are observed between 927–937 cm−1 for the complexes with LMe. Elemental analyses 
(C,H,N) were consistent with the formation of the compounds (3.1 and 3.2) indicating 
excellent agreement with the single crystal compositions, while (3.3) repeatedly gave 
poor data with extremely low C %, presumably because of the product decomposition 
during analysis or transport to the analytical centre in London, or the possibility of the 
formation of metal carbides.  
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19F{1H}-NMR (376 MHz, C6D6): [Sb(p-HC6F4NC2H4NMe2)Cl2] (3.1)  
 
1H-NMR (400 MHz, C6D6): [Sb(p-HC6F4NC2H4NMe2)Cl2] (3.1) 
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Table 3.1 N–C Stretching in IR spectra for antimony (III) 
tetrafluorophenylaminate complexes 3.1 - 2.3 (υ 4000 - 400 cm-1) 
Compound                                                                 N–C stretching vibration (cm-1) 
[Sb(p-HC6F4NC2H4NMe2)Cl2]              (3.1) 1651 
[Sb(p-HC6F4NC2H4NMe2)2Cl]              (3.2) 1647 
[Sb(p-HC6F4NC2H4NMe2)3]                  (3.3) 1651 
 
 
Table 3.2 1H-NMR chemical shift data in ppm for antimony (III)  
tetrafluorophenylaminate complexes 3.1 - 2.3 in C6D6 
1H-NMR                                 3.1 3.2 3.3     
Aromatic H 6.24-6.28 5.91-5.99 6.14-6.22 
NH  – – –   
CH3 1.63 1.93 1.95 
CH2                                        3.09, 2.05            3.15, 2.14                 3.71, 2.06      
 
 
Table 3.3 19F{1H}-NMR chemical shift data in ppm for antimony (III) 
tetrafluorophenylaminate complexes 3.1 - 2.3 in C6D6 
19F{1H}–NMR        3.1    3.2 3.3 
F 3,5              –140.91 –140.95  –140.11 
F 2,6              –147.26 –147.28  –148.20 
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3.3.3 Crystal structure determinations 
 
[Sb(p-HC6F4NC2H4NMe2)Cl2] (3.1) 
 
The monomeric Sb+3 complex [Sb(p-HC6F4NC2H4NMe2)Cl2] (3.1) crystallised 
in the orthorhombic space group Pna21 (Table 3.5), with one molecule in the 
asymmetric unit. Bright yellow crystals of (3.1) were obtained in moderate yield from 
the 1:1 direct reaction of HLMe with SbCl3 (Scheme 3.3). Figure 3.2 displays the 
mononuclear complex (3.1) with the antimony centre chelated by N,N'-
bis(polyfluorophenyl)ethane-1,2-diaminate and two cis chloride ligands, giving the 
antimony atom centre a coordination number of four. The overall stereochemistry 
around the antimony centre is best described as heavily distorted tetrahedral. The LMe 
chelating mode with the Sb atom in (3.1) is similar to that observed in [SbLCl2] (L = 
the multidentate ketoiminato ligand with a bulky substituent on one side = 
RN(H)C(Me)CHC(Me)=O, R = C2H4NEt2 ), but with square pyramidal geometry.22 
The latter was generated from the in situ lithiation of L and subsequent reaction with 
SbCl3. The N–Sb bond lengths in (3.1) are 2.039(3) and 2.372(4) Å, and these values 
are shorter and longer than the sum of the covalent radii of the corresponding atoms 
(∑rcov(Sb–N) = 2.11 Å);23 however, they are comparable to the value observed in the 
N,N-chelated analogue [C4H3N-2-(CH=N-2',6'-iPr2C6H3)]SbCl2 [2.0810(15) and 
2.3234(17) Å].24 Deviation from 90° for the N–Sb–N angle is driven by the bite angle 
(75.70°) of the chelating ligand. The Sb-Cl bond distances found to be 2.405(11) and 
2.522(10) Å, which are comparable to the values observed for Sb-Cl in [C4H3N-2-
(CH=N-2',6'-iPr2C6H3)]SbCl2 [2.3691(6) and 2.5616(6) Å].24 The N–Sb–N angle for 
[Sb(p-HC6F4NC2H4NMe2)Cl2] found to be 75.70 (12)°, which is bigger than the N–Sb–
N angle of 73.90 (6)° reported for [C4H3N-2-(CH=N-2',6'-iPr2C6H3)]SbCl2. While, the 
Cl–Sb–Cl angle for (3.1) found to be 87.35 (4)° that is considerably smaller comparing 
with the Cl–Sb–Cl angle of 92.21 (2)° detected in [C4H3N-2-(CH=N-2',6'-
iPr2C6H3)]SbCl2.24  
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Figure 3.2. Molecular structure of monomeric [Sb(p-HC6F4NC2H4NMe2)Cl2] (3.1) 
with the atom numbering system; thermal ellipsoids are drawn at the 50 % probability 
level, and hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and 
angles (°): Sb(1)–N(1): 2.039(3), Sb(1)–N(2): 2.372(4), Sb(1)–Cl(2): 2.405(11), Sb(1)–
Cl(1): 2.522(10), N(1)–C(1): 1.410(5), N(1)–Sb(1)–N(2): 75.70(12), Cl(2)–Sb(1)–
Cl(1): 87.35(4), N(1)–Sb(1)–Cl(1): 88.45(10), N(1)–Sb(1)–Cl(2): 98.65(10), N(2)–
Sb(1)–Cl(1): 160.64(8), N(2)–Sb(1)–Cl(2): 84.18(10), C(1)–N(1)–Sb(1): 123.3(2), 
C(7)–N(1)–Sb(1): 121.1(2), C(10)–N(2)–Sb(1): 115.4(3), C(8)–N(2)–Sb(1): 105.0(2).         
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[Sb(p-HC6F4NC2H4NMe2)2Cl] (3.2) 
 
The in situ lithiation of HLMe and subsequent reaction with SbCl3 in a 2:1 ratio, 
yields complex [Sb(p-HC6F4NC2H4NMe2)2Cl] (3.2) (Scheme 3.5). The monomeric Sb+3 
complex [Sb(p-HC6F4NC2H4NMe2)Cl2] (3.2) crystallised in the monoclinic space group 
P21/c (Table 3.5), with the full molecule in the asymmetric unit. Figure 3.3 displays the 
mononuclear complex (3.2). The antimony atom centre is coordinated by two terminal 
LMe ligands, one adopting typical η2 (N,N′) coordination through two nitrogen donors 
of the p-HC6F4NC2H4NMe2 ligand, and the other showing monodentate LMe 
coordination through one nitrogen donor. The antimony atom also coordinates one 
terminal chloride ligand, showing Sb-Cl bond length of 2.536(8) Å, giving the antimony 
atom a coordination number of four (Scheme 3.7). The geometry around the antimony 
centre can be best described as heavily distorted tetrahedral with a Sb–N distance ranged 
between 2.049(2) and 2.404(2) Å. As expected, when complex (3.2) was analysed by X-
ray crystallography, no C-F interactions were observed, owing to coordination 
saturation by the LMe ligand. Compound (3.2) was obtained in almost high (70 %) yield, 
giving a satisfactory elemental analysis and allowing characterisation (Table 3.1, 3.2 
and 3.3).    
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.7 Two coordination modes introduced in [Sb(LMe)2Cl], a: the chelating 
mode and b: the terminal mode. 
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Figure 3.3. Molecular structure of monomeric [Sb(p-HC6F4NC2H4NMe2)2Cl] (3.2) 
with the atom numbering system; thermal ellipsoids are drawn at the 50 % probability 
level, and hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and 
angles (°): Sb(1)–N(1): 2.049(2), Sb(1)–N(2): 2.404(2), Sb(1)–N(3): 2.059(2), Sb(1)–
Cl(1): 2.536(8), N(1)–C(1): 1.406(3), N(3)–C(11): 1.400(3), N(3)–Sb(1)–N(2): 
86.29(8), N(1)–Sb(1)–N(2): 75.66(8), N(1)–Sb(1)–N(3): 96.25(8), N(1)–Sb(1)–Cl(1): 
85.39(6), N(3)–Sb(1)–Cl(1): 90.74(6), N(2)–Sb(1)–Cl(1): 160.35(5), C(1)–N(1)–
Sb(1): 120.42(15), C(7)–N(1)–Sb(1): 120.10(15), C(8)–N(2)–Sb(1): 104.01(14), 
C(10)–N(2)–Sb(1): 113.03(16), C(11)–N(3)–Sb(1): 120.27(16), C(17)–N(3)–Sb(1): 
121.21(15).       
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[Sb(p-HC6F4NC2H4NMe2)3] (3.3)  
 
The three coordinate homoleptic complex [Sb(LMe)3] crystallised in the 
orthorhombic space group Pna21 (Table 3.5), with one molecule in the asymmetric unit. 
The molecular structure of [Sb(LMe)3] is shown in (Fig. 3.4).  
In complex (3.3), three of the amido ligands are monodentate κ1 (N,N′) with an 
uncoordinated ‒(CH2)2NEt2 group (2.803, 5.477 and 5.492 Å) (the first value could be 
regarded as a weak interaction). This signifies an uncommon model of linkage, 
indicative of weaker coordination of the neutral crowded nitrogen atoms in [Sb(LMe)3]. 
In addition, all tetrafluorophenyl groups are directed away from the metal centre due to 
the steric crowding. This novel fascinating linkage variation appears to be driven by 
steric factors. The X-ray crystal structure for (3.3) compound shows that in the solid 
state its geometry exists as mononuclear species with distorted trigonal pyramidal with 
three tetrafluorophenyl groups bound by N at the base of the pyramid, presumably a 
lone pair positioned at the apical site. Coordination of the three ligands results in less 
available coordination space for the three other amino N donors of the ligands (Scheme 
3.8), unlike the same type of the ligand in [Eu(p-HC6F4N(CH2)2NMe2)3] ([Eu(LMe)3]),19 
which has tris-bidentate binding due to Eu+3 being much larger than Sb+3. The Sb (III) 
centre in (3.3) cannot induce C–F activation for the three LMe ligands, probably because 
of the long distance between the Sb centre and F atoms, (Sb-F2 4.487, Sb-F6 3.164 Å), 
(Sb-F8 3.091, Sb-F12 4.612 Å), (Sb-F14 4.593, Sb-F18 2.969 Å).  
 
 
 
 
 
 
 
 
 
Scheme 3.8 The coordination mode in (Sb(LMe)3) complex. 
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(b) 
 
Figure 3.4. Molecular structure of monomeric [Sb(p-HC6F4NC2H4NMe2)3] (3.3) with 
the atom numbering system; thermal ellipsoids are drawn at the 50 % probability level, 
and hydrogen atoms have been omitted for clarity; (a) Viewed onto the N3 plane; (b) 
Highlighting the pyramidal nature of the antimony coordination. Selected bond lengths 
(Å) and angles (°): Sb(1)–N(1): 2.045(12), Sb(1)–N(3): 2.121(16), Sb(1)–N(5): 
2.025(15), N(1)–C(1): 1.39(3), N(3)–C(11): 1.34(3), N(5)–C(21): 1.44(3), N(1)–Sb(1)–
N(3): 102.9(6), N(5)–Sb(1)–N(3): 86.9(7), N(5)–Sb(1)–N(1): 88.8(7), C(1)–N(1)–
Sb(1): 119.0(12), C(7)–N(1)–Sb(1): 125.9(11), C(11)–N(3)–Sb(1) 115.8(13), C(17)–
N(3)–Sb(1): 125.2(12), C(21)–N(5)–Sb(1): 117.5(12),  C(27)–N(5)–Sb(1): 117.1(14). 
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The complexes (3.1, 3.2 and 3.3) are notable for the presence of somewhat short 
Sb–N bond lengths, which are in agreement with the Sb–N bond lengths reported for 
[SbLCl2] (L = C4H2N-2,5-(CH2NMe2)2) (Table 3.4).24 Particularly, Sb(1)–N(1) bond 
length values for all these complexes are only slightly shorter than the sum of covalent 
radii of the corresponding atoms (∑rcov (Sb–N) = 2.11 Å).23 The average Sb–Cl bond 
lengths of (3.1 and 3.2) found to be 2.48 Å, which is comparable to the average Sb–Cl 
bond lengths 2.58 Å, reported for [Sb(C4H2N-2,5-(CH2NMe2)2)Cl2].24  
 
 
 
Table 3.4 Selected bond lengths (Å) for [Sb(LMe)Cl2], [Sb(LMe)2Cl], [Sb(LMe)3] 
and [Sb(C4H2N-2,5-(CH2NMe2)2)Cl2].24  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 [Sb(LMe)Cl2] [Sb(LMe)2Cl] [Sb(LMe)3] [Sb(C4H2N-2,5-(CH2NMe2)2)Cl2] 
Sb(1)–N(1) 2.039(3) 2.049(2) 2.045(12) 2.033(3) 
Sb(1)–N(3) – 2.059(2) 2.121(16) 2.446(3) 
Sb(1)–N(2) 2.372(4) 2.404(2) 2.025(15) 2.462(3) 
Sb(1)–Cl(1) 2.405(11)/2.522(10) 2.536(8) – 2.5573(10)/2.6181(10) 
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Table 3.5 Crystallographic data for compounds 3.1 - 3.3 
 
Compound 3.1 3.2 3.3 
formula C10H11Cl2F4N2Sb C20H22ClF8N4Sb C30H33F12N6Sb 
fw 427.87 627.61 827.38 
crystal system orthorhombic monoclinic orthorhombic 
space group Pna21 P21/c Pna21 
a, Å 19.127(4) 11.441(2) 9.880(2) 
b, Å 9.971(2) 8.8610(18) 39.689(8) 
c, Å 7.3740(15) 23.614(5) 8.7610(18) 
α, deg 90 90 90 
β, deg 90 101.50(3) 90 
γ, deg 90 90 90 
V, Å3 1406.3(5) 2345.9(9) 3435.4(12) 
Z 4 4 4 
T, K 100(2) 100.15 100(2) 
no. of rflns collected 14398 28296 28927 
no. of indep rflns 2265 4127 5783 
Rint 0.0618 0.0385 0.0836 
Final R1 values (I > 2σ(I)) 0.0220 0.0236 0.0902 
Final wR(F2) values (I >2σ(I)) 0.0521 0.0604 0.2233 
Final R1 values (all data) 0.0220 0.0259 0.0914 
Final wR(F2) values (all data) 0.0521 0.0616 0.2235 
GooF (on F2) 1.122 1.055 1.245 
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3.4  Conclusion 
 
In summary, we examined the coordination preferences of the 
tetrafluorophenylethylenediaminate ligand, along with how preferred metal geometry 
affects the product outcome. This chapter describes two synthetic methods to Sb (III) 
polyfluorophenylaminoamidate complexes, namely metathesis or direct reactions. 
Complex [Sb(p-HC6F4NC2H4NMe2)Cl2] (3.1) was synthesised by direct reaction 
between N,N-dimethyl-N′-(2,3,5,6-tetrafluorophenyl)ethane-1,2-diaminate (HLMe) 
(p_HC6F4NHC2H4NMe2) and anhydrous SbCl3 in THF, as well as by metathesis, while 
the heteroleptic chloride [Sb(p-HC6F4NC2H4NMe2)2Cl] (3.2) and the homoleptic 
[Sb(p-HC6F4NC2H4NMe2)3] (3.3) were synthesised by treatment of anhydrous SbCl3 in 
PhMe with [Li(p-HC6F4NC2H4NMe2)]2 in hexane in 2:1 and 3:1 molar ratio 
respectively. The yields of the complexes obtained were somewhat similar between the 
two methods. Both of these synthetic approaches have benefits and shortcomings. The 
direct route bypasses the need for air-sensitive starting materials; however, monitoring 
the reaction through the use of 1H- and 19F{1H}-NMR spectroscopy can be done with 
the metathesis route. Therefore, it can be considered that the synthesis of Sb (III) 
aminoamidate complexes is more convenient by the metathesis route than the direct 
route. Attempted production of [SbLEt3-nCln] (n = 2, 1, 0) under the conditions studied 
failed. At this stage, this work is largely incomplete, however a wide range of 
complexes have been synthesised with both heteroleptic and homoleptic constituents. 
Such results indicate this area contains rich potential that warrants further 
investigations. Bidentate (N,N') coordination is predominantly detected with (LMe). 
However, in the three-coordinate [Sb(LMe)3] complex, the three ligands (LMe) are 
monodentate with η N,N′-binding with a three free –(CH2)2NMe2 groups. This novel 
linkage variation could be attributed to steric factors.  
As further comparison, the difficulties associated with the synthesis of a tri-valent antimony 
LMe complexes are discussed. 
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The antimony centres in (3.1) and (3.2) are four-coordinate forming heavily distorted 
tetrahedral geometry, whereas the stereochemistry of the three-coordinate component 
(3.3) can be described as trigonal pyramidal with three ligands bound at the base. No 
any evidence of subsequent fluorine bond mediated assembly (C–F activation reactions) 
shown either in the solid or in the solution state neither at low temperature nor on 
prolonged heating of the complexes in C6D6 at 80 °C, which can be attributed either to 
the redox unresponsiveness of the Sb (III) state or to the long distance between Sb and 
F atoms. Molecular structures of all Sb-amide monomeric constructions (3.1- 3.3) were 
described both in the solid state analysis by mounted single crystals using X–ray 
crystallography diffraction, and in solution by 1H- and 19F{1H}-NMR spectra. In addition 
to IR spectroscopy, elemental analysis and melting point. These compounds are now well 
set for potential reduction to low valent species. Reaction with KC8 should form 
isolable low valent Sb complexes and this work could be performed in future work. 
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3.5 Experimental  
 
General Considerations/Air Sensitive Techniques 
 
The lithium compound and antimony complexes described herein are extremely 
air and/or moisture sensitive, thus all manipulations, including syntheses, were 
performed under anaerobic and anhydrous conditions requiring use of both 
conventional standard Schlenk techniques interfaced to a high vacuum (10−2 Torr) line, 
and a glovebox under an inert atmosphere of dry nitrogen. All glassware comprising 
Schlenk-type flasks were dried at 120 0C for no less than 12 h before use, then used 
immediately from the oven to limit exposure to moisture.  
Hexane and PhMe were dried and deoxygenated by an LC solvent purification 
system, whereas tetrahydrofuran was dried/purified and deoxygenated by refluxing 
over and freshly distilled from sodium wire/benzophenone ketyl under nitrogen. After 
distillation, solvents were stored in vacuum Schlenk flasks and degassed prior to use. 
The synthesis of the tetrafluorophenylamine ligand, HLMe = N,N-dimethyl-N'-2,3,5,6-
tetrafluorophenylethane-1,2-di-amine was according to a slight modification of the 
published procedure.18 Li(LMe), (Li[p-HC6F4NC2H4NMe2]), was prepared in 
quantitative yield by treating n-BuLi with the corresponding polyfluorophenylamine. 
Anhydrous SbCl3 and other starting materials such as n-butyllithium were 
commercially available from Aldrich and were freshly used as supplied without further 
purification. Pentafluorobenzene was stored over (4Å) molecular sieves, but was 
otherwise used as purchased from Aldrich Chemical Company. 
All characterisation other than X-ray crystallography was on bulk, vacuum 
dried (at room temperature) product, either powder or crystals. Multinuclear 1H- and 
19F{1H}-NMR spectra of air and moisture sensitive compounds were recorded using 
J.Young valve inert atmosphere NMR tubes protecting the sample from air on a Bruker 
AVANCE III HD 400 MHz spectrometer instrument. The chemical shifts are expressed 
in parts per million (ppm). 1H-NMR resonances were referenced against residual H in 
C6D6 (δ = 7.15 ppm), while 19F{1H}-NMR resonances were referenced against the 
known resonance of the N,N-dimethyl-N'-2,3,5,6-tetrafluorophenylethane-1,2-di-
amine starting materials (δ = ‒142.3, ‒161.0 ppm). 
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Perdeutero-benzene (C6D6) (all ≥ 99 atom % D) as solvent for NMR 
spectroscopy was obtained from Sigma-Aldrich, and was degassed, pre-dried over 
sodium metal for 24 h and then distilled under an atmosphere of nitrogen before being 
stored in a resealable greaseless Schlenk flask prior to use.  
Infrared spectra were recorded as Nujol mulls between NaCl plates using a 
Nicolet-Nexus FT-IR spectrophotometer within the range (ύ = 4000-400 cm-1). 
Samples were sent in sealed glass pipettes under nitrogen for elemental analyses (C, H, 
N) to the Microanalytical Laboratory service, Science Centre, London Metropolitan 
University, England, and were performed on the single crystals isolated. Melting points 
were measured in sealed glass capillaries and are uncalibrated.  
 
Synthesis of ligand (HLMe) followed by deprotonation by n-BuLi in hexane  
 
p-HC6F4NHC2H4NMe2 (HLMe)  
 
This synthesis followed a slight modification of the published procedure.18 Thus,  
pentafluorobenzene (33.6 g, 22.2 ml, 200 mmol) was added to N,N-dimethylethane-
1,2-diamine (17.6 g, 21.85 ml, 200 mmol) and triethylamine (20 g, 27.8 ml, 198 mmol) 
in dry ethanol (10 ml) and then heated to reflux 70-80 0C under nitrogen with stirring 
for 12 h. Evaporating the solution under vacuum, gave an orange gel. The gel was 
treated with diethyl ether/water and was extracted four times with diethylether. The 
combined organic extracts were dried over anhydrous MgSO4 and then evaporated 
under vacuum leaving a high boiling point liquid. Two distillations under vacuum, gave 
pure HLMe (12.0 g, 68 %). B.P. 50 0C. 1H-NMR (400 MHz, C6D6, 25 °C): δ (ppm) = 
1.86 (s, 6H, Me2N), 2.02 (m, 2H, CH2NMe), 3.09 (m, 2H, CH2NAr), 4.70 (br s, 1H, 
NH), 6.02 (m, 1H, p-HC6F4). 19F{1H}-NMR (376 MHz, C6D6, 25 °C): δ (ppm) = 
−141.78 (m, 2F, F3,5), −161.16 (m, 2F, F2,6). IR (υ/cm-1, Nujol mull): 3355 (m), 3089 
(w), 2979 (m), 2925 (s), 2893 (m), 2860 (m), 2808 (s), 2779 (s), 1655 (s), 1601 (w), 
1528 (vs), 1510 (s), 1475 (s), 1459 (s), 1399 (m), 1374 (m), 1342 (m), 1329 (w), 1285 
(m), 1260 (m), 1246 (s), 1180 (m), 1166 (vs), 1144 (vs), 1097 (m), 1073 (vs), 1055 (s), 
1033 (s), 965 (vs), 921 (s), 875 (w), 785 (m), 719 (m), 662 (w). 
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[Li2(p-HC6F4NC2H4NMe2)2] (Li-LMe)  
 
To a Schlenk flask charged with a solution of p-HC6F4NHC2H4NMe2 (1.42 g, 6.0 
mmol) in hexane (10 ml), was added through a syringe n-BuLi solution in cyclohexane 
(2 M, 3.0 ml, 6.4 mmol) at - 60 0C under a flow of nitrogen with stirring for ½ h. After 
the addition, the cooling bath was removed, the reaction mixture was allowed to warm 
to ambient temperature and the solvent was reduced to ca. 5 ml under vacuum. A light 
yellow crystalline solid precipitated and the slurry was heated gently till the solid 
redissolved and was left standing overnight. The solution was decanted with a cannula, 
the residue washed with hexane (2×10 ml) and dried under vacuum for 1 h, and an off 
white powder (0.95 g, 65 %) was collected. M.P. 124 0C (decomp). 
1H-NMR (400 MHz, C6D6, 25 °C): δ (ppm) = 1.50 (s, 6H, Me2N), 2.08-2.10 (m, 2H, 
CH2NMe), 3.43-3.49 (m, 2H, CH2NAr), 6.08-6.11 (m, 1H, p-HC6F4). 19F{1H}-NMR 
(376 MHz, C6D6, 25 °C): δ (ppm) = −143.71 (m, 2F, F3,5), −166.38 (m, 2F, F2,6). IR 
(υ/cm-1, Nujol mull): 1635 (s), 1550 (s), 1457 (s), 1379 (m), 1340 (s), 1296 (s), 1242 
(m), 1182 (w), 1179 (w), 1139 (m), 1066 (m), 1041 (w), 1005 (m), 914 (s), 859 (m), 
779 (w), 750 (w), 731 (m), 710 (w), 689 (w).  
 
Synthesis of trivalent antimony LMe complexes in THF or PhMe/hexane  
 
[Sb(p-HC6F4NC2H4NMe2)Cl2] (3.1) 
  
a: A solution of HLMe (1.42 g, 6.0 mmol) in THF (20 ml) was added with stirring using 
a cannula at ‾ 78 0C to a solution of SbCl3 (1.32 g, 5.8 mmol) in THF (30 ml). An 
immediate colour change to yellow brown was observed indicating the formation of the 
desired product. Hydrogen chloride was bubbled through a stirred tetrahydrofuran 
solution of the reaction mixture indicated the progress of the reaction. Stirring was 
continued for few days at room temperature; volatiles were removed in vacuo. The 
yellow brown solution was concentrated to ca. 20 ml and set aside for 2 days at -15 0C, 
whereupon a bright yellow crystalline compound of unsolvated [Sb(p-
HC6F4NC2H4NMe2)Cl2] (3.1) deposited. Crystals for the X-ray crystal structure were 
obtained by recrystallisation from hexane for further purification. Yield = 0.79 g (31%).  
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b: In an alternative approach, hexane solution of n-BuLi (1.6 M solution in hexanes, 4.0 
ml, 6.0 mmol) was added to pre-cooled (‾ 78 0C) solution of HLMe (1.42 g, 6.0 mmol) in 
hexane (30 ml) and stirred for 1 h at r.t, generating effectively [Li(LMe)]2 as yellow crystals 
in the solution. Gently heating the crystals and the resulting yellow solution was added 
to a pre-cooled solution (‾ 78 0C) of SbCl3 (1.32 g, 6.0 mmol) in PhMe (20 ml). The 
reaction mixture was stirred for 3 h at r.t. The remaining insoluble solid was required 
about 2-3 days to be entirely stabilised. Filtration and concentration under reduced 
pressure of the solution to ca.10 ml and storage for two days at − 30 °C afforded the 
titled compound [Sb(p-HC6F4NC2H4NMe2)Cl2] (3.1) as a bright yellow crystalline solid 
in good yield (35 %). 
3.1: M.P. 186-192 0C (decomp). 1H-NMR (400 MHz, C6D6, 25 °C): δ (ppm) = 1.63 (s, 
6H, Me2N), 2.05-2.14 (m, 2H, CH2NMe), 3.09-3.19 (m, 2H, CH2NAr), 6.24-6.28 (m, 
1H, p-HC6F4); 19F{1H}-NMR (376 MHz, C6D6, 25 °C): δ (ppm) = −140.22 (m, 2F, 
F3,5), −147.19 (m, 2F, F2,6); Elemental analysis calcd. (%) for C10H11Cl2F4N2Sb (M = 
427.87 g/mol): C 28.11, H 2.57, N 6.56; found: C 28.11, H 2.76, N 6.67. IR (υ/cm-1, 
Nujol mull): 1651 (s), 1455 (s), 1376 (s), 1260 (s), 1095 (w), 1018 (m), 937 (s), 798 (s).  
  
 
[Sb(p-HC6F4NC2H4NMe2)2Cl] (3.2)  
 
A solution of Li(LMe) prepared in situ from drop-wise addition of n-BuLi (2.0 M 
solution in cyclohexane, 3.0 ml, 6.0 mmol) to a solution of HLMe (1.42 g, 6.0 mmol) in 
hexane (20 ml) at -78 0C without stirring. The reaction mixture was allowed to warm 
to ambient temperature and stirred for 3 h. The hexane solution was then slowly added 
over 10 minutes by cannula to a stirred suspension of SbCl3 (0.66 g, 3.0 mmol) in PhMe 
(20 ml) at room temperature. The original yellow-brown reaction progressively turned 
orange-brown and was allowed to stir overnight. The precipitate was required about 2-3 
days to be entirely stabilised. Filtration through a filter cannula and concentration under 
reduced pressure of the solution to ca.10 ml and storage at − 30 °C afforded the titled 
compound [Sb(p-HC6F4NC2H4NMe2)2Cl] (3.2) as brown-yellow crystals. Yield = 1.0 
g (70 %).  
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3.2: M.P. 188-190 0C (decomp). 1H-NMR (400 MHz, C6D6, 25 °C ): δ (ppm) = 1.93 (s, 
12H, Me2N), 2.14-2.19 (m, 4H, CH2NMe), 3.15-3.17 (m, 4H, CH2NAr), 5.91-5.99 (m, 
2H, p-HC6F4); 19F{1H}NMR (376 MHz, C6D6, 25 °C): δ (ppm) = −140.95 (m, 4F, 
F3,5), −147.28 (m, 4F, F2,6); Elemental analysis calcd. (%) for C20H22ClF8N4Sb (M = 
627.61 g/mol): C 38.27, H 3.53, N 8.92; found: C 38.37, H 3.44, N 9.13. IR (υ/cm-1, 
Nujol mull): 1644 (s), 1610 (w), 1463 (m), 1377 (s), 1275 (s), 1262 (s), 1174 (m), 1081 
(m), 1020 (s), 989 (s), 963 (m), 937 (s), 871 (s), 829 (s), 785 (s), 714 (s), 690 (s).  
 
 [Sb(p-HC6F4NC2H4NMe2)3] (3.3)  
 
[Li(p-HC6F4NC2H4NMe2)]2 was synthesised in situ by the reaction of p-
HC6F4NHC2H4NMe2 (1.42 g, 6.0 mmol) with n-BuLi (1.6 M solution in hexanes, 4.0 
ml, 6.0 mmol) in hexane (20 ml). Addition of the hexane solution drop-wise through a 
cannula to a well stirred solution of SbCl3 (0.44 g, 2.0 mmol) in PhMe (10 ml) with 
cooling to − 78 0C using a dry ice/acetone bath. The reaction mixture was allowed to 
warm to ambient temperature and continued stirring for several days. The resultant 
yellow-brown solution was filtered from LiCl through a filter cannula and the volume 
was reduced to incipient crystallisation (10 ml). Last step requires highly caution, as 
the compound can be quickly decomposed on reduction to the point of crystallisation. 
Storage with slow cooling to − 30 0C for 48 h of this solution left a brown crystalline 
solid of [Sb(p-HC6F4NC2H4NMe2)3] (3.3) suitable for X-ray diffraction. Yield = 0.43 g 
(30 %).  
3.3: M.P. 184-186 0C (decomp). 1H-NMR (400 MHz, C6D6, 25 °C): δ (ppm) = 1.95 (s, 
18H, Me2N), 2.06-2.09 (m, 6H, CH2NMe), 3.71-3.74 (m, 6H, CH2NAr), 6.14-6.22 (m, 
3H, p-HC6F4); 19F{1H}-NMR (376 MHz, C6D6, 25 °C): δ (ppm) = −140.11 (m, 6F, 
F3,5), −148.20 (m, 6F, F2,6). Elemental analysis calcd. (%) for C30H33F12N6Sb (M = 
827.38 g/mol): C 43.55, H 4.02, N 10.15; C,H,N couldn’t be obtained, as it repeatedly 
gave poor data with extremely low C %, probably because of product contamination 
during analysis or transport to the analytical centre in London. IR (υ/cm-1, Nujol mull): 
1651 (w), 1600 (m), 1455 (w), 1310 (s), 1262 (w), 1200 (w), 1109 (m), 927 (m), 905 
(s), 790 (m), 715 (m), 639 (m), 581 (s).  
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3.6  Single crystal X-ray structure determination/analysis and Refinement model 
           description 
 
Crystals were initially isolated as suitable single crystals and immersed in 
viscous hydrocarbon oil (Paratone-N) that was used on a glass fibre and mounted on 
the diffractometer under a stream of liquid nitrogen. X-ray crystallography was used to 
determine the solid-state structures of the crystalline samples, and was measured 
providing intensity data on either a Bruker APEX II CCD diffractometer for complex 
(3.3) at 100(2) K using graphite-monochromate MoKα radiation with a single 
wavelength (λ = 0.71073 Å), or at the Australian Synchrotron diffractometer using the 
MX1 macromolecular beam lines (3.1 and 3.2) at 100(2) K. Structure solutions were 
performed using SHELXS-97 and SHELXL- 9725,26 program using Direct Methods via 
the graphical interface X-Seed27 and OLEX 228 that also were used for generating 
figures. An absorption correction using MULTISCAN were applied. All CIF files were 
checked at www.iucr.org. Crystal data and refinement parameters are amassed below. 
 
[Sb(p-HC6F4NC2H4NMe2)Cl2] (3.1)  
1: C10H11Cl2F4N2Sb (M = 427.87 g/mol):  orthorhombic, space group Pna21, a = 
19.127(4) Å, b = 9.971(2) Å, c = 7.3740(15) Å, α = 90°, β = 90°, γ = 90°, Volume = 
1406.3(5) Å3, Z = 4, T = 100(2) K, Dcalc = 2.021 g/cm3, μ = 2.373 mm‑1, F (000) = 824.0, 
2Θmax = 8.088 - 49.984°,  14398 reflections collected, 2265 unique (Rint = 0.0618, Rsigma 
= 0.0412), 2265/1/175  parameters, GooF on F2 1.122, The final R1 was 0.0220 ( I >2σ 
(I)) and wR2 was 0.0521 (all data), Largest diff. peak/hole/e = 0.42 to -0.39 Å-3. 
 
[Sb(p-HC6F4NC2H4NMe2)2Cl] (3.2)  
2: C20H22ClF8N4Sb (M = 627.61 g/mol):  monoclinic, space group P21/c, a = 11.441(2) 
Å, b = 8.8610(18) Å, c = 23.614(5) Å, α = 90°, β = 101.50(3)°, γ = 90°, Volume = 
2345.9(9) Å3, Z = 4, T = 100(2) K, Dcalc = 1.777 g/cm3, μ = 1.370 mm‑1, F (000) = 
1240.0, 2Θmax = 3.632 - 49.984°, 28296 reflections collected, 4127 unique (Rint = 
0.0385, Rsigma = 0.0209), 4127/0/312  parameters, GooF on F2 1.055, The final R1 was 
0.0236 ( I >2σ (I)) and wR2 was 0.0617 (all data), Largest diff. peak/hole / e = 0.68 to 
-0.45 Å-3. 
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[Sb(p-HC6F4NC2H4NMe2)3] (3.3) 
3: C30H33F12N6Sb (M = 827.38 g/mol): orthorhombic, space group  Pna21, a = 9.880(2) 
Å, b = 39.689(8) Å, c = 8.7610(18) Å, α = 90°, β = 90°, γ = 90°, Volume = 3435.4(12) 
Å3, Z = 4, T = 100(2) K, Dcalc = 1.600 g/cm3, μ = 0.899 mm‑1, F (000) = 1656.0, 2Θmax 
= 4.122 - 49.998°, 28927 reflections collected, 5783 unique (Rint = 0.0836, Rsigma = 
0.0512), 5783/111/450  parameters, GooF on F2 1.245, The final R1 was 0.0902 ( I >2σ 
(I)) and wR2 was 0.2235 (all data), Largest diff. peak/hole / e = 1.96 to -1.16 Å-3. 
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Outline 
 
This chapter describes the synthetic method used to examine different reactions 
between aluminium (III) halides AlX3 (X = Cl, Br, I) and deprotonated formamidinate 
ligands (XylForm) and (DippForm), to increase the range of the 
haloorgano(formamidinato) aluminium (III) system. In addition, a chlorine/methyl 
exchange reaction was used for forming bimetallic Al/Sb (III) ionic complexes. The 
majority of the aluminium (III)-containing compounds have been successfully obtained 
as monomeric structures in the solid state. The structural nature of the synthesised 
complexes and reactions pathway are elucidated along with their spectroscopic 
characterisation. 
 
 
4.1  Introduction 
 
Monodentate nitrogen- or oxygen-based species have been the most common 
ligands utilised in aluminium chemistry. Extensive attention has been increasing around 
the coordination chemistry of the four-electron donor, monoanionic ancillary amidinate 
ligands [RNC(R')NR] ¯, as it is stated earlier in chapter two of this thesis. This class of 
ligand features readily substitutable groups associated to the nitrogen atoms and 
backbone carbon centres, modifying the coordination environment at the metal 
center.1,2 Sterically demanding substituents on the carbon and nitrogen atoms thrust the 
lone pairs of electrons on the nitrogen atoms to the metal centre to form the chelating 
bonding mode rather the bridging bonding mode. Generally, non-bulky hydrogen and 
methyl groups attached to the carbon centre tend to form the chelating bonding mode, 
although in some cases form the bridging or monodentate bonding modes (Figure 4.1).3 
Thus, a range of transition-, lanthanide- and main group-metal amidinate complexes 
have been synthesised.4,5 
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Figure 4.1. Steric effects of ligand substituents. 
 
Over recent years, Group 13 amidinate complexes of metal alkyl and halide 
fragments haven’t been exceptions,6,7 along with their applications as efficient 
homogeneous catalysts in olefin polymerisation reactions,8,9,1,10 and chemical vapour 
deposition (CVD) precursors.11 Aluminium amidinate complexes have also served as 
lone source precursors to materials containing the nitride ion.12 Considering the 
emerging importance of amidinato aluminium alkyl and halide complexes to a number 
of areas, deprotonation of the formamidine by different metal alkyl/amide such as (n-
BuLi, LiN(SiMe3)2, NaN(SiMe3)2, KN(SiMe3)2) followed by combination with 
aluminium compounds have been convenient methods to synthesise a variety of hetero 
aluminium complexes displaying novel structural features.  
 
A recent study was performed on Group 13 metals, Al and Ga, by treatment of 
formamidines [Form (ArNCHNAr) = EtForm (Ar = 2,6-Et2C6H3) or DippForm (Ar = 
2,6-iPr2C6H3)] with AlCl3 in a 1:3 reaction stoichiometry that led to obtain dialuminium 
formamidinate complexes [Me2Al(μ-Form)(μ-Me)AlMe2] in good yields, while  
protolysis reactions of MMe3 (M = Al, Ga) with (FormH) in a 1:1 stoichiometry 
resulted in [M(Form)Me2] (M = Al, Form = DippForm, EtForm; M = Ga, Form = 
DippForm) in high yields.13 Concentration of the thf/n-hexane solution of [Me2Al(μ-
DippForm)(μ-Me)AlMe2] to dryness yielded [Al(DippForm)Me2], which is can also be 
achieved from reaction of AlMe3 with [Ga(DippForm)Me2].13  
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In an attempt to investigate the effect of ligand steric bulk on metal-complex formation, 
nitrogen-bound alkyl groups of varying steric bulk (isopropyl and cyclohexyl) have 
been treated with phenyllithium yielding lithium amidinates. The latter, when treated 
with AlCl(THF)n formed three aluminium (III) amidinate complexes: 
[Al{PhC[N(iPr)]2}3], [Al{PhC[N(iPr)]2}2Cl] and [Al[PhC(NCy)2]2Cl.0.675THF].14 
More recently, complexes of the general formula [Al(Form)2X], [Form = XylForm, 
EtForm, DippForm] (X = Me, Cl), were produced from the reactions of N,N'-
bis(aryl)formamidines/ates with half an equivalent of AlMe3/AlCl3.15 
 
Abeysekera, et al. described the synthesis of dialkylaluminium m-terphenyl-
substituted amidinate complexes, which are robust in the crystalline state and can be 
simply handled in air for short periods of time without observable decomposition. The 
syntheses were an aqueous workup reaction of 2,4,6-triphenylphenylbromide,                 
n-butyllithium and dialkylcarbodiimides (RN=C=NR, R = cyclohexyl or isopropyl), 
followed by reaction with an excess of trimethylaluminium in hexane and stirring 
overnight (Scheme 4.1).3  
 
 
 
 
 
 
 
 
 
Scheme 4.1 Synthesis of dialkylaluminium m-terphenyl-substituted amidinate 
complexes. 
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The reaction of the bulky benzamidine N,N'-bis(2,6-diisopropylphenyl)-4-
toluamidine (HDippAm) with AlMe3 in a 1:1 molar ratio in Et2O yielded the 
mononuclear aluminium benzamidinate compound [Al(DippAm)Me2]. This compound 
displays remarkable thermal and aerobic stability, and was also achieved by salt 
elimination between dimethylaluminium chloride and [Li(DippAm)(THF)2].6 Also, 
reaction of [PhC(NSiMe3)2]Li(OEt2) with AlC13 in PhMe afforded the bis(N,N'-
bis(trimethylsilyl)benzamidinato) aluminium chloro compound 
[A1{PhC(NSiMe3)2}2Cl]. The latter, when treated with KBEt3H at room temperature 
yielded monomeric hydrido derivative [{PhC(NSiMe3)2}2AlH].16 
 
Treatment of an N-arylanilido-imine ligand [o-C6H4(NHAr)CH=N]2CH2CH2 
(Ar = 2,6-Me2C6H3) with AlMe3 in a 1:1 molar ratio affords a monometallic complex 
[C6H4(NHAr)–CH=N)]CH2CH2(C6H4(NAr)CH=NAlMe2). Reaction of this compound 
with one equivalent of ZnEt2 gave a heterobimetallic complex [C6H4(NAr)–
CH=NZnEt]CH2CH2[C6H4(NAr)–CH=NAlMe2] (Scheme 4.2). The Al/Zn example 
reflects the possibility of forming a heterobimetallic complex with an ethylene bridged 
N-arylanilido-imine ligand. This type of complex is an effective catalyst for ring-
opening polymerisation of µ-caprolactone in the presence of benzyl alcohol to produce 
polymers with narrow polydispersity standards.17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER FOUR: INTRODUCTION  
 
156 
 
 
 
 
 
Scheme 4.2 Reaction of ethylene bridged N-arylanilido-imine with AlMe3 and ZnEt2. 
 
Hamidi, et al. reported that the structurally interesting bimetallic monomeric six-
coordinate formamidinate complexes [Ln(Form)(AlMe4)2] (Ln = Y, Form = EtForm 
(2,6-Et2C6H3), MesForm (2,4,6-Me3C6H2), DippForm (2,6-iPr2C6H3), tBuForm (2-
tBuC6H4); Ln = La, Form = DippForm, tBuForm) were achieved in high yield by 
protonolysis reactions between formamidines and Ln(AlMe4)3,18 which could work as 
pre-catalysts in olefin polymerisation. Also [Y(Form)(AlMe4)2] (Form = EtForm, 
DippForm) were synthesised by treatment of Y(Form)[N(SiHMe2)2]2(thf) with AlMe3.  
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4.2  The current study 
 
This chapter describes the synthesis and structural characterisation of eight 
heteroleptic aluminium (III) formamidinate complexes (Scheme 4.3). Two types of 
formamidinate ligands were selected, N,N′-bis(2,6-dimethylphenyl) formamidinate 
(XylForm) and N,N′-bis(2,6-diisopropylphenyl)formamidinate (DippForm) as 
subclasses of amidinate ligands, to study a variation of the possible coordination modes of 
the formamidinate functional group and compare the synthesised complexes with those 
reported in the literature. Metathesis reactions were carried out in a donor solvent THF 
and/or PhMe. Moreover, all complexes were crystallised from THF or PhMe/hexane and 
their structures have been identified by X-ray crystallography (except for 4.10), 1H_, 
13C_NMR, IR spectroscopy, elemental analyses and melting point.  
 
 
 
Scheme 4.3. Overall synthetic routes to formamidinato aluminium (III) complexes. 
 
Also included is a tri-aluminium formamidinate complex that features both bridging 
form ligands and a bridging oxygen ion, [Al3(XylForm)2(µ3-O)(OH)Cl4]2.PhMe (4.4). 
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Structural elucidation shows monomeric complexes with a coordinated thf 
molecule on the Al atom in (4.6) and (4.7), whereas for (4.3) and (4.5) species have the 
formamidine binding in a monodentate mode to the AlBr3 through the lone pair on the 
non-protonated N-atome. Attempts to achieve homoleptic complexes of the type tris-
(N,N′-bis(2,6-dimethylphenyl)formamidinato) aluminium (III) [Al(XylForm)3] or tris-
(N,N′-bis(2,6-diisopropylphenyl)formamidinato) aluminium (III) [Al(DippForm)3] 
were unsuccessful. Different coordination modes possibly occur, but the two most 
common ones have been shown in (Figure 4.2).  
 
 
 
 
 
 
 
Figure 4.2. Two common coordination modes for substituted formamidinates with 
aluminium (III). 
 
The proposed goal of forming bimetallic antimony/aluminium (III) complexes 
by treatment of AlMe3 with SbCl3 in the presence of PhMe gave the 
tetrachloroaluminate salt bearing a stibinostibonium cation in the form of [Me3Sb-
SbMe2][AlCl4] (4.9). The reaction was chlorine/methyl exchange and the complex 
represents a new route to stibinostibonium cations. A dichloroaluminium salt bearing 
an anion of [(Br4Sb)SbBr3]‒ in [Br3Sb-µBr-SbBr3][AlCl2(thf)4] (4.10) was isolated from 
the reaction of SbBr3 with AlCl3 in THF/PhMe at ambient temperature. The solid state 
structures for these complexes are described, in which the Sb and Al in (4.9) and (4.10) 
performed in relatively rare coordination modes.  
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GLOSSARY OF COMPOUNDS AND CODES 
 
The following structures are a summary of the notable complexes discussed 
throughout this chapter, together with respective codes. These structures show 
aluminium atoms in different colours representing the colours of the compounds 
observed in the solid state.  
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4.3       Results and discussion  
 
4.3.1 Synthesis by metathesis reactions in THF/PhMe 
 
Following the same method described earlier in chapter two of this thesis to 
synthesise antimony formamidinato complexes, we turned to another Lewis acid 
(aluminium compounds) to prepare their formamidinate analogues. Scheme 4.4 and 4.5 
show the metathesis reactions used in this study incorporating the two formamidine 
pro-ligands XylFormH and DippFormH. Syntheses of related complexes with other 
ligands, have been described previously and can have diverse structural geometry, 
allowing for comparisons in this work. Initially, to a stirred solution of N,N′-
bis(aryl)formamidine in THF or PhMe, ML was added dropwise (M = Li, Na, K; L = 
n-Bu, N(SiMe3)2) at 0 °C. This was followed by addition of this solution dropwise to a 
stirred solution of AlX3 (X = Cl, Br, I) in THF or PhMe at room temperature until an 
insignificant colour change was observed in the solution (after 10 minutes), indicating 
the formation of new haloformamidinatoaluminium species. For example, reaction of 
AlX3 (X = Cl, I) with two equivalents of a substituted deprotonated N,N-
bis(aryl)formamidinate ligand were investigated under varying conditions, and resulted 
in bis-substituted [Al(Form)2X] complexes: [Al(XylForm)2Cl] (4.1), 
[Al(XylForm)2I].PhMe (4.2), [Al(DippForm)2Cl] (4.8) (Scheme 4.4 and 4.5). Reaction 
of NaN(SiMe3)2 with the formamidine ligands in PhMe, then addition of the reaction 
mixture to a solution of AlBr3 in PhMe at room temperature in a 1:1 molar ratio 
produced bromoformamidine aluminium (III) complexes [Al(FormH)Br3]: [FormH = 
XylFormH (4.3), DippFormH (4.5)] (Scheme 4.4 and 4.5). [Al3(XylForm)2(µ3-
O)(OH)Cl4]2.PhMe (4.4) was isolated as unexpected product from attempt to synthesise 
[Al(XylForm)Cl2(thf)].PhMe (Scheme 4.4) by reaction of K(XylForm) with AlCl3 in 
THF/PhMe at room temperature in a 1:1 molar ratio.  
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Treatment of AlX3 (X = Cl and/or Br) in the presence of a lithium 
formamidinate species in a 1:1 molar ratio reactions gave thf solvated 
haloformamidinate aluminium (III) complexes [Al(DippForm)X2(thf)]: [X = Cl (4.6), 
Cl and Br (4.7)] (Scheme 4.5). In several instances, despite the use of a 3:1 ratio of the 
formamidinates to AlX3, only mono- and bis-substituted complexes were obtained, 
which reflects the steric bulk of the ligands by the inability for these ligands to bind to 
the small Al+3. 
The in situ reaction of AlMe3 with SbCl3 at − 78 0C in presence of PhMe resulted 
in low yield colourless crystals of an ionic complex [Me3Sb-SbMe2][AlCl4] (4.9). In 
spite of several attempts and different reaction conditions, we were unable to obtain 
adequate crystals of (4.9) from this particular reaction.  
Following the route described by Hamidi, et al. to synthesise bimetallic 
complexes but with slight modification,18 we worked up with antimony and aluminium 
(eqn. 4.1) to synthesise their analogues, but all attempts to isolate any components 
involving formamidinato ligands of antimony/aluminium were unsuccessful. 
Competition between the two Lewis acidic Al3+ and Sb3+ for N-donor ligands have been 
attempted. Because of the strong Lewis acid Al3+ has a high affinity towards nitrogen 
donor ligands,19,20,21 Al3+ reflected its highest acidity compared with antimony species, 
and the results were aluminium (III) N,N′-bis(2,6-dimethyl(or 
isopropyl)phenyl)formamidinate forms. Surprisingly, no isolated byproduct of 
formamidinato antimony species such as [Sb(Form)X2] was noticed from the examined 
reaction between Al, Sb and formamidine. However, deliberately synthesis of a variety 
of aluminium formamidinate complexes have been carried out in this study, thereby 
confirming isolation of pure products. These structures are relatively similar to the 
previously designated organoaluminium formamidinates.15  
 
 
 
 
 
Equation 4.1 
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Scheme 4.4. Reagents and Conditions: (i) AlCl3, LiN(SiMe3)2, r.t, PhMe. (ii) AlI3, 
KN(SiMe3)2, r.t, PhMe. Note: compound (4.2) crystallised as a monomer with one 
PhMe molecule in the crystallographic asymmetric unit. (iii) AlBr3, NaN(SiMe3)2, r.t, 
PhMe. (iv) AlCl3, KN(SiMe3)2, r.t, THF/PhMe. 
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Scheme 4.5. Reagents and Conditions: (i) AlBr3, NaN(SiMe3)2, r.t, PhMe. (ii) AlCl3 
(4.6), AlCl3 + AlBr3 (4.7), n-BuLi, r.t, THF/PhMe. (iii) AlCl3, LiN(SiMe3)2, r.t, 
THF/PhMe. 
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4.3.2 Characterisation 
  
All the aluminium (III) complexes, incorporating XylFormH and DippFormH 
ligands displayed in Scheme 4.4 and 4.5, were initially isolated as single crystals, and 
were structurally characterised on the basis of X-ray crystallography using the MX1 
beamline at the Australian Synchrotron, and their molecular structures are depicted in 
(Figures 4.3 – 4.13). Additional characterisations were supported by IR spectroscopic 
techniques (Table 4.1), 1H- and 13C-NMR spectroscopy  (Table 4.2 and 4.3 
respectively), and elemental analyses (with the exception of for 4.9 which was obtained 
only in very poor yield), as well as melting point analysis.  
Single crystals for compounds (4.2) and (4.4) were achieved from solution in 
PhMe with one uncoordinated PhMe molecule in the asymmetric unit. In contrast, the 
aluminium centres in (4.6) and (4.7) are weakly coordinated by a thf molecule, while 
(4.1, 4.3, 4.5 and 4.8) were achieved from solution in PhMe as solvent free complexes 
after storage overnight at _ 30 0C. The formamidinate moieties in (4.1, 4.2, 4.6, 4.7 and 
4.8) serve as chelating κ2(N,N') four-electron donor ligands, and the monodentate mode 
in (4.3 and 4.5) is established. A feature of compounds (4.1 – 4.8) is that the assemblage 
of the monomer is favoured rather than a dimer in the solid state, presumably due to the 
large steric bulk of the ligands inhibiting aggregation. Crystal data, data collection 
parameters and structure refinement details are summarised in (Tables 4.5, 4.6 and 4.8) 
and also in the Experimental Section.  
Suitable crystals of the stibinostibonium salt of (4.9) C5H15AlCl4Sb2 were 
obtained in very low yield (< 8 %), and unequivocally proven by X-ray structure 
determination. However, the data from the other spectroscopy, 1H-NMR and IR, 
couldn’t be sufficient to allow a detailed discussion and no C, H, N analytical data could 
be obtained. Crystallisation of this type of complexes, particularly those containing 
sterically less demanding substituents such as the Me group, is relatively difficult since 
they normally have low melting points and are very sensitive toward oxygen.22 Crystals 
of (4.9) are slightly soluble in nonpolar organic solvents. They are colourless, unlike 
other Sb-Sb bonded compounds, which are normally yellow or red distibines or 
cyclostibines. 
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Unfortunately, efforts to accurately refine the anionic [Br3Sb-µBr-SbBr3] ‒ in 
(4.10) failed, since good quality crystals for X-ray analysis couldn’t be obtained. 
Therefore, X-ray diffraction data for this compound were of lower quality and has only 
been included as confirmation of connectivity. 
Infrared spectroscopic data of (4.1 – 4.8) (except [Al(XylFormH)Br3] (4.3) and 
[Al(DippFormH)Br3] (4.5) as they have formamidine ligands rather than formamidinate 
ligands) are devoid of an N–H stretch signal usually observed at 3300-3100 cm-1, which 
is indicative of comprehensive deprotonation of the parent formamidines and 
complexation with aluminium through the Al-N bond. IR spectra for all the 
formamidinate complexes showed that the N-H stretch at ca. 3300 cm-1 reappeared after 
the formamidinate complexes were exposed to air for two minutes. The N–C stretching 
for compounds (4.1 – 4.8) displayed the characteristic absorption for an aluminium 
coordinated formamidinate group distinguished at 1637-1651 cm-1 (Table 4.1). These 
results showed successful synthesis of the haloformamidinato aluminium (III) 
complexes. Crystalline compounds (4.3 and 4.5) exhibits a sharp stretch in the IR 
spectrum at 3322 cm-1, confirming presence of the parent formamidine.23 An OH stretch 
for (4.4) was confirmed in the infrared spectrum at 3712 cm-1, which is slightly different 
to that recorded in related complexes.24,25 
 The 1H-NMR spectra studies of the bulk vacuum dried materials show the lack 
of the signal attributed to the N-H resonance, and distinct resonances consistent with 
formamidinate ligands, which differs from the parent formamidines. More specifically, 
the 1H- and 13C-NMR spectra of the complexes pointed out to the expected resonances 
due to the existence of the organic substituents 2,6 diisopropyl, 2,6 dimethyl and the 
NCHN environment of the formamidinate moiety, which occur almost in the same 
range as was detected for the corresponding haloformamidinato stibines in the previous 
chapter of this study. The existence of protonated formamidine in (4.3) and (4.5) 
presumably results from inappropriate deprotonation of the formamidine ligands 
forming Lewis Base/Acid adduct rather than the expected [Al(Form)Br2] (Form = 
XylForm, DippForm) complexes.  
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1H-NMR spectra of (4.3 and 4.5) displayed the resonances due to the organic 
substituents 2,6 dimethyl and 2,6 diisopropyl of the formamidine moiety. However, 
they show two sets of methyl resonances (CH3) at 1.59 and 2.29 ppm in (4.3), while for 
(4.5) two sets of methyl resonances CH(CH3)2 were found at 1.14 and 1.51 ppm, and 
two sets of CH(CH3)2 at 2.62 and 3.31 ppm, were present all of them in a 1:1 ratio. 
Also, the presence of the hydrogen atom on N2 represented by a slightly broad doublet 
peak of N–H resonance at δ = 5.69 ppm (4.3) and 6.06 ppm (4.5) (with J value = 12 
Hz) for both of the complexes that couple to doublet of NCHN at δ = 7.78 ppm (4.3) 
and 8.01 ppm (4.5) (with J  value = 16 Hz) for both of the complexes, which are slightly 
different from the chemical shifts of 8.98 and 8.67 ppm reported for 
[Al{MeC(NDipp)2H}I3] and [Ga{HC(NDipp)2H}Cl3] examples, respectively.26 These 
data are inclusion proof of a protonated XylFormH/DippFormH and aluminium-
XylFormH/aluminium-DippFormH coordination environment in (4.3 and 4.5).  
The 1H-NMR spectrum of (4.4) exhibits three sets of methyl resonances in a 
1:2:1 ratio and a well-defined formamidinate NCHN resonance at δ = 7.29 ppm. The 
terminal hydroxyl group is identified by 1H-NMR with signal at 0.41 ppm that is in the 
normal range of other reported Al–OH signals.24,25 Taking into account the relatively 
good yield of formamidinate complex (4.4), (65 %), we assumed that the presence of 
oxygen arises from ring-opining of the THF molecule, or more probably moisture 
introduced from accidental exposure to moisture. This highlight to the extreme 
sensitivity of these compounds to moisture. Such sensitivity caused even difficulties in 
handling.  
Frustration to achieve acceptable C, H, N microanalytical data for complex (4.4) 
could be resulted from the occurrence of oxygen (O2‒ and OH‒) arising from 
adventitious H2O. It is worth mentioning that many aluminium compounds used in this 
chapter react violently towards the air and moisture,27,28,29,30,31,18 thus attempts to 
achieve satisfactory carbon, hydrogen and nitrogen microanalytical data for some 
complexes (4.1, 4.2, 4.5 and 4.10) (except 4.9 obtained in low yield < 8 %), were 
unsuccessful. However, the other products (4.3, 4.6, 4.7 and 4.8) were isolated as pure 
crystalline species. Yields ranged from low such as (4.7) (0.14 g, 40 %) to moderate 
such as (4.8) (0.51 g, 70 %). 
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Table 4.1 N–C Stretching in IR spectra for aluminium formamidinate complexes 
4.1 - 4.8 (υ 4000 - 400 cm-1) 
Compound                                                    N–C stretching vibration (cm-1) 
[Al(XylForm)2Cl]                                   (4.1) 1651 
[Al(XylForm)2I].PhMe                          (4.2) 1644 
[Al(XylFormH)Br3]                                   (4.3) 1642 
[Al3(XylForm)2(µ3-O)(OH)Cl4]2.PhMe       (4.4) 1637 
[Al(DippFormH)Br3]                                (4.5) 1646 
[Al(DippForm)Cl2(thf)]                         (4.6) 1639 
[Al(DippForm)ClBr(thf)]                      (4.7) 1640 
[Al(DippForm)2Cl]                                (4.8) 1641 
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Table 4.2 1H-NMR chemical shift data in ppm for aluminium formamidinate complexes 4.1 - 4.8 in C6D6  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1H-NMR 4.1 4.2 4.3 4.4 4.5 4.6 4.7   4.8 
NCHN 7.36 7.97 7.78 7.29 8.01 7.50 7.53   7.85 
Aromatic H 6.91-7.10 6.75-6.88 6.68-6.90 6.76-7.04 7.02-7.09 6.99-7.10 7.01-7.11   6.98-7.10 
CH(CH3)2 – – – – 3.31 3.77 3.80   3.51 
OH – – – 0.41 – – –   – 
NH – – 5.69 – 6.06 – –   – 
OCH2, thf – – – – – 3.56 3.54   – 
CH2, thf – – – – – 1.03 1.02   – 
ArH, PhMe – 7.18 – 7.25 – – –   – 
CH3, PhMe – 2.16 – 2.24 – – –   – 
CH3/CH(CH3)2 2.34 2.32 2.29 2.47 1.51 1.25 1.26   1.48 
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Table 4.3 13C-NMR chemical shift data in ppm for aluminium formamidinate complexes 4.1 - 4.8 in C6D6  
13C-NMR 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 
NCN 173.0 159.3 159.9 152.4 160.11 151.44 151.01 160.4 
Aromatic C 125.2-143.2 127.8-141.5 127.8-148.2 126.8-142.8 124.4-144.6 123.4-144.4 123.7-144.6 124.5-144.8 
CH(CH3)2 – – – – 28.77 28.05 28.26 28.66 
OCH2, thf – – – – – 70.46 70.27 – 
CH2, thf – – – – – 24.12 24.58 – 
ArC, PhMe – 134.5 – 131.20 – – – – 
CH3, PhMe – 20.16 – 21.43 – – – – 
CH3/CH(CH3)2 19.64 18.41 19.19 19.93 23.74 24.55 24.89 23.66 
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4.3.3 Crystal structure determinations 
        
[Al(XylForm)2X] (X = Cl (4.1) and I (4.2).PhMe) 
 
The trivalent aluminum complexes [Al(XylForm)2X] (X = Cl (4.1) and I 
(4.2).PhMe) were synthesised (Scheme 4.4). The monomeric complex (4.1) crystallised 
in the monoclinic space group P21/c, while complex (4.2) crystallised in the triclinic 
space group P-1 (Table 4.5), with one molecule within the asymmetric unit. The 
coordination environment for the Al atom in (4.2), except the existence of additional 
PhMe solvent molecule, is similar to that observed in trivalent (4.1), where the iodide 
replaces the chloride ligand. The structural parameters observed for (4.2) were very 
similar to that of (4.1), although crystallising in different space groups. The Al+3 metal 
centre in both complexes is five-coordinate, bound by two deprotonated κ2(N,N') 
XylForm ligands through the nitrogen donor atoms, and one terminal halide ligand (Cl 
(4.1) and I (4.2). X-ray crystallographic analysis for the two complexes (4.1 and 4.2) 
showed that the coordination geometries about Al+3 are distorted from trigonal 
bipyramid and square pyramid due to the very narrow bite of the formamidinate ligand 
(Figures 4.3 and 4.4).  
 
As expected, compound (4.1) exhibits Al–N bond lengths 1.919(4) Å shorter 
comparing with those in the axial positions 2.033(4) Å. These distances are similar to 
1.925(12) and 2.096(12) Å detected for Neq–Al, Nax–Al, respectively, in the related 
complexes [Al{MeC(NiPr)2}2Me],32 1.914(2) and 2.041(2) Å [Al{MeC(NiPr)2}2Cl],33 
1.9324(12) and 2.1005(13) Å [Al(XylForm)2Me],15 in addition to 1.928(3) and 2.093(3) 
Å reported in [Al{HC(NDipp)2}2Me].34 The bond angles in (4.1): N(3)–Al(1)–Cl(1) 
103.21(14), N(1)–Al(1)–Cl(1)  102.24(13) and N(3)–Al(1)–N(1) 154.54(19) ° confirm 
the formation of distorted square pyramid rather distorted trigonal bipyramid geometry.  
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Likewise the related aluminium structures [{MeC(NiPr)2}2AlCl],33 
[{MeC(NiPr)2}2AlMe],32 [{PhC(NSiMe3)2}2AlH],16 and [{HC(NDipp)2}2AlH],35 the 
N(1)–Al(1)–N(4) bond angle of 100.65(17) °in (4.1), displays a high distortion from 
the expected 180 ° that may due to the rather acute bite angles of 67.52(16) ° and 
67.27(16) ° for N(1)–Al(1)–N(2) and N(3)–Al(1)–N(4), respectively. Same observation 
was found in (4.2). It is worthy to mention that although there are size and electronic 
differences between CH, CPh and CMe of the C backbone, the structural differences 
between (4.1) and [Al{PhC(N(iPr))2}2Cl], [Al{MeC(N(iPr))2}2Cl] are insignificant, 
with bond lengths that mostly agree within 0.02 Å. 
The C–N bond lengths of NCN in (4.1) suggest delocalisation of the anionic 
charge across the backbone (N1/N2–C9: 1.313(6) and 1.336(6) Å, N3/N4–C26: 
1.310(6) and 1.333(6) Å; DippFormH: 1.311(17) and 1.310(16) Å).1,5 In addition, the 
NCN angle of 112.1(4) ° and Al–N bond lengths of Al1–N1/N2: 2.033(4) and 1.919(4), 
Al1–N3/N4: 2.040(4) and 1.925(4) Å, (Figure 4.3), are reasonably typical for bulky 
formamidinate coordinated to aluminium (analogous angles and bond lengths for 
[Al(DippForm)2Me]; NCN 111.7(3)/113.1(3) °, Al1–N1/N2: 1.928(3) and 2.093(3), 
Al1–N3/N4: 1.923(3) and 2.113(3) Å).34 Same findings can be seen with structure (4.2) 
(Figure 4.4). In comparison between bond lengths of N-C(N) with N-C(C6H3-2,6-Me2) 
in complex (4.1), the N-C(N) bond lengths are in the range of 1.310 (6) – 1.336 (6) Å 
and the N-C(C6H3-2,6-Me2) bond lengths are in the range 1.414 (6) – 1.425 (6) Å 
(Scheme 4.6).  
 
 
 
 
 
 
 
 
Scheme 4.6. Comparison between N-C(N) and N-C(C6H3-2,6-Me2) distances in (4.1). 
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The Al–Cl bond length of (4.1) found to be 2.119 (2) Å which is slightly shorter 
than the Al–Cl bond length (2.141 (15) Å) reported for [Al(EtForm)2Cl]15 and 
significantly shorter than the Al–Cl bond lengths (2.16 – 2.20 Å) for those of the seven 
reported [Al(Form)2Cl] complexes (Form = chelating amidinate), noting an increase in 
bulk (2,6-dimethylphenyl vs. 2,6-diethylphenyl) and at the N-substituents (2,6-
dimethylphenyl vs. N-isopropyl or N-cyclohexyl).11,36,37,14 While, Al–Cl bond length in 
(4.1) is in close agreement with those reported in the heteroleptic aluminium amidinate 
[Al{MeC(N(iPr))2}Cl2] (2.1057(10) and 2.1078(11) Å).38   
 
In (4.2), the Al–I bond length of 2.5456 (9) Å is in the normal range;4, 33,36,26 
however, the Al–I connection is slightly longer than those of [Al(Priso)I2] (2.50, 2.51 
Å)39 and [Al(CGiso)I2] (2.50 Å),15 even though two sites of the Al centre are occupied 
by the bulky formamidinate ligands (2 vs. 1). The bond lengths and angles in (4.2) are 
relatively similar to those in [Al(CGiso)I2] [Cgiso = N,N'-bis(2,6-disopropylphenyl)-
N''-dicyclohexylguanidinate].15 In general, the bond lengths in (4.2) are within 0.02 Å 
of those reported in [Al(Priso)I2],39 and the angles in (4.2) are similarly close. The N–
C(N) bond lengths are 1.311 (3) – 1.343 (3) and 1.304 (3) – 1.341 (3) Å, with the N–
C(C6H3-2,6-Me2)  bond lengths are 1.418 (3), 1.434 (3), 1.414 (3) and 1.436 (3) Å 
respectively.  
 
 4.1 4.2 [Al{HC(NDipp)2}2Me] [Al{Me2NC(NiPr)2}2Cl] 
Al-N1 2.033(4) 1.925(2) 1.928(3) 1.927(1) 
Al-N2 1.919(4) 2.031(19) 2.093(3) 1.979(1) 
Al-N3 2.040(4) 1.924(2) 1.923(3) 1.993(1) 
Al-N4 1.925(4) 2.038(19) 2.113(3) 1.929(1) 
 
Table 4.4 Selected Al-N bond lengths (Å) for complexes: [Al(XylForm)2Cl] (4.1), 
[Al(XylForm)2I] (4.2) and [Al{HC(NDipp)2}2Me]34 and [Al{Me2NC(NiPr)2}2Cl].39 
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Figure 4.3. Molecular structure of monomeric [Al(XylForm)2Cl] (4.1) with the atom 
numbering system; thermal ellipsoids are drawn at the 50 % probability level, hydrogen 
atoms have been omitted for clarity. Selected bond lengths (Å) and angles (°): Al(1)–
N(1): 2.033(4), Al(1)–N(2): 1.919(4), Al(1)–N(3): 2.040(4), Al(1)–N(4): 1.925(4), 
Al(1)–Cl(1): 2.119(2), N(2)–C(10): 1.414(6), N(2)–C(9): 1.336(6), N(1)–C(1): 
1.425(6), N(1)–C(9): 1.313(6), N(3)–C(18): 1.422(6), N(3)–C(26): 1.310(6), N(4)–
C(27): 1.425(6), N(4)–C(26): 1.333(6), N(2)–Al(1)–N(1): 67.52(16), N(4)–Al(1)–
N(3): 67.27(16), N(2)–Al(1)–N(3): 99.04(17), N(4)–Al(1)–N(1): 100.65(17), N(4)–
Al(1)–N(2): 122.07(19), N(1)–Al(1)–N(3): 154.54(19), N(2)–Al(1)–Cl(1): 118.86(15), 
N(4)–Al(1)–Cl(1): 119.07(15), Cl(1)–Al(1)–N(1): 102.24(13), Cl(1)–Al(1)–N(3): 
103.21(14), N(1)–C(9)–N(2): 112.1(4), N(3)–C(26)–N(4): 112.6(4), C(10)–N(2)–
Al(1): 143.9(3), C(1)–N(1)–Al(1): 149.9(3), C(18)–N(3)–Al(1): 148.6(3), C(27)–N(4)–
Al(1): 143.3(3), C(9)–N(2)–Al(1): 92.3(3), C(9)–N(1)–Al(1): 88.0(3), C(26)–N(3)–
Al(1): 87.9(3), C(26)–N(4)–Al(1): 92.2(3), C(1)–N(1)–C(9): 123.30(10), C(9)–N(2)–
C(10): 121.87(10), C(18)–N(3)–C(26): 123.91(11), C(26)–N(4)–C(27): 122.76(11).  
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Figure 4.4. Molecular structure of monomeric [Al(XylForm)2I].PhMe (4.2) with the 
atom numbering system; thermal ellipsoids are drawn at the 50 % probability level, 
hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and angles 
(°): Al(1)–N(1): 1.925(2), Al(1)–N(2): 2.0317(19), Al(1)–N(3): 1.924(2), Al(1)–N(4): 
2.0382(19), Al(1)–I(1): 2.5456(9), N(2)–C(10): 1.434(3), N(2)–C(9): 1.311(3), N(1)–
C(1): 1.418(3), N(1)–C(9): 1.343(3), N(3)–C(18): 1.414(3), N(3)–C(26): 1.341(3), 
N(4)–C(27): 1.436(3), N(4)–C(26): 1.304(3), N(2)–Al(1)–N(1): 67.48(8), N(4)–Al(1)–
N(3): 67.33(8), N(2)–Al(1)–N(3): 100.88(9), N(4)–Al(1)–N(1): 100.47(8), N(1)–
Al(1)–N(3): 125.40(9), N(4)–Al(1)–N(2): 154.95(8), N(2)–Al(1)–I(1): 102.07(6), 
N(4)–Al(1)–I(1): 102.98(6), I(1)–Al(1)–N(1): 117.61(7), I(1)–Al(1)–N(3): 116.98(7), 
N(1)–C(9)–N(2): 111.95(19), N(3)–C(26)–N(4): 112.45(19), C(10)–N(2)–Al(1): 
149.99(16), C(1)–N(1)–Al(1): 144.39(15), C(18)–N(3)–Al(1): 144.26(14), C(27)–
N(4)–Al(1): 149.86(16), C(9)–N(2)–Al(1): 88.44(13), C(9)–N(1)–Al(1): 92.11(14), 
C(26)–N(3)–Al(1): 92.05(14), C(26)–N(4)–Al(1): 88.16(13), C(1)–N(1)–C(9): 
123.34(10), C(9)–N(2)–C(10): 121.22(19), C(18)–N(3)–C(26): 123.59(11), C(26)–
N(4)–C(27): 121.81(11).  
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[Al(XylFormH)Br3] (4.3) 
 
The reaction of Na(XylForm) with AlBr3 in PhMe at room temperature was 
performed with the goal of isolating [Al(XylForm)Br2], however, [Al(XylFormH)Br3] 
was isolated instead in moderate yield (56 %) (Scheme 4.4). Complex (4.3) crystallised 
from PhMe in the monoclinic space group P21/n (Table 4.5), with one molecule within 
the asymmetric unit. In (4.3) the aluminum atom, Al1, is coordinated with a dative 
nitrogen from the formamidine ligand (through κ1(N1) XylForm), and three terminal 
bromine atoms. Complex (4.3) showed a distorted tetrahedral geometry about the four-
coordinate trivalent aluminium (Figure 4.5).  
In the molecular structure of (4.3), the Al1–N1 bond length was found to be 
1.904 (2) Å in the normal range.33 Complex (4.3) is geometrically remarkable as the 
monodentate coordination mode of aluminium in formamidinate/formamidine 
chemistry fairly rare.26 Assessment of the N1– C9 and N2– C9 bond lengths: 1.315(3) 
and 1.326(3) Å, respectively, suggests delocalisation of the double bond.  
It is believed that the crystal structure of the metal complex crystallises better 
as the E isomer with respect to the N1–C9 bond if the hydrogen was attached to the 
NCN backbone, rather than a more bulky alkyl group such as the methyl group. For 
instance, the formamidinate gallium complex, [Ga{HC(NDipp)2H}Cl3],26 and 
[Al{HC(NDipp)2H}MeCl2] and [Al{HC(NDipp)2H}Cl1.4I1.6],34 crystallise as the E 
isomer, while the acetamidinate aluminium [Al{MeC(NDipp)2H}I3]26 and 
molybdenum [Mo{MeC(NDipp)2H}(CO)5]40 complexes crystallise in the Z form.41 
However, product (4.3) is very unusual having a hydrogen attached to the NCN 
backbone and displaying Z form. As expected, the Al–N distance 1.904(2) Å is shorter 
than those Al–N distances in the higher coordination number complexes (4.1 and 4.2) 
with range between 1.919 (4) – 2.084 (13) Å even though the ligand is uncharged in 
(4.3).  
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Figure 4.5. Molecular structure of monomeric [Al(XylFormH)Br3] (4.3) with the atom 
numbering system; thermal ellipsoids are drawn at the 50 % probability level, hydrogen 
atoms have been omitted for clarity. Selected bond lengths (Å) and angles (°): Al(1)–
N(1): 1.904(2), N(1)–C(1): 1.455(3), N(1)–C(9): 1.315(3), N(2)–C(9): 1.326(3), N(2)–
C(10): 1.441(3), Br(1)–Al(1): 2.3038(10), Br(2)–Al(1): 2.2916(10), Br(3)–Al(1): 
2.2687(9), C(1)–N(1)–Al(1): 120.90(18), C(9)–N(1)–Al(1): 121.03(18), C(9)–N(1)–
C(1): 117.9(2), C(9)–N(2)–C(10): 121.8(2), N(2)–C(9)–N(1): 126.3(2), Br(2)–Al(1)–
Br(1): 107.99(4), Br(3)–Al(1)–Br(1): 110.64(4), Br(3)–Al(1)–Br(2): 114.24(4), N(1)–
Al(1)–Br(1): 110.32(8), N(1)–Al(1)–Br(2): 105.84(8), N(1)–Al(1)–Br(3): 107.70(7). 
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Table 4.5 Crystallographic data for compounds 4.1 ‒ 4.3 
 
Compound 4.1 4.2 4.3 
formula C34H38AlClN4 C41H46AlIN4 C17H20AlBr3N2 
fw 565.11 748.70 519.06 
crystal system monoclinic triclinic monoclinic 
space group P21/c P-1 P21/n 
a, Å 8.0280(16) 8.2260(16) 7.7260(15) 
b, Å 8.5240(17) 15.064(3) 14.013(3) 
c, Å 44.624(9) 15.169(3) 18.307(4) 
α, deg 90 93.96(3) 90 
β, deg 92.20(3) 96.63(3) 93.93(3) 
γ, deg 90 96.34(3) 90 
V, Å3 3051.4(11) 1849.3(7) 1977.3(7) 
Z 4 2 4 
T, K 100(2) 100(2) 100(2) 
no. of rflns collected 35848 22141 15215 
no. of indep rflns 5120 5936 3240 
Rint 0.0477 0.0338 0.0572 
Final R1 values (I > 2σ(I)) 0.0588 0.0273 0.0348 
Final wR(F2) values (I >2σ(I)) 0.1535 0.0735 0.0960 
Final R1 values (all data) 0.0656 0.0293 0.0358 
Final wR(F2) values (all data) 0.1568 0.0748 0.0970 
GooF (on F2) 1.198 1.064 1.071 
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[Al3(XylForm)2(µ3-O)(OH)Cl4]2.PhMe (4.4) 
 
In an attempt to examine the chemistry of the system, we looked to synthesise 
[Al(XylForm)Cl2(thf)].PhMe. The in situ reaction of K(XylForm) in THF with AlCl3 in 
PhMe was performed in a 1:1 molar ratio (Scheme 4.4), however, colourless crystals of 
the unexpected [Al3(XylForm)2(µ3-O)(OH)Cl4]2.PhMe were isolated from PhMe. The 
fact that the compound has O2‒ and OH‒ present indicates the high air and moisture 
sensitivity of these compounds. Complex (4.4) crystallised in triclinic space group P-1 
(Table 4.6). Two crystallographically unique molecules, with similar fundamental 
coordination geometries are present in the asymmetric unit. The difference between the 
two molecules which is most pronounced in the opposite positions of the formamidinate 
rings (Fig. 4.6). The X-ray crystallographic study for complex (4.4) showed that each 
of the two molecules has two deprotonated ligands supporting three aluminium centres 
through a µ-[κ1-N: κ1-N] mode, forming a bridged formamidinate structure (Fig. 4.7). 
A terminal chlorides and a terminal OH‒ group are present on each aluminium centre. 
It is assumed that the occurrence of oxygen (O2‒ and OH‒) arises from adventitious H2O 
highlighting the reactivity of (4.4).42,43,44,45 
 
Figure 4.6. A view of (4.4), showing the two crystallographically unique molecules 
and the atom-numbering scheme. 
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Three aluminium atoms are present in complex (4.4). The aluminium atom, Al1, 
is bonded by one nitrogen donor atom, N1, one chloride atom, one OH group, and is 
connected to a µ3 oxygen atom O1 that links the three aluminium centres. The second 
aluminium centre, Al2, is bridged by two nitrogen atoms from the two XylForm ligands, 
N2 and N3 displaying κ1(N,N') bridged mode, as well as bonded to one chloride atom 
and connected to the µ3 oxygen atom O1. The third aluminium centre, Al3, is bonded 
by one nitrogen donor atom, N4, two chloride atoms, and connected to the µ3 oxygen 
atom O1. Overall, the coordination sites around the µ3 oxygen atom centre O2‒ are 
occupied by the three aluminium atoms. Models of a three-coordinate oxygen centre 
with bonds to three aluminium atoms are exceptional but not unprecedented.46,47,48 The 
best description for this structure is two merged six membered rings, that share Al2 and 
O1. Each Al centre has slightly distorted tetrahedral geometry.  
 
The cationic charge of + 9 about the three Al3+ ions is balanced by a ‒ 1 charge 
observed for each NCN ligand, (‒ 2), and a ‒ 1 charge for each terminal chloride ion, 
(‒ 4), a ‒1 charge for terminal hydroxyl group, (‒1), as well as a charge on the central 
bridged oxygen ion, (‒ 2). The Al (III) centre in each of the monomeric 
[Al(XylForm)2Cl] (4.1) and [Al(XylForm)2I].PhMe (4.2) is bound by the four nitrogen 
atoms of the chelating ligands, displaying κ2(N,N') chelating mode, while in the 
trinuclear (4.4) each Al centre is bridged by one of the nitrogen atoms of the ligand.  
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The Al—N bond lengths are in the range between 1.891(5) – 1.935(5) Å, and 
together with NCN angles are similar to those reported in neutral chelated 
formamidinate complexes.32,33 Of these, the Al2—N2 and Al2—N3 bond lengths are 
slightly shorter than the others, which is may not be chemically significant. As observed 
in complex (4.4) the bond lengths of the ligand: N3/N4–C26 and N1/N2–C9 are 
1.317(6)/1.462(6) and 1.329(6)/1.455(6) Å, respectively. These distances are 
intermediate between that of single and double bond distances. Single and double bond 
distances are reported previously in Chapter two of this thesis, indicating the π 
delocalisation within the NCN unit. The Al—N metric parameters are very comparable 
to those of the heteroleptic Al (III) amidinate complex reported by Lesikar and 
Richards.34 The bond lengths and bond angles equivalent to within ± 0.07 Å and ± 2 °, 
respectively.  
 
Complex [Al3(XylForm)2(µ3-O)(OH)Cl4]2.PhMe exhibits Al1/Al2/Al3–O1 distances of 
1.795(4), 1.769(4) and 1.809(4) Å, respectively, which correspond closely to the 
[{DippNCHDipp}2Al3µ3O(OH)2(Cl/OH)ClMe] complex with distances of 1.782(4), 
1.772(4) and 1.792(4) Å respectively.34 The Al–O bond lengths in both complexes are 
significantly shorter than the ionic radii of Al–O bond lengths (l.90 Å),49 but slightly 
shorter than the Al–O bond length of 1.827(3) Å reported for [Me2AIO(CH2)2OMe]2. 
However, the three Al–O–Al bond angles in (4.4) at the values 125.7(2), 119.9(2) and 
114.3(2) ° are larger than the Al–O–Al bond angle of 103° identified in 
[Me2AIO(CH2)2OMe]2.50,51 
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Figure 4.7. Molecular structure of trinuclear [Al3(XylForm)2(µ3-O)(OH)Cl4]2.PhMe 
(4.4) with the atom numbering system; thermal ellipsoids are drawn at the 50 % 
probability level, hydrogen atoms have been omitted for clarity. Selected bond lengths 
(Å) and angles (°): Al(1)–N(1): 1.935(5), Al(2)–N(2): 1.891(5), Al(2)–N(3): 1.892(4), 
Al(3)–N(4): 1.931(4), Al(1)–Cl(1): 2.164(2), Al(1)–O(1): 1.795(4), Al(1)–O(2): 
1.974(4), Al(2)–Cl(2): 2.080(2), Al(2)–O(1): 1.769(4), Al(3)–Cl(4): 2.126(3), Al(3)–
Cl(3): 2.031(3), Al(3)–O(1): 1.809(4), N(2)–C(10): 1.340(6), N(1)–C(1): 1.448(6), 
N(1)–C(9): 1.329(6), N(2)–C(9): 1.455(6), N(3)–C(18): 1.454(6), N(3)–C(26): 
1.317(6), N(4)–C(27): 1.330(6), N(4)–C(26): 1.462(6), N(2)–Al(2)–N(3): 115.42(18), 
N(2)–Al(1)–N(3): 102.1(7), N(2)–Al(2)–Cl(2): 111.48(16), N(3)–Al(2)–Cl(2): 
110.35(16), N(4)–Al(3)–Cl(4): 109.83(16), N(4)–Al(3)–Cl(3): 114.52(17), O(1)–
Al(1)–Cl(1): 106.54(14), O(2)–Al(1)–Cl(1): 114.50(17), O(1)–Al(2)–Cl(2): 
107.46(14), O(1)–Al(3)–Cl(4): 107.05(16), O(1)–Al(3)–Cl(3): 113.34(16), O(1)–
Al(1)–N(1): 100.26(19), O(1)–Al(2)–N(2): 108.84(19), O(1)–Al(2)–N(3): 102.64(19), 
O(1)–Al(3)–N(4): 100.64(18), O(1)–Al(1)–O(2): 117.2(2), N(1)–Al(1)–Cl(1): 
105.46(15), N(1)–Al(1)–O(2): 111.38(19), Cl(3)–Al(3)–Cl(4): 110.82(12), Al(1)–
O(1)–Al(3): 125.7(2), Al(2)–O(1)–Al(1): 119.9(2), Al(2)–O(1)–Al(3): 114.3(2), C(9)–
N(1)–Al(1): 126.7(3), C(1)–N(1)–Al(1): 116.3(3), C(10)–N(2)–Al(2): 120.8(3), C(9)–
N(2)–Al(2): 122.0(3), C(26)–N(4)–Al(3): 115.0(3), C(27)–N(4)–Al(3): 129.9(4), 
C(18)–N(3)–Al(2): 123.8(3), C(18)–N(3)–Al(2): 119.9(3). Atoms generated by 
symmetry: 11-X,1-Y,-Z.  
CHAPTER FOUR: RESULTS AND DISCUSSION  
 
182 
 
 
[Al(DippFormH)Br3] (4.5) 
 
Examination of the reaction of AlBr3 with one equivalent of Na(DippForm) in 
PhMe at room temperature generated the resultant tribromoaluminium formamidine 
complex [Al(DippFormH)Br3], which was isolated in good yield (61 %). The 
monomeric (4.5) crystallised in the monoclinic space group P21/c (Table 4.6), with one 
molecule within the asymmetric unit. Structural determination revealed an aluminum 
atom, Al1, is four coordinated with a dative nitrogen from the formamidine ligand 
(through κ1(N1) XylForm), and three terminal bromine atoms, showing an overall 
distorted tetrahedral geometry.  
 
The molecular structure of compound (4.5) is depicted in (Figure 4.8), showing 
Al1–N1 bond length of 1.885(3) Å in the normal range.33 The coordination environment 
for the aluminium bromide formamidine compound (4.5) is isostructural with that 
observed in trivalent (4.3), where the bulky DippFormH ligand replaces the XylFormH 
ligand. A feature of compounds (4.3 and 4.5) is that the formation of the monomer is 
favoured rather than a dimer and this presumably arises due to the steric bulk of the ligands 
limiting bridging halides. Attempts to repeat the synthesis of [Al(Form)Br2] (Form = 
XylForm, DippForm) met with repeated failure. The X-ray analysis showed the 
formation of the formamidine ligand (XylFormH (4.3) or DippFormH (4.5)) binding in 
a monodentate mode to the AlBr3 through the lone pair on the non-protonated N-atom 
and protonated at the other nitrogen atom. 
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Figure 4.8. Molecular structure of monomeric [Al(DippFormH)Br3] (4.5) with the 
atom numbering system; thermal ellipsoids are drawn at the 50 % probability level, 
hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and angles 
(°): Al(1)–N(1): 1.885(3), N(1)–C(1): 1.446(4), N(1)–C(13): 1.309(4), N(2)–C(13): 
1.311(4), N(2)–C(14): 1.444(4), Br(1)–Al(1): 2.2774(12), Br(2)–Al(1): 2.2783(13), 
Br(3)–Al(1): 2.2502(11), C(1)–N(1)–Al(1): 126.5(2), C(13)–N(1)–Al(1): 115.0(2), 
C(13)–N(1)–C(1): 118.5(3), C(13)–N(2)–C(14): 118.7(3), N(2)–C(13)–N(1): 128.8(3), 
Br(2)–Al(1)–Br(1): 106.27(5), Br(3)–Al(1)–Br(1): 114.02(4), Br(3)–Al(1)–Br(2): 
115.35(5), N(1)–Al(1)–Br(1): 106.58(9), N(1)–Al(1)–Br(2): 104.70(9), N(1)–Al(1)–
Br(3): 109.19(9). 
 
 
CHAPTER FOUR: RESULTS AND DISCUSSION  
 
184 
 
 
[Al(DippForm)X2(thf)] (X = Cl (4.6), Cl, Br (4.7)) 
 
In order to compare the coordination preferences and products obtained from 
aluminium halide reactions with the deprotonated DippformH ligand, two reactions 
with AlX3 (X = Cl, Br) were performed. The monomeric complexes of (4.6 and 4.7) 
were found to crystallise in the triclinic space group P-1 (Table 4.6). The five-
coordinate aluminium centre in each of the complexes (4.6 and 4.7) is ligated by two 
nitrogen atoms from the formamidinato ligand, and the other three sites are occupied 
by a two halide atoms (2Cl (4.6) and ClBr (4.7)) and a tetrahydrofuran solvent 
molecule. The coordination geometry of Al+3 in (4.6 and 4.7) assume distorted from 
trigonal bipyramid and square pyramid due to the very narrow bite of the DippForm 
ligand (Scheme 4.5). The coordination environment for the Al atom in (4.7) is similar 
to that observed in trivalent (4.6), where the bromide ligand replaced one of the chloride 
ligands. The formamidinate moieties in (4.6 and 4.7) serve as (η2) N,N'-chelating four–
electron donor ligands and they are almost similar to the structures observed for the 
corresponding [GaMe2(PhNCPhNPh)],12 [E{RC(NR')2}Cl2] [E = Sb, R = tBu, R' = iPr, 
Cy, 2,6-iPr2C6H3 (DippForm); R= nBu, R' = iPr; E = Bi, R = tBu, R' = iPr , DippForm]52 
and [Sb(Form)X2] [X = F, N3; Form = tBuC(NiPr)2 or tBuC(N{2,6-iPr2C6H3})2].53 In 
addition, in the solid state of these two complexes showed comparable structures to the 
bismuth formamidinate complexes of the type [Bi(Form)X2(Et2O)] (X = Cl, Br), except 
the latter have formed solvent-coordinated (Et2O).54 Al1–N1 and Al1–N2 distances in 
(4.6 and 4.7) were found to be 1.928(3)/2.104(3) and 1.925(5)/2.118(5) Å that are in 
the usual range.32,33,34,4 The formation of a four-membered Al-N-C-N ring system 
confirmed the distorted delocalisation of the π-electrons in the formamidinate 
backbone, which is supported by the very slightly dissimilar bond lengths between N1–
C13 1.329(4)/N2–C13 1.300(4) Å (4.6) and N1–C13 1.314(7)/N2–C13 1.299(7) Å 
(4.7). The N1–Al–N2 bond angle of 66.1(2) ° in complex (4.7) is slightly bigger than 
that in complex (4.6) 65.8(11) °, and both of them are normal for metal formamidinate 
complexes. Also, the most prominent structural consistency between (4.6) and (4.7) is 
shown by the exocyclic X(1)–Al–X(2) bond angles (X = Cl and/or Br), 115.14(9) ° in 
complex (4.6) which is identical with that in complex (4.7) 115.15(11) ° (Fig. 4.9 and 
4.10).  
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Figure 4.9. Molecular structure of monomeric [Al(DippForm)Cl2(thf)] (4.6) with the 
atom numbering system; thermal ellipsoids are drawn at the 50 % probability level, 
hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and angles 
(°): Al(1)–N(1): 1.928(3), Al(1)–N(2): 2.104(3), N(1)–C(1): 1.429(4), N(1)–C(13): 
1.329(4), N(2)–C(14): 1.421(4), N(2)–C(13): 1.300(4), Cl(1)–Al(1): 2.0851(18), 
Cl(2)–Al(1): 2.1094(18), Al(1)–O(1): 2.000(3), C(1)–N(1)–Al(1): 145.6(2), C(13)–
N(1)–Al(1): 93.91(19), C(13)–N(2)–Al(1): 87.0(2), C(13)–N(1)–C(1): 120.4(3), 
C(13)–N(2)–C(14): 122.4(3), C(14)–N(2)–Al(1): 149.6(2), N(2)–C(13)–N(1): 
113.2(3), Cl(1)–Al(1)–Cl(2): 115.14(9), O(1)–Al(1)–Cl(1): 94.43(10), O(1)–Al(1)–
Cl(2): 93.57(10), O(1)–Al(1)–N(2): 156.29(12), N(1)–Al(1)–Cl(1): 123.98(11), N(2)–
Al(1)–Cl(1): 97.00(9), N(1)–Al(1)–Cl(2): 120.16(11), N(2)–Al(1)–Cl(2): 100.20(10), 
N(1)–Al(1)–O(1): 90.60(12), N(1)–Al(1)–N(2): 65.80(11). 
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Figure 4.10. Molecular structure of monomeric [Al(DippForm)ClBr(thf)] (4.7) with 
the atom numbering system; thermal ellipsoids are drawn at the 50 % probability level, 
hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and angles 
(°): Al(1)–N(1): 1.925(5), Al(1)–N(2): 2.118(5), N(1)–C(1): 1.412(7), N(1)–C(13): 
1.314(7), N(2)–C(14): 1.424(8), N(2)–C(13): 1.299(7), Br(1)–Al(1): 2.284(2), Cl(1)–
Al(1): 2.177(3), Al(1)–O(1): 2.017(5), C(1)–N(1)–Al(1): 146.4(4), C(13)–N(1)–Al(1): 
93.2(4), C(13)–N(2)–Al(1): 85.2(4), C(13)–N(1)–C(1): 120.4(5), C(13)–N(2)–C(14): 
123.4(5), C(14)–N(2)–Al(1): 150.1(4), N(2)–C(13)–N(1): 115.5(6), Cl(1)–Al(1)–
Br(1): 15.15(11), O(1)–Al(1)–Br(1): 92.94(15), O(1)–Al(1)–Cl(1): 95.88(16), O(1)–
Al(1)–N(2): 155.7(2), N(1)–Al(1)–Br(1): 118.57(16), N(2)–Al(1)–Br(1): 99.63(15), 
N(1)–Al(1)–Cl(1): 125.58(18), N(2)–Al(1)–Cl(1): 97.45(16), N(1)–Al(1)–O(1): 
89.6(2), N(1)–Al(1)–N(2): 66.1(2), C(26)–O(1)–Al(1): 120.7(4), C(29)–O(1)–Al(1): 
123.9(4).  
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Table 4.6 Crystallographic data for compounds 4.4 - 4.7 
 
Compound 4.4 4.5 4.6 4.7 
formula C75H86Al6Cl8N8O4 C25H36AlBr3N2 C29H43AlCl2N2O C29H43AlBrClN2O 
fw 1609.00 631.27 533.53 577.99 
crystal system triclinic monoclinic triclinic triclinic 
space group P-1 P21/c P-1 P-1 
a, Å 10.906(2) 10.278(2) 10.3175(4) 10.222(2) 
b, Å 12.427(3) 19.974(4) 10.7120(4) 10.720(2) 
c, Å 16.934(3) 14.178(3) 14.7854(5) 14.529(3) 
α, deg 87.83(3) 90 91.983(2) 91.85(3) 
β, deg 72.56(3) 108.59(3) 98.268(2) 98.80(3) 
γ, deg 67.89(3) 90 103.631(2) 104.04(3) 
V, Å3 2021.2(9) 2758.7(11) 1567.57(10) 1522.3(6) 
Z 2 4 2 2 
T, K 100(2) 100(2) 296(2) 173(2) 
no. of rflns collected 17460 27489 15311 18551 
no. of indep rflns 6653 4822 5297 4871 
Rint 0.0926 0.0384 0.0408 0.0297 
Final R1 values (I > 2σ(I)) 0.0846 0.0385 0.0821 0.0674 
Final wR(F2) values (I >2σ(I)) 0.2249 0.0993 0.2646 0.1998 
Final R1 values (all data) 0.1312 0.0415 0.0990 0.0686 
Final wR(F2) values (all data) 0.2590 0.1015 0.2880 0.2007 
GooF (on F2) 1.040 1.081 1.052 1.111 
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[Al(DippForm)2Cl] (4.8)   
 
The heteroleptic chloride-bis(N,N'-diisopropylphenylformamidinato) aluminium (III) 
complex [Al(DippForm)2Cl] crystallised in the monoclinic space group P21/n, as a 
solvent-free complex (Table 4.8), with one molecule within the asymmetric unit. 
Complex (4.8) has been synthesised in reasonable yield (70 %). This compound was 
previously reported in the literature with weak data and very poor quality and the 
structure was reported ″for connectivity only″.15 Therefore, we intended to resynthesise 
it and collect much improved data and this is presented here.  
The two formamidinate moieties in (4.8) serve as chelating η2(N,N') four-
electron nitrogen donor ligands, similarly to those was previously observed for 
[Bi(DippForm)2Bun] complex.54 X-ray crystallographic analysis for (4.8) displayed that 
the coordination geometry about Al+3 distorted from trigonal bipyramid and square 
pyramid due to the very narrow bite of the DippForm ligand (Figures 4.11). The two 
formamidinate ligands are symmetrically bound to Al with the four N atoms forming a 
fairly accurate trapezium with the Al atom in the centre of the structure (N(2)–Al–N(3) 
104.22(5)◦ and N(1)–Al–N(4) 103.87(5)◦). 
The structure of the chloride complex (4.8) is analogous to those of 
Al(XylForm)2Cl (4.1) and [Al(XylForm)2I].PhMe (4.2) above, but shows a different 
ligand arrangement. The variance in the Al–N bond lengths (0.146, 0.124 Å) are 
different from those of the Al(XylForm)2Cl (4.1) (0.114, 0.115 Å) and 
[Al(XylForm)2I].PhMe (4.2) (0.106, 0.114 Å) complexes above. The Al–Cl bond is 
perpendicular to the AlN4 plane and the bond length at the value of (2.1531(10) Å) is 
typical for Al chloride bond,11,14,15,36,37 but is longer than those found in (4.1) with the 
value of 2.119 (2) Å. The iPr groups are occupied above and below the plane. 
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Figure 4.11. Molecular structure of monomeric [Al(DippForm)2Cl] (4.8) with the 
atom numbering system; thermal ellipsoids are drawn at the 50 % probability level, 
hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and angles 
(°): Al(1)–N(1): 2.0610(13), Al(1)–N(2): 1.9158(13), Al(1)–N(3): 2.0423(13), Al(1)–
N(4): 1.9185(13), Al(1)–Cl(1): 2.1531(10), N(2)–C(14): 1.4324(18), N(2)–C(13): 
1.3397(18), N(1)–C(1): 1.4398(18), N(1)–C(13): 1.3108(19), N(3)–C(26): 1.4281(18), 
N(3)–C(38): 1.3068(19), N(4)–C(38): 1.3359(18), N(4)–C(39): 1.4234(19), N(2)–
Al(1)–N(1): 67.48(5), N(2)–Al(1)–N(3): 104.22(5), N(2)–Al(1)–Cl(1): 117.19(4), 
N(1)–Al(1)–N(3): 161.82(5), N(4)–Al(1)–N(2): 126.87(6), N(4)–Al(1)–N(1): 
103.87(5), N(4)–Al(1)–N(3): 67.36(5), N(4)–Al(1)–Cl(1): 115.94(4), N(1)–C(13)–
N(2): 113.14(13), Cl(1)–Al(1)–N(1): 100.02(4), Cl(1)–Al(1)–N(3): 98.16(4), C(13)–
N(2)–Al(1): 92.35(9), C(14)–N(2)–Al(1): 146.78(10), C(1)–N(1)–Al(1): 152.11(10), 
C(13)–N(1)–Al(1): 86.92(9), N(3)–C(38)–N(4): 112.61(13), C(38)–N(3)–Al(1): 
87.59(9), C(26)–N(3)–Al(1): 147.21(11), C(39)–N(4)–Al(1): 144.99(10), C(38)–N(4)–
Al(1): 92.11(9). 
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The N(1)–Al(1)–N(2) 67.48(5) and N(3)–Al(1)–N(4) 67.36(5)° are larger than 
the typical bond angle in the metal amidinate complexes (60°). The N(1)–C(13)–N(2) 
113.14(13) and N(3)–C(38)–N(4) 112.59(13)° angles of (4.8) are almost identical and 
the sum of bond angles at C(13) 359.9, C(38) 360.0, N(1) 359.3, N(2) 359.8, N(3) 357.8 
and N(4) 359.6°, pointing to sp2-hybridised carbon and nitrogen atoms. On the other 
hand, the delocalisation of the π-electrons in the formamidinate backbone is slightly 
distorted as indicated by the difference of bond lengths C(13)–N(1)/(2) 1.310 
(19)/1.339 (18) and C(38)–N(3)/(4) 1.306 (19)/1.335 (18) Å. Analogous findings were 
previously detected in formamidinate complexes of the type [Al(L)2Cl] complexes [L 
= chelating formamidinate].11,14, 36, 37  
 
Table (4.7) displays all the selected bond lengths for each of the obtained 
trivalent aluminium compounds. These Al-N bond lengths are virtually asymmetric. 
The shortest Sb-N bond length for the trivalent species observed in the four-coordinate 
[Al(DippFormH)Br3] (4.5) (1.885 Å), while the longest Sb-N bond length was observed 
for the five-coordinate [Al(DippForm)ClBr(thf)] (4.7) (2.118 Å).  
 
 4.1 4.2 4.3 4.4 4.5 2.6 2.7 2.8 
Al-N1 2.033(4) 1.925(2) 1.904(2) 1.935(5) 1.885(3) 1.928(3) 1.925(5) 2.061(13) 
Al -N2 1.919(4) 2.031(19) - 1.891(5) - 2.104(3) 2.118(5) 1.915(13) 
Al -N3 2.040(4) 1.924(2) - 1.892(4) - - - 2.042(13) 
Al -N4 1.925(4) 2.038(19) - 1.931(4) - - - 1.918(13) 
 
Table 4.7 Selected bond lengths (Å) for complexes: [Al(XylForm)2Cl] (4.1), 
[Al(XylForm)2I].PhMe (4.2), [Al(XylFormH)Br3] (4.3), [Al3(XylForm)2(µ3-
O)(OH)Cl4]2.PhMe (4.4), [Al(DippFormH)Br3] (4.5), [Al(DippForm)Cl2(thf)] (4.6), 
[Al(DippForm)ClBr(thf)] (4.7) and [Al(DippForm)2Cl] (4.8). 
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[Me3Sb-SbMe2][AlCl4]  (4.9) 
 
[Me3Sb-SbMe2][AlCl4] crystallised in the monoclinic space group P21/c (Table 
4.8), with one molecule in the asymmetric unit. The cation of complex (4.9) can be 
considered a trimethylstibine adduct of the dimethylstibenium ion, involving a slightly 
distorted trigonal pyramidal Me3Sb unit bound to a bent Me2Sb unit through an 
antimony-antimony bond. The tetrachloroaluminium anion adopts tetrahedral geometry 
(Fig. 4.12).  
 
The Sb–Sb bond distance observed in the antimony backbone of the cation of 
(4.9) is short (2.823(4) Å), showing a typical single bond since it is virtually equidistant 
with the calculated Sb–Sb single bond covalent radii (Σrcov(Sb–Sb) = 2.80 Å),55 but is 
shorter than the sum of the van der Waals radii (Sb: 4.12 Å).56 Also, the Sb–Sb bond 
length lies in good agreement with those identified in [PhSb2]-3 [2.8198(7)],57 [Me2Sb–
SbMe2–SbMe2][Me2SbBr2] [2.8203(4)],58 [Me3Sb-SbMe2]2[(MeSbBr3)2] 
[2.8205(12)]59 and [Me3Sb-SbMe2]2[GaCl4] [2.8273(3) Å],60 but is a little shorter 
compared to those stated in tetramethyldistibane [Me2Sb-SbMe2]+2 [2.862(2)]61, 
tetraphenyldistibane [Ph4Sb2]+2 [2.867(1)],62 (Me3Sb–Sb(Me)I2) [2.859(1)]63 and 
(Me3Sb–SbI3.thf) [2.843(1) Å].64 The Sb–C single bonds of the tetracoordinated 
(stibonium) and the tricoordinated Sb atoms (stibino centers) are in the predictable 
range (2.112(5) – 2.154(5) Å, (Σrcov (Sb–C) = 2.15 Å).55 The average bond angles in 
(4.9) of C–Sb–C are 101.9(3) ° and C–Sb–Sb 105.9(17) °, which are slightly larger than 
those reported for [Me3Sb-SbMe2][GaCl4].60 Comparable findings can be observed for 
transition metal complexes of tetramethyldistibine such as [(OC)5Cr]2[Sb2Me4].65 
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Figure 4.12. Molecular structure of ionic [Me2Sb-SbMe3][AlCl4] (4.9) with the atom 
numbering system; thermal ellipsoids are drawn at the 50 % probability level, hydrogen 
atoms have been omitted for clarity. Selected bond lengths (Å) and angles (°): Al(1)–
Cl(1): 2.1280(18), Al(1)–Cl(2): 2.1244(17), Al(1)–Cl(3): 2.118(2), Al(1)–Cl(4): 
2.1219(19), Sb(1)–Sb(2): 2.8238(4), Sb(2)–C(5): 2.149(5), Sb(1)–C(2): 2.119(4), 
Sb(1)–C(3): 2.115(5), Sb(1)–C(4): 2.112(5), Sb(2)–C(1): 2.154(5), C(2)–Sb(1)–Sb(2): 
116.99(13), C(5)–Sb(2)–C(1): 96.1(3), C(3)–Sb(1)–Sb(2): 110.03(15), Cl(2)–Al(1)–
Cl(1): 110.29(8), C(3)–Sb(1)–C(2): 104.0(2), Cl(3)–Al(1)–Cl(1): 108.40(8), C(4)–
Sb(1)–Sb(2): 114.78(15), Cl(3)–Al(1)–Cl(2): 109.77(10), C(4)–Sb(1)–C(2): 106.3(2), 
Cl(3)–Al(1)–Cl(4): 109.99(10), C(4)–Sb(1)–C(3): 103.4(2), Cl(4)–Al(1)–Cl(1): 
110.14(9), C(1)–Sb(2)–Sb(1): 94.09(16), Cl(4)–Al(1)–Cl(2): 108.24(8), C(5)–Sb(2)–
Sb(1): 93.82(17). 
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[Br3Sb-µBr-SbBr3][AlCl2(thf)4] (4.10)  
 
In an attempt to form bimetallics involving DippFormH, AlCl3 and SbBr3, the 
three were mixed in THF/PhMe and produced complex (4.10) in moderate yield, as 
very shiny cubic crystals. Crystals of complex (4.10) crystallised in the triclinic space 
group P-1 (Table 4.8). The formation of these crystals was accompanied by dark 
red/purple plates, which only diffracted very poorly. These crystals were obtained on 
multiple occasions, but we were unable to achieve a good X-ray data set, so were not 
explored any further.   
Unfortunately, good quality crystals for X-ray analysis of (4.10) could not be 
obtained. As a result, X-ray diffraction data for this compound were of lower quality 
and has only been included as confirmation of connectivity. The molecular structure of 
the crystalline compound (4.10) is shown in (Fig. 4.13). The coordination environment 
of (4.10) consists of an anionic hexabromodiantimonate (III), with Sb1 and Sb2 are 
tetrahedrally share the Br4 bridge [Br3Sb-µBr-SbBr3] ‾. While the cation involves four 
thf solvation coordinated dichloroaluminium. The Sb–Br bond lengths are in the range 
of 2.532(4) _ 2.960(4), in which the bromine bridges of Sb(1)–Br(4) 2.901(4) and 
Sb(2)–Br(4) 2.960(4) are almost identical. However, Clegg, et al. reported that the same 
type of bromine bridges were established with bond lengths 2.8280(12) and 3.5954(12) 
for which the difference is 0.767 Å in [Sb3Br3(dmpe)3].66 Same Sb-Br linkages, but is 
anionic cyclic tetramers observed for crystal structures of empirical formula 
[C3H5N2]6[Bi4Cl18],67 and the two polymorphic of pyrazolium bromoantimonates (III), 
[C3N2H5]6Sb4Br18·2H2O: α modification– tetragonal form and β modification– triclinic 
form.68  
The average Sb–Br(terminal bromine) bond lengths of [Br3Sb-µBr-SbBr3][AlCl2(thf)4] was 
found to be 2.70 Å, which is approximately in agreement with the average Sb–Br(terminal 
bromine) 2.78 Å reported for bis(diisobutylammonium) octabromodiantimonate (III), [(i-
C4H9)2NH2]2Sb2Br8,69 but the average of Sb–Br(bridge bromine) bond lengths of [Br3Sb-
µBr-SbBr3][AlCl2(thf)4] was found to be 2.93 Å that is significantly shorter than the 
average of Sb–Br(bridge bromine) 3.14 Å bond length of [(i-C4H9)2NH2]2Sb2Br8.69 
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Figure. 4.13. Molecular structure of ionic [Br3Sb-µBr-SbBr3][AlCl2(thf)4] (4.10) with 
the atom numbering system; thermal ellipsoids are drawn at the 50 % probability level, 
hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and angles (°): 
Sb(1)–Br(1) 2.582(4), Sb(1)–Br(2) 2.748(4), Sb(1)–Br(3) 2.532(4), Sb(1)–Br(4) 
2.901(4), Sb(2)–Br(4) 2.960(4), Sb(2)–Br(5) 2.691(4), Sb(2)–Br(6) 2.911(4), Sb(2)–
Br(7) 2.791(4), Al(1)–Cl(1) 2.237(4), Al(1)–Cl(2) 2.280(4), Al(1)–O(1) 1.976(4), 
Al(1)–O(2) 1.940(4), Al(1)–O(3) 1.954(4), Al(1)–O(4) 1.904(4). 
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Table 4.8 Crystallographic data for compounds 4.8 - 4.10 
Compound 4.8 4.9 4.10                               
formula C50H70AlClN4 C5H15AlCl4Sb2 C16H32AlCl2Br7O4Sb2 
fw 789.53 487.45 1189.09 
crystal system monoclinic monoclinic triclinic 
space group P21/n P21/c P-1 
a, Å 14.509(3) 9.1410(9) 23.604(5) 
b, Å 16.288(3) 10.0801(10) 33.287(7) 
c, Å 21.112(4) 17.3566(17) 23.911(5) 
α, deg 90 90 89.97(3) 
β, deg 109.86(3) 96.993(4) 105.23(3) 
γ, deg 90 90 89.97(3) 
V, Å3 4692.6(18) 1587.4(3) 18127.2 
Z 4 4 2 
T, K 100(2) 296(2) 100 
no. of rflns collected 56762 18644 173092 
no. of indep rflns 8217 3644 67470 
Rint 0.0369 0.0519 0.0539 
Final R1 values (I > 2σ(I)) 0.0491 0.0334 0.2527 
Final wR(F2) values (I >2σ(I)) 0.1226 0.0886 0.5710 
Final R1 values (all data) 0.0527 0.0428 0.3604 
Final wR(F2) values (all data) 0.1249 0.0950 0.6352 
GooF (on F2) 1.118 1.033 1.735 
 
Note. X-ray diffraction data of (4.10) has been included as confirmation of connectivity 
only. 
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4.4  Conclusions 
 
In conclusion, this chapter describes utilising two formamidinate ligands of 
large, but varying steric bulk, electronic properties and functionality (XylForm and 
DippForm) that led to isolation of eight new aluminium (III) formamidinate complexes. 
The reactions were metathesis routes between stoichiometric amounts of metal 
alkyl/amide such as (n-BuLi, LiN(SiMe3)2, NaN(SiMe3)2, KN(SiMe3)2) and the two 
formamidinate ligands in THF and/or PhMe, followed by combination with AlX3 (X = 
Cl, Br, I), and resulted in the complexes [Al(XylForm)2Cl] (4.1), 
[Al(XylForm)2I].PhMe (4.2), [Al(XylFormH)Br3] (4.3), [Al(DippFormH)Br3] (4.5) 
and [Al(DippForm)2Cl] (4.8). Using the bulkier formamidinate ligand (DippForm) 
allowed the isolation of the thf solvate dichlorido- or chloridobromido-(N,N'-
diisopropylformamidinato) aluminium (III), [Al(DippForm)Cl2(thf)] (4.6) and 
[Al(DippForm)ClBr(thf)] (4.7) respectively. The common feature of these complexes 
is formation of monomers. The heteroleptic aluminium complex [Al3(XylForm)2(µ3-
O)(OH)Cl4]2.PhMe (4.4) was isolated as a monomer and represents a compound 
containing three aluminium atoms bridged by an oxygen atom. The synthesised 
complexes have been fully characterised by X-ray crystallography in the solid state, 
and characterised by 1H- and 13C-NMR, IR spectroscopic techniques, elemental 
analysis as well as melting points. Dichloroaluminium and tetrachloroaluminate salts 
bearing different stibinostibonium cations and anions such as [Me3Sb-SbMe2]+ and 
[(Br4Sb)SbBr3] ̄ were isolated from SbCl3, SbBr3/AlMe3, AlCl3 mixtures, depending on 
the reaction conditions. The cation of [Me3Sb-SbMe2][AlCl4] has a tetrahedral Me3Sb 
bound to a bent SbMe2 unit with a short (2.82 Å) Sb-Sb bond, and the anion adopts the 
geometry of tetrahedral, consequently this form represents a type of heterobimetallic 
complex containing antimony and aluminium. Overall, this work has enriched the 
knowledge regarding formamidinato aluminium (III) complexes and much more 
information has been obtained concerning their structures and bonding modes. Many 
of these compounds could be used as a useful precursors in the search for low valent 
aluminium compounds, after treating the haloaluminium complexes with strong 
reducing agents such as KC8.   
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4.5  Experimental  
 
General Considerations/Air Sensitive Techniques 
 
All aluminium complexes described herein are extremely air and/or moisture 
sensitive, decomposing immediately with dramatic colour changes (colourless to 
brown) upon exposure to air. Therefore, all manipulations, including syntheses, were 
performed under oxygen- and moisture-free conditions requiring Schlenk-type 
glassware (flask), using both conventional standard Schlenk techniques interfaced to a 
high vacuum (10−2 Torr) on a double manifold vacuum line, and under an inert 
atmosphere of high purity dry nitrogen in a glovebox. All glassware were oven-dried at 
120 0C for no less than of 12 h before use, then used immediately from the oven to 
avoid exposure to moisture.  
Solvents were purified/dried and deoxygenated by an LC solvent purification 
system (hexane and PhMe), and by refluxing over and fresh distilled from sodium 
wire/benzophenone ketyl under nitrogen (tetrahydrofuran). After distillation solvents 
were stored in vacuum Schlenk flasks and degassed prior to use. The synthesis of the 
two sterically bulky formamidine proligands: XylFormH = N,N′-bis(2,6-
dimethylphenyl)formamidine and DippFormH = N,N′-bis(2,6-
diisopropylphenyl)formamidine, was according to a published procedure.70,71 
Anhydrous AlMe3, AlCl3, AlBr3, AlI3 and other starting materials such as lithium-
/sodium-/potassium-bis(trimethylsilyl)amide and n-butyllithium, were purchased from 
Sigma Aldrich Chemical Co and used as received without further purification.  
1H- and 13C-NMR spectra of air and moisture sensitive compounds were 
recorded by J.Young valve inert atmosphere NMR tubes protecting the sample from air 
at 25 0C on a Bruker AVANCE III HD 400 MHz spectrometer instrument. The chemical 
shifts are expressed in parts per million (ppm). 1H-NMR resonances were referenced 
against residual H in C6D6 (δ = 7.15), whereas 13C-NMR resonances were referenced to 
the deuterated C6D6 solvent (δ = 128.39). Perdeutero-benzene C6D6 (all ≥ 99 atom % 
D) was obtained from Sigma-Aldrich, pre-dried over sodium metal for 24 h, then 
distilled under an atmosphere of nitrogen before being stored in resealable greaseless 
Schlenk flasks and freeze-thaw degassed prior to use. 
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Infrared spectra were obtained from samples in Nujol mulls between NaCl 
plates, with a Nicolet-Nexus FTIR spectrophotometer within the range (ύ = 4000-400 
cm-1). Elemental analyses (C, H, N) were performed on single crystals by sending 
samples in sealed glass pipettes under nitrogen to the Microanalytical Laboratory 
Service, Science Centre, London Metropolitan University, England. Melting points 
were determined in sealed glass capillaries under nitrogen and are uncalibrated.  
 
 
Synthesis of trivalent aluminium formamidinato (XylForm and DippForm) 
complexes by metalation reactions in THF or PhMe/hexane  
 
[Al(XylForm)2Cl] (4.1)  
 
LiN(SiMe3)2 (1 M solution in THF, 2.0 ml, 2.0 mmol) was added dropwise to 
XylFormH (0.50 g, 2.0 mmol) in PhMe (20 ml), forming the solution of Li(XylForm). 
This solution was added dropwise through a cannula to a solution of AlCl3 (0.13 g, 1.0 
mmol) in PhMe (10 ml) at room temperature with stirring. The reaction mixture was 
stirred for 18 h to yield a yellow solution with a white precipitate of LiCl. Filtration and 
concentration to the point of incipient crystallisation, followed by cooling to − 30 0C 
overnight afforded a colorless crystalline sample of (4.1) suitable for X-ray diffraction 
structure determination. Yield = 0.20 g (40 %).  
4.1: M.P. 172-174 0C (dec). 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 2.34 (s, 24H, 
CH3), 6.91 (m, 4H, p-ArH), 7.03 (m, 8H, m-ArH), 8.95 (s, 2H, NC(H)N); 13C-NMR 
(101 MHz, C6D6, 25 0C): δ (ppm) = 19.02 (CH3), 125.26 (p-C), 133.86 (m-C), 136.75 
(o-C), 141.66 (N-C), 173.37 (NCN); Elemental analysis calcd. (%) for C34H38AlClN4 
(M = 565.18 g/mol): C 72.25, H 6.77, N 9.91; found: C 50.49, H 6.66, N 6.23 
(significantly low C and N percentage). IR (υ/cm-1, Nujol mull): 2727 (s), 2451 (m), 
2352 (s), 2022 (m), 1933 (m), 1908 (s),1841 (s), 1772 (s), 1735 (w), 1651 (s), 1588 (s), 
1557 (s), 1455 (s), 1377 (s), 1304 (m), 1260 (s), 1201 (s), 1150 (m), 1096 (m), 1024 
(m), 972 (m), 888 (s), 803 (m), 771 (m), 758 (s), 722 (s), 662 (m), 620 (w). 
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[Al(XylForm)2I].PhMe (4.2)  
 
A solution of K(XylForm), prepared from XylFormH (0.50 g, 2.0 mmol) in 
PhMe (20 ml) and KN(SiMe3)2 (0.5 M solution in PhMe, 4 ml, 2.0 mmol) at room 
temperature, was added dropwise through a cannula to a solution of AlI3 (0.41 g, 1.0 
mmol) in PhMe (10 ml) at room temperature with stirring. The reaction mixture was 
continued stirring for 18 h to yield a yellow solution with a white precipitate of KI. 
Filtration, concentration and slow cooling to − 30 0C overnight of this solution 
deposited light yellow crystals of (4.2). Yield = 0.31 g (62 %).  
4.2: M.P. 140-144 0C (dec). 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 2.15 (s, 3H, 
CH3-PhMe), 2.32 (s, 24H, CH3), 6.54 (m, 4H, p-ArH), 6.75 (m, 8H, m-ArH), 6.88 (m, 
5H, ArH-PhMe), 7.97 (s, 2H, NC(H)N); 13C-NMR (101 MHz, C6D6, 25 0C): δ (ppm) = 
18.41 (CH3), 20.16 (CH3, PhMe), 129.24 (p-C), 130.15 (m-C), 133.47 (o-C), 134.53 
(ArC, PhMe), 136.22 (N-C), 159.36 (NCN); Elemental analysis calcd. (%) for 
C41H46AlIN4 (M = 748.72 g/mol): C 65.78, H 6.19, N 7.48. Calcd (%) for C34H38AlIN4 
(656.58 g/mol after loss of PhMe solvation): C 62.19, H 5.83, N 8.53; found: C 34.22, 
H 5.04, N 4.81 (significantly low C and N percentage). IR (υ/cm-1, Nujol mull): 2924 
(s), 2411 (m), 2360 (s), 2335 (s), 2172 (w), 2023 (w), 1963 (s), 1871 (vs), 1785 (s), 
1644 (s), 1462 (vs), 1376 (vs), 1257 (w), 1146 (w), 1022 (w), 917 (m), 892 (m), 835 
(m), 720 (s), 625 (w).  
 
 
[Al(XylFormH)Br3] (4.3)  
 
A solution of Na(XylForm), prepared from XylFormH (0.25 g, 1.0 mmol) in 
PhMe (20 ml) and NaN(SiMe3)2 (0.6 M solution in PhMe, 0.6 ml, 1.0 mmol), was added 
dropwise to a solution of AlBr3 (0.27 g, 1.0 mmol) in PhMe (10 ml) at room temperature 
with stirring. The reaction mixture was continued stirring for 12 h to yield a yellow 
solution with a white precipitate of NaBr. Filtration, concentration and slow cooling to 
− 30 0C overnight of this solution leaving slightly unexpected white crystals of (4.3). 
Yield = 0.14 g (56 %). 
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4.3: M.P. 168-170 0C (dec). 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 2.29 (s, 12H, 
CH3), 5.69 (d, J = 12 Hz, 1H, NH), 6.68 (br m, 2H, p-ArH), 6.90 (br m, 4H, m-ArH), 
7.78 (d, J = 16 Hz, 1H, NC(H)N); 13C-NMR (101 MHz, C6D6, 25 0C): δ (ppm) = 19.19 
(CH3), 129.29 (p-C), 130.18 (m-C), 133.33(o-C), 134.41 (N-C), 159.35 (NCN); 
Elemental analysis calcd. (%) for C17H19AlBr3N2 (M = 518.03 g/mol): C 39.41, H 3.69, 
N 5.40; found: C 39.28, H 5.01, N 5.42. IR (υ/cm-1, Nujol mull): 3186 (w), 2727 (m), 
2408 (w), 2347 (m), 2281 (w), 2201 (w), 2033 (m), 1956 (m), 1880 (m), 1778 (s), 1677 
(w), 1642 (m), 1588 (m), 1454 (s), 1376 (s), 1305 (w), 1192 (s), 1090 (s), 946 (s), 892 
(m), 828 (s),768 (s), 722 (s), 628 (w). 
 
[Al3(XylForm)2(µ3-O)(OH)Cl4]2.PhMe (4.4) 
 
A solution of K(XylForm), prepared from XylFormH (0.75 g, 3.0 mmol) and 
KN(SiMe3)2 (0.5 M solution in PhMe, 6 ml, 3.0 mmol) in THF (30 ml), was added 
dropwise through a cannula to a solution of AlCl3 (0.39 g, 3.0 mmol) in PhMe (30 ml) 
at room temperature with stirring. The reaction mixture was stirred for 18 h to yield a 
yellow solution with a white precipitate of KCl. Volatiles were removed under reduced 
pressure, and the residue dried to the point of dryness and extracted into PhMe (20 ml) 
to ensure the complete composition of KCl. Filtration, concentration and slow cooling 
to − 30 0C overnight deposited light white crystals of (4.4). Yield = 0.49 g (65 %).  
4.4: M.P. 196-198 0C (dec). 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 0.41 (s, Al–
OH), 2.24 (br m, 3H, CH3-PhMe), 2.47 (br m, 24H, CH3), 6.76 (m, 4H, p-ArH), 7.04 
(m, 8H, m-ArH), 7.25 (m, 5H, ArH-PhMe), 8.19 (s, 2H, NC(H)N); 13C-NMR (101 
MHz, C6D6, 25 0C): δ (ppm) = 19.93 (CH3), 21.43 (CH3, PhMe), 129.23 (p-C), 133.54 
(m-C), 134.39 (o-C), 137.10 (ArC, PhMe), 139.81 (N-C), 172.49 (NCN) (partially 
obscured by resonances probably from the C6D6 impurities). Elemental analysis calcd. 
(%) for C75H86Al6Cl8N8O4 (M = 1609.0 g/mol): C 55.98, H 5.38, N 6.96. Calcd (%) for 
C68H78Al6Cl8N8O4 (1516.96 g/mol after loss of PhMe solvation): C 53.84, H 5.18, N 
7.38; found: C 34.22, H 5.04, N 4.81 (significantly low C and N percentage).  
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IR (υ/cm-1, Nujol mull): 2830 (w), 2730 (s), 2665 (w), 2468 (w), 2418 (vs), 2337 (s), 
2280 (m), 2114 (m), 2055 (s), 2038 (s),1936 (s), 1875 (vs), 1857 (s),1781 (s), 1637 (s), 
1596 (s), 1537 (m), 1439 (w), 1366 (w), 1257 (s), 1205 (s), 1169 (s), 1093 (s), 1020 (s), 
987 (vs), 936 (s), 917 (vs), 891 (s), 846 (s),782 (w), 720 (m), 602 (s), 584 (s), 557 (s), 
424 (w). 
 
[Al(DippFormH)Br3] (4.5)  
 
A solution of Na(DippForm), prepared from DippFormH (1.08 g, 3.0 mmol) 
and NaN(SiMe3)2 (0.6 M solution in PhMe, 1.8 ml, 3.0 mmol) in PhMe (20 ml), was 
added dropwise through a cannula to a solution of AlBr3 (0.81 g, 3.0 mmol) in PhMe 
(10 ml) at room temperature with stirring. The reaction mixture was continued stirring 
for 2 h to yield a yellow solution with a white precipitate of NaBr. Filtration, 
concentration under vacuum to the point of crystallisation ca.5 ml, and slow cooling to 
− 30 0C over 12 h gave pink-white crystals of (4.5). The single crystals were dried under 
vacuum after separated from the mother solution via syringe. Yield = 0.65 g (61 %).  
4.5: M.P. 168-170 0C. 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 1.51 (d, J = 6.6 
Hz, 24H, CH(CH3)2), 3.31 (sept, 4H, CH(CH3)2), 6.06 (d, J = 12 Hz, 1H, NH), 7.02 (br 
m, 2H, p-ArH), 7.09 (br m, 4H, m-ArH), 8.01 (d, J = 16 Hz, 1H, NC(H)N); 13C-NMR 
(101 MHz, C6D6, 25 0C): δ (ppm) = 24.33 (CH3-iPr), 28.77 (CH-iPr), 124.46 (p-C), 
125.83 (m-C), 132.44 (o-C), 146.6 (N-C), 160.57 (NCN); Elemental analysis calcd. (%) 
for C25H36AlBr3N2 (M = 631.25 g/mol): C 47.56, H 5.74, N 4.43; found: C 43.10, H 
7.25, N 4.17 (low in C and high in H percentage). IR (υ/cm-1, Nujol mull): 2727 (m), 
2665 (w), 2360 (s), 2340 (w), 1733 (s), 1646 (s), 1623 (s), 1506 (s), 1418 (s), 1339 (w), 
1152 (m), 1095 (w), 934 (m), 835 (m), 776 (s), 721 (vs), 668 (vs). 
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[Al(DippForm)Cl2(thf)] (4.6)  
 
A solution of Li(DippForm), was prepared from DippFormH (0.36 g, 1.0 mmol) 
and n-BuLi (1.6 M solution in hexanes, 0.6 ml, 1.0 mmol) in THF (20 ml) at room 
temperature. After 2 h stirring, the solution was added dropwise through a cannula to a 
stirred solution of AlCl3 (0.13 g, 1.0 mmol) in THF (10 ml) at 0 0C. The reaction mixture 
was continued stirring for 16 h. After 1 day the reaction mixture was dried under 
vacuum to the point of dryness and extracted into PhMe (20 ml), forming a precipitate 
of LiCl. Filtration and concentration to the point of incipient crystallisation, followed 
by cooling − 30 0C overnight afforded a white crystalline sample of (4.6) suitable for 
X-ray diffraction. Yield = 0.15 g (42 %).  
4.6: M.P. 160-162 0C; 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 1.03 (br m, 4H, 
CH2-thf), 1.25 (d, J = 6.9 Hz, 24H, CH(CH3)2), 3.56 (br m, 4H, OCH2-thf), 3.77 (sept, 
4H, CH(CH3)2), 6.99 (br m, 2H, p-ArH), 7.10 (br m 4H, m-ArH), 7.50 (s, 1H, NC(H)N); 
13C-NMR (101 MHz, C6D6, 25 0C): δ (ppm) = 24.12 (CH2-thf), 24.55 (CH3-iPr), 28.05 
(CH-iPr), 70.46 (OCH2-thf), 123.48 (p-C), 125.93 (m-C), 139.69 (o-C), 145.45 (N-C), 
166.36 (NCN); Elemental analysis calcd. (%) for C29H44AlCl2N2O (M = 534.56 g/mol): 
C 65.15, H 8.29, N 5.24. Calcd for C27H40AlCl2N2O (506.50 g/mol after lost ½ of thf 
solvation) C 64.02, H 7.96, N 5.53. Found: C 64.55, H 7.90, N 5.36. IR (υ/cm-1, Nujol 
mull): 2928 (w), 2721 (s), 2636 (m), 2504 (s), 2415 (s), 2379 (s), 2294 (s), 2223 (w), 
2040 (s), 1993 (s), 1870 (s), 1799 (s), 1639 (s), 1555 (m), 1459 (m), 1383 (m), 1259 
(w), 1104 (s), 1057 (w), 924 (m), 802 (s), 757 (s), 668 (w), 592 (s), 566 (s).  
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[Al(DippForm)ClBr(thf)] (4.7)  
 
A solution of Li(DippForm), prepared from DippFormH (0.36 g, 1.0 mmol) and 
n-BuLi (1.6 M solution in hexanes, 0.6 ml, 1.0 mmol) in THF (20 ml), was added 
dropwise through a cannula to a solution of AlBr3 (0.135 g, 0.5 mmol) and AlCl3 (0.065 
g, 0.5 mmol) in THF (10 ml) at room temperature with stirring. The colourless reaction 
mixture was continued stirring for 16 h at ambient temperature. The solvent was 
evaporated under vacuum to the point of dryness and PhMe (20 ml) added. The mixture 
was then filtered to remove LiCl. The solvent was then concentrated under reduced 
pressure, then slowly cooled to ‒30 0C, whereupon colourless crystals of (4.7) were 
deposited. Yield = 0.14 g (40 %).  
4.7: M.P. 158-160 0C (dec). 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 1.02 (br m, 
4H, CH2-thf), 1.26 (d, J = 6.8 Hz, 24H, CH(CH3)2), 3.54 (br m, 4H, OCH2-thf), 3.80 
(sept, 4H, CH(CH3)2), 7.01 (br m, 2H, p-ArH), 7.11 (br m 4H, m-ArH), 7.53 (s, 1H, 
NC(H)N); 13C-NMR (101 MHz, C6D6, 25 0C): δ (ppm) = 24.58 (CH2-thf), 24.89 (CH3-
iPr), 28.26 (CH-iPr), 70.27 (OCH2-thf), 123.73 (p-C), 125.97 (m-C), 139.83 (o-C), 
144.64 (N-C), 165.47 (NCN); Elemental analysis calcd. (%) for C29H44AlBrClN2O 
(M = 579.01 g/mol): C 60.15, H 7.65, N 4.83. Calcd for C27H40AlBrClN2O (550.95 
g/mol after lost ½ of thf solvation) C 58.86, H 7.31, N 5.08. Found: C 58.44, H 7.02, N 
4.71. IR (υ/cm-1, Nujol mull): 2721 (s), 2662 (s), 2611 (m), 2504 (s), 2414 (s), 2357 (s), 
2293 (s), 2245 (s), 2221 (m), 2169 (s), 2035 (vs), 1993 (vs), 1934 (s), 1867 (vs), 1799 
(vs), 1658 (s), 1640 (s), 1436 (w), 1289 (w), 1105 (s), 921 (m), 803 (s), 770 (s), 665 
(w), 556 (s), 406 (w).  
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[Al(DippForm)2Cl] (4.8)  
 
Li(DippForm) was prepared from DippFormH (0.72 g, 2.0 mmol) and 
LiN(SiMe3)2 (1 M solution in thf, 2.0 ml, 2.0 mmol) in THF (20 ml) at room 
temperature. This solution was added dropwise via a cannula to a solution of AlCl3 
(0.13 g, 1.0 mmol) in THF (10 ml) at room temperature with stirring. The reaction 
mixture was subsequently continued stirring over the course of 24 h, and after that dried 
in vacuum and extracted into PhMe (25 ml). Filtration, concentration to approximately 
(10 ml) and storage at ‒ 30 0C for 48 h yielded light off white blocks of (4.8) on the 
glass wall of the flask. Yield = 0.51 g (70 %).  
4.8: M.P. 208-210 0C (dec). 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 1.48 (d, J = 
6.7 Hz, 48H, CH(CH3)2), 3.51 (sept, 8H, CH(CH3)2), 6.98 (m, 4H, p-ArH), 7.10 (m, 
8H, m-ArH), 7.85 (s, 2H, NC(H)N); 13C-NMR (101 MHz, C6D6, 25 0C): δ (ppm) = 
23.66 (CH3-iPr), 28.66 (CH-iPr), 24.5 (p-C), 125.7 (m-C), 139.3 (o-C), 144,8 (N-C), 
160.40 (NCN); Elemental analysis calcd. (%) for C50H70AlClN4 (M = 789.56 g/mol):  
C 76.06, H 8.93, N 7.09; found: C 75.35, H 8.76, N 6.66. IR (υ/cm-1, Nujol mull): 2923 
(w), 2757 (s), 2593 (m), 2464 (w), 2361 (w), 2024 (m), 1959 (s), 1887 (s), 1813 (s), 
1641 (m), 1586 (s), 1381 (w), 1058 (w), 980 (w), 756 (s), 580 (w). 
 
[Me2Sb-SbMe3][AlCl4] (4.9)  
 
To a solution of SbCl3 (0.66 g, 3.0 mmol) in PhMe (10 ml) was added a solution 
of AlMe3 (2 M in PhMe, 1.5 ml, 3.0 mmol) dropwise by syringe under a nitrogen stream 
without stirring at − 78 0C. The resulting colourless reaction mixture was allowed to 
warm to ambient temperature and stirred very slowly for half an hour. Upon 
concentration to ca. 5 ml an oily dark layer deposited with a clear white supernatant on 
top. The supernatant was removed followed by extraction of the black oily residue with 
hexane (5 ml). The hexane extract was then concentrated to (3 ml) and allowed to rest 
at ambient temperatures for 1 day; after which a few colourless crystals of (4.9) formed. 
Yield = 0.08 g (8 %).  
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4.9: M.P. 120–123 0C (smooth decomposition starts at 211 0C). 1H-NMR (400 MHz, 
C6D6, 25 0C): δ (ppm) = 1.15 (s, Sb(CH3)3), 1.02 (s, Sb(CH3)2). No 13C-NMR could be 
obtained due to the poor yield. Elemental analysis calcd. (%) for C5H15AlCl4Sb2 (M = 
847.47 g/mol):  C 7.08, H 17.84 (very low yield). IR (υ/cm-1, Nujol mull): 2959 (m), 
2923 (s), 2853 (s), 2725 (m), 2668 (w), 2349 (s), 1630 (w), 1461 (s), 1376 (s), 1304 
(w), 1262 (s), 1163 (w), 1094 (m), 1020 (m), 899 (w), 805 (s), 726 (s), 716 (s), 676 (m), 
400 (w). 
 
[Br3Sb-µBr-SbBr3][AlCl2(thf)4] (4.10)  
 
To a solution of SbBr3 (0.36 g, 1.0 mmol) in PhMe (10 ml), was added dropwise 
through a cannula a mixture of DippFormH (0.36 g, 1.0 mmol) and AlCl3 (0.13 g, 1.0 
mmol) in THF (10 ml) at room temperature with stirring, as an attempt to exam the 
possibility of forming a bimetallic formamidinate complex. The reaction mixture was 
continued stirring for 12 h. The residue was extracted with hexane (20 ml). Filtration 
and solvent evaporation then slow cooling to _ 30 0C of this solution, produced very 
shiny cubic crystals of (4.10). Yield = 0.17 g (48 %). 
4.10: M.P. 184-186 0C (dec). 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 1.32 (s, 
16H, CH2-thf), 3.43 (s, 16H, OCH2-thf); 13C-NMR (101 MHz, C6D6, 25 0C): δ (ppm) = 
25.66 (CH2-thf), 67.81 (OCH2-thf); Elemental analysis calcd. (%) for 
C16H32AlCl2Br7O4Sb2 (M = 1189.09 g/mol): C 16.16, H 2.71. Calcd for 
C2H4AlCl2Br7Sb2 (928.75 g/mol after lost 3½ of thf solvation) C 2.58, H 4.34. Found: 
C 3.77, H 1.92 (slightly high in C and low in H percentage). IR (υ/cm-1, Nujol mull): 
2360 (s), 2340 (s), 1772 (s), 1646 (s), 1569 (s), 1507 (s), 1418 (s), 1395 (s), 1257 (m), 
1092 (w), 806 (w), 668 (m). 
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4.6  Single crystal X-ray structure determination/analysis and Refinement model 
           description 
 
Crystals were initially isolated as suitable single crystals immersed in viscous 
hydrocarbon oil (Paratone-N) and mounted on a glass fibre that was placed on the 
diffractometer under a stream of liquid nitrogen. Crystalline samples were measured 
providing intensity data on either a Bruker APEX II CCD diffractometer for complexes 
(4.1, 4.8, 4.10), or at the Australian Synchrotron diffractometer using the MX1 or MX2 
macromolecular beam lines for complexes (4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.9) at 173 or 293 
K using graphite monochromated Mo-Kα X-ray radiation with a single wavelength (λ 
= 0.71073 Å). Structure solutions and refinements package were performed using 
SHELXS-97 and SHELXL- 97,72,73 program using Direct Methods via the graphical 
interface X-Seed,74 and OLEX2,75 both of which were also used for figures’ generating. 
Absorption improvements using MULTISCAN were applied. All CIF files were 
checked at www.iucr.org. A summary of crystallographic data and collection 
parameters can be found for each compound below.  
 
[Al(XylForm)2Cl] (4.1)  
1: C34H38AlClN4 (M = 565.11 g/mol): monoclinic, space group P21/c, a = 
8.0280(16) Å, b = 8.5240(17) Å, c = 44.624(9) Å, α = 90°, β = 92.20(3)°, γ = 90°, 
Volume = 3051.4(11) Å3, Z = 4, T = 100(2)  K, μ = 0.184 mm-1, Dcalc = 1.230 g/cm3, F 
(000) = 1200.0, 2Θmax = 1.826 - 49.998, 35848 reflections measured, 5120 unique 
(Rint =  0.0477, Rsigma = 0.0244), 5120/0/370 parameters, GooF on F2 1.198, The 
final R1 was 0.0588 ( I >2σ (I)) and wR2 was 0.1568 (all data), Largest diff. peak/hole/e 
= 0.54 to - 0.51 Å-3.  
 
[Al(XylForm)2I].PhMe (4.2)  
2: C41H46AlIN4 (M = 748.70 g/mol): triclinic, space group P-1, a = 8.2260(16) Å, b = 
15.064(3) Å, c = 15.169(3) Å, α = 93.96(3)°, β 96.63(3)°, γ = 96.34(3)°, Volume = 
1849.3(7) Å3, Z = 2, T = 100(2) K, μ = 0.923 mm-1, Dcalc = 1.345 g/cm3, F (000) = 772.0, 
2Θmax = 2.712 - 49.998, 22141 reflections measured, 5936 unique (Rint = 0.0338, 
Rsigma = 0.0292), 5936/0/434 parameters, GooF on F2 1.064, The final R1 was  0.0273 
(I >2σ (I)) and wR2 was 0.0748 (all data), Largest diff. peak/hole/e = 0.45 to - 0.69 Å-3.  
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[Al(XylFormH)Br3] (4.3)  
3: C17H20AlBr3N2 (M = 519.06 g/mol): monoclinic, space group P21/n, a = 
7.7260(15) Å, b = 14.013(3) Å, c = 18.307(4) Å, α = 90°, β 93.93(3)°, γ = 90°, 
Volume = 1977.3(7) Å3, Z = 4, T = 100(2) K, μ = 6.165 mm-1, Dcalc = 1.744 g/cm3, F 
(000) = 1016.0, 2Θmax = 3.664 - 49.998, 15215 reflections measured, 3240 unique (Rint = 
0.0572, Rsigma = 0.0439), 3240/0/212 parameters, GooF on F2 1.071, The final R1 was 
0.0348 ( I >2σ (I)) and wR2 was 0.0970 (all data), Largest diff. peak/hole/e = 0.52 to -
0.98 Å-3.  
 
[Al3(XylForm)2(µ3-O)(OH)Cl4]2.PhMe (4.4) 
4: C75H86Al6Cl8N8O4 (M = 1609.0 g/mol): triclinic, space group P-1, a = 
10.906(2) Å, b = 12.427(3) Å, c = 16.934(3) Å, α = 87.83(3)°, β = 72.56(3)°, γ = 
67.89(3)°, Volume = 2021.2(9) Å3, Z = 2, T = 100(2) K, μ = 0.396 mm-1, Dcalc = 
1.322  g/cm3, F (000) = 838.0, 2Θmax = 2.53 - 50, 17460 reflections measured, 6653 
unique (Rint = 0.0926, Rsigma = 0.1001), 6653/6/463 parameters, GooF on F2 1.040, The 
final R1 was  0.0846 ( I >2σ (I)) and wR2 was 0.2590 (all data), Largest diff. peak/hole/e 
= 0.53 to - 1.41 Å-3.  
 
[Al(DippFormH)Br3] (4.5)  
5: C25H36AlBr3N2 (M = 631.27 g/mol): monoclinic, space group P21/c, a = 
10.278(2) Å, b = 19.974(4) Å, c = 14.178(3) Å, α = 90°, β = 108.59(3) °, γ = 90°, 
Volume = 2758.7(11) Å3, Z = 4, T = 100(2)  K, μ = 4.434  mm-1, Dcalc = 1.520 g/cm3, F 
(000) = 1272.0, 2Θmax = 3.652 - 49.998, 27489 reflections measured, 4822 unique (Rint = 
0.0384, Rsigma = 0.0252), 4822/0/289 parameters, GooF on F2 1.081, The final R1 was 
0.0385 ( I >2σ (I)) and wR2 was 0.1015 (all data), Largest diff. peak/hole/e = 1.71 to -
1.29 Å-3.  
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[Al(DippForm)Cl2(thf)] (4.6)  
6: C29H43AlCl2N2O (M = 533.53 g/mol): triclinic, space group P-1, a = 
10.3175(4) Å, b = 10.7120(4) Å, c = 14.7854(5) Å, α =  91.983(2)°, β = 98.268(2)°, γ 
= 103.631(2)°, Volume = 1567.57(10) Å3, Z = 2, T = 296(2)  K, μ = 0.257 mm-1, Dcalc = 
1.130 g/cm3, F (000) = 572.0, 2Θmax = 2.79 - 49.996, 15311 reflections measured, 5297 
unique (Rint = 0.0408, Rsigma = 0.0350), 5297/0/324 parameters, GooF on F2 1.052, The 
final R1 was 0.0821 (I >2σ (I)) and wR2 was 0.2880 (all data), Largest diff.     
peak/hole/e = 0.42 and - 0.94 Å-3.  
 
[Al(DippForm)ClBr(thf)] (4.7)  
7: C29H43AlBrClN2O (M = 577.99 g/mol): triclinic, space group P-1, a = 
10.222(2) Å, b = 10.720(2) Å, c = 14.529(3) Å, α = 91.85(3)°, β = 98.80(3)°, γ = 
104.04(3)°, Volume = 1522.3(6) Å3, Z = 2, T = 173(2)  K, μ = 1.490 mm-1, Dcalc = 
1.261 g/cm3, F (000) = 608.0, 2Θmax =  4.166 - 50, 18551 reflections measured, 4871 
unique (Rint = 0.0297, Rsigma = 0.0256), 4871/0/318 parameters, GooF on F2 1.111, The 
final R1 was 0.0674 ( I >2σ (I)) and wR2 was 0.2007 (all data), Largest diff.     
peak/hole/e = 1.27 to -1.64 Å-3.  
 
[Al(DippForm)2Cl] (4.8)  
8: C50H70AlClN4 (M = 789.53 g/mol): monoclinic, space group P21/n, a = 
14.509(3) Å, b = 16.288(3) Å, c = 21.112(4) Å, α = 90°, β = 109.86(3)°, γ = 90°, 
Volume = 4692.6(18) Å3, Z = 4, T = 100(2)  K, μ = 0.137  mm-1, Dcalc = 1.118 g/cm3, F 
(000) = 1712.0, 2Θmax = 2.992 - 49.994, 56762 reflections measured, 8217 unique (Rint = 
0.0369, Rsigma = 0.0199), 8217/0/521 parameters, GooF on F2 1.118, The final R1 was 
0.0491 ( I >2σ (I)) and wR2 was 0.1249 (all data), Largest diff. peak/hole/e = 0.72 to -
0.57 Å-3.  
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[Me2Sb-SbMe3][AlCl4] (4.9)   
9: C5H15AlCl4Sb2 (M = 487.45 g/mol): monoclinic, space group P21/c, a = 
9.1410(9) Å, b = 10.0801(10) Å, c = 17.3566(17) Å, α = 90°, β = 96.993(4)°, γ = 90°, 
Volume = 1587.4(3) Å3, Z = 4, T = 296(2)  K, μ = 4.094 mm-1, Dcalc = 2.040 g/cm3, F 
(000) = 912.0, 2Θmax = 4.49 to 54.998, 18644 reflections measured, 3644 unique (Rint = 
0.0519, Rsigma = 0.0393), 3644/0/114 parameters, GooF on F2 1.033, The final R1 was 
0.0334 ( I >2σ (I)) and wR2 was 0.0950 (all data), Largest diff. peak/hole/e = 1.03 to -
0.86  Å-3.  
 
[Br3Sb-µBr-SbBr3][AlCl2(thf)4] (4.10)  
Note. X-ray diffraction data has been included as confirmation of connectivity only. 
10: C16H32AlCl2Br7O4Sb2 (M = 1189.09 g/mol): triclinic, space group P-1, a = 
23.604(5) Å, b = 33.287(7) Å, c = 23.911(5) Å, α = 89.97(3)°, β = 105.23(3)°, γ = 
89.97(3)°, Volume = 18127(7) Å3, Z = 2, T = N/A K, μ = 9.214 mm-1, Dcalc = 2.2220 
g/cm3, F (000) = 10966.8, 2Θmax = 1.76 to 52.74, 173092 reflections measured, 67470 
unique (Rint = 0.0539, Rsigma = 0.0649), 67470/0/3286 parameters, GooF on F2 1.735, 
The final R1 was 0.2527 ( I >2σ (I)) and wR2 was 0.6352 (all data), Largest diff. 
peak/hole/e = 61.76 to - 13.50Å-3. 
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A0.1: General Experimental Information. The complexes described in the 
appendices own highly air- and moisture-sensitive nature, an inert atmosphere of dry 
nitrogen had to be maintained throughout the reaction and subsequent characterisation 
steps, requiring a glovebox and Schlenk techniques. All solvents were per-dried over 
sodium metal, and then further dried by distillation over sodium wire/benzophenone. 
Anhydrous SbCl3 and AlCl3 along with other starting materials such as LiN(SiMe3)2 
and phenol ligand (2,6-di–tert-butyl-4-Me) were procured from Sigma-Aldrich and 
were used as supplied without further purification although in the case of the phenol, it 
was essential for this to be dried. Microanalytical Laboratory service, Science Centre, 
London Metropolitan University, England, performed the elemental analyses (C,H,N). 
Listed infrared data using a Nicolet-Nexus FTIR spectrometer, are of a Nujol mull for 
the region (ύ = 4000 - 400 cm-1). 1H- and 13C-NMR spectra were recorded on a Bruker 
AVANCE III HD 400 MHz spectrometer. 1H-NMR resonances were referenced against 
residual H in C6D6 (δ = 7.15), whereas 13C-NMR resonances were referenced to the 
deuterated C6D6 solvent (δ = 128.39). X-ray structure determinations were performed 
on either a Bruker APEX II CCD diffractometer or at the Australian Synchrotron 
diffractometer using the MX1 macromolecular beam lines. Further details regarding 
general considerations were described in Chapter two (experiment section 2.5), Chapter 
three (experiment section 3.5) and Chapter four (experiment section 4.5). 
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The Synthesis and X-ray Structure Determination of  
[Sb(OC6H2-2,6-tBu2-4-Me)3]  
 
A1.1: Introduction. The homoleptic mononuclear phenolates of antimony are extremely rare, 
being limited to just [Sb(OC6H3-2,6-Me2)3],1 and [Sb{OC6H3-2,6-(C6H5)2}3],2 representing the 
phenols with sterically demanding 2,6-substituents. This study presents only the third example 
of homoleptic, mononuclear antimony (III) phenolate to be structurally characterised as 
[Sb(OAr)3] (OAr = OC6H2-2,6-tBu2-4-Me).               
 
A1.2: Synthesis of [Sb(OC6H2-2,6-tBu2-4-Me)3] by metathesis in THF/PhMe and 
Characterisation by 1H-, 13C-NMR, IR spectroscopy, C,H,N analysis and melting point. 
A solution of HOAr (0.66 g, 3.0 mmol) in THF (20 ml) was treated successively with 
LiN(SiMe3)2 (1 M solution in THF, 3.0 ml, 3.0 mmol). The solution of Li(OAr) was added 
dropwise to a Schlenk flask charged with a cooled (_ 78 0C) solution of SbCl3 (0.22 g, 1.0 
mmol) in THF (10 ml) with stirring (Scheme A1.1). Colour changed to yellow brown and the 
solution was then stirred further for 24 h at room temperature. After this time, the resulting 
solution was evaporated under vacuum to dryness and then PhMe added. The solution was 
filtered and the filtrate was concentrated to ca.10 ml and stand at _ 15 0C for 2 days, during 
which time a moisture-sensitive small shiny white-yellow crystals formed and were 
characterised by X-ray crystallography. Yield = 0.46 g (69 %). 
 M.P. 175-177 0C (dec); 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 1.48 (m, 54H, C(CH3)3), 
2.20 (s, 9H, CH3-pMe), 7.08 (m, 6H, m-ArH); 13C-NMR (101 MHz, C6D6, 25 0C): δ (ppm) = 
21.23 (CH3-pMe), 33.96 (C(CH3)3), 36.25 (C(CH3)3), 127.74 (p-C), 128.03 (m-C), 141.47 (o-
C), 155.71 (O-C); Elemental analysis calcd. (%) for C45H69O3Sb (M = 779.80 g/mol): C 69.31, 
H 8.91; found: C 68.84, H 9.05. IR (υ/cm-1, Nujol mull): 1747 (s), 1564 (s), 1448 (w), 1313 
(w), 1254 (m), 1105 (s), 1026(s), 926 (s), 880 (s), 860 (s), 726 (s), 644 (s), 613 (s), 553 (m). 
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Scheme A1.1: The proposed synthesis of [Sb(OC6H2-2,6-tBu2-4-Me)3]. 
 
A1.3: X-ray single crystal structure determination of [Sb(OC6H2-2,6-tBu2-4-Me)3].  
Complex [Sb(OC6H2-2,6-tBu2-4-Me)3] crystallised in the triclinic space group P-1 (A1.4), 
with one monomer within the asymmetric unit. The antimony atom is surrounded by three 
phenolate oxygens. The arene rings form a propeller-like arrangement around the antimony. 
The molecular structure of [Sb(OC6H2-2,6-tBu2-4-Me)3] shows a mononuclear Sb+3 complex 
which is isostructural with the literature complexes [Sb(OC6H3-2,6-Me2)3],1 and [Sb{OC6H3-
2,6-(C6H5)2}3].2 [Ʃ O–Sb–O = 283.7(6) °] and the O-Sb-O angles are close to 90 0 giving a 
stereochemistry for Sb+3 in [Sb(OC6H2-2,6-tBu2-4-Me)3] best described as heavily distorted 
three-coordinate trigonal pyramidal with a stereochemically active lone pair residing in a fourth 
coordination site (Figure A1.1). The O-Sb-O angles in [Sb(OC6H2-2,6-tBu2-4-Me)3] are 
comparable with those of [Sb(OC6H3-2,6-Me2)3],1 whereas these angles are bigger than those 
observed in [Sb{OC6H3-2,6-(C6H5)2}3],2 that are described as acute from orthogonality. 
Furthermore, it was found that an average Sb-O bond length in [Sb(OC6H2-2,6-tBu2-4-Me)3]: 
1.969(15) Å, range: 1.973 (15) - 1.961 (15) Å and Sb–O–C angle 119.4(14) °, range: 117.31(14) 
- 120.54(13) °, which are very similar in overall comparing with those in [Sb(OC6H3-2,6-
Me2)3],1 and [Sb{OC6H3-2,6-(C6H5)2}3].2   
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Generally, the three structures are slightly different due to the ligand environments. For 
example, in [Sb{OC6H3-2,6-(C6H5)2}3],2 the three phenyl rings formed a cone-shaped cavity 
covering the lone pair, dissimilar to the isostructural complexes [Sb(OC6H2-2,6-tBu2-4-Me)3] 
and [Sb(OC6H3-2,6-Me2)3].1 
 
 
 
 
(a) 
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(b) 
Figure A1.1 Molecular structure of monomeric [Sb(OC6H2-2,6-tBu2-4-Me)3] with the atom 
numbering system; thermal ellipsoids are drawn at the 50 % probability level, and hydrogen 
atoms have been omitted for clarity; (a) Viewed onto the O3 plane; (b) Highlighting the 
pyramidal nature of the antimony coordination. Selected bond lengths (Å) and angles (°): 
Sb(1)–O(1): 1.9739(15), Sb(1)–O(2): 1.9753(15), Sb(1)–O(3): 1.9616(15), C(1)–O(1): 
1.394(3), C(16)–O(2): 1.393(3), C(31)–O(3): 1.398(3), O(1)–Sb(1)–O(2): 94.65(6), O(2)–
Sb(1)–O(3): 93.74(6), O(3)–Sb(1)–O(1): 95.36(7), C(1)–O(1)–Sb(1): 120.54(13), C(16)–
O(2)–Sb(1): 117.31(14), C(31)–O(3)–Sb(1): 120.37(14). 
 
A1.4: Crystal Refinement Data. C45H69O3Sb (M = 779.80 g/mol):  triclinic, space group P-1, 
a = 9.8926(5) Å, b = 11.5120(6) Å, c = 20.1505(10) Å, α = 80.523(2)°, β = 89.109(2)°, γ = 
77.142(2)°, Volume = 2206.2(2) Å3, Z = 2, T = 296(2) K, Dcalc = 1.174 g/cm3, μ = 0.660      
mm‑1, F (000) = 828.0, 2Θmax = 2.05 - 54.994°, 41366 reflections collected, 10070 unique (Rint 
= 0.0409, Rsigma = 0.0326), 10070/0/464  parameters, GooF on F2 1.065, The final R1 was 
0.0320 (I >2σ (I)) and wR2 was 0.0928 (all data), Largest diff. peak/hole/e = 0.57 to-0.42 Å-3. 
 
A1.5: References 
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Myers, Inorg. Chem., 2002, 41, 1652-1657. 
2. M. Brym, C. Jones and P. C. Junk, Main Group Chem., 2006, 5, 13-19. 
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The Synthesis and X-ray Structure Determination of  
[Al(OC6H2-2,6-tBu2-4-Me)(OH)Cl(thf)]  
 
A2.1: Introduction. An unexpected product [Al(OC6H2-2,6-tBu2-4-Me)(OH)Cl(thf)] was 
isolated from an attempt to synthesise [Al(OC6H2-2,6-tBu2-4-Me)2Cl], in order to examine the 
capability of metathesis method, and also the ability of the symmetrical substituted phenol 
ligand HOC6H2-2,6-tBu2-4-Me to promote a variety of structural types depending on the choice 
of the metal. This finding strengthen the already impressive reputation of the metathesis 
reaction and it introduces a simple example of halogenated heteroleptic species in this study. 
 
A2.2: Synthesis of [Al(OC6H2-2,6-tBu2-4-Me)(OH)Cl(thf)] by metathesis in THF and 
Characterisation by 1H-, 13C-NMR, IR spectroscopy, C,H,N analysis and melting point. 
A solution of Li(OC6H2-2,6-tBu2-4-Me) was prepared in situ from dried HOAr (0.22 g, 1.0 
mmol) and LiN(SiMe3)2 (1 M solution in THF, 1.0 ml, 1.0 mmol) in THF (20 ml). The solution 
of Li(OAr) was added dropwise to a Schlenk flask charged with a solution of AlCl3 (0.13 g, 
1.0 mmol) in THF (10 ml), with stirring at room temperature, which resulted in an immediate 
colour change to bright yellow (Scheme A2.1). The reaction mixture was stirred further for 36 
h. The mixture was allowed to stand overnight and the white precipitate was filtered off. The 
volume of the yellow solution was reduced to about ca. 5 ml under vacuum and stored at _ 30 
0C for two days during which time small off white crystals formed. The crystals were suitable 
for X-ray crystallography determination. Yield = 0.12 g (54.5 %).  
M.P. 144-146 0C. 1H-NMR (400 MHz, C6D6, 25 0C): δ (ppm) = 1.49 (m, 18H, C(CH3)3), 2.01 
(br s, 4H, CH2-thf), 2.23 (s, 3H, CH3-pMe), 3.49 (br s, 4H, OCH2-thf), 4.68 (s, 1H, Al-OH), 
7.05 (m, 2H, m-ArH); 13C-NMR (101 MHz, C6D6, 25 0C): δ (ppm) = 21.39 (CH3-pMe), 25.07 
(CH2-thf), 30.58 (C(CH3)3), 34.32 (C(CH3)3), 70.61 (OCH2-thf), 126.02 (p-C), 127.64 (m-C), 
136.13 (o-C), 152.04 (O-C). Elemental analysis calcd. (%) for C19H32AlClO3 (M = 370.81 
g/mol): C 61.37, H 8.94. Calcd (%) for C15H24AlClO2 (298.78 g/mol after loss the lonely THF 
solvation): C 60.30, H 8.10; found: C 56.51, H 7.98, showing low in carbon percentage. IR 
(υ/cm-1, Nujol mull): 2730 (vs), 2710 (m), 2586 (m), 2524 (m), 2465 (s), 2413 (m), 2378 (s), 
2282 (s), 2221 (s), 2146 (s), 2060 (s), 1939 (s), 1902 (s), 1862 (s), 1793 (s), 1756 (s), 1657 (s), 
1568 (m), 1459 (w), 1252 (w), 1128 (m), 1039 (m), 989 (m), 773 (s), 622 (m). 
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Scheme A2.1: The proposed synthesis of [Al(OC6H2-2,6-tBu2-4-Me)(OH)Cl(thf)]. 
 
A2.3: X-ray single crystal structure determination of [Al(OC6H2-2,6-tBu2-4-
Me)(OH)Cl(thf)]. The Al+3 complex [Al(OC6H2-2,6-tBu2-4-Me)(OH)Cl(thf)] crystallised in 
the monoclinic space group P21/n (A2.4), with one molecular within the asymmetric unit. As 
it can be seen from the crystal structure depicted in (Figure A2.1), complex [Al(OC6H2-2,6-
tBu2-4-Me)(OH)Cl(thf)] is monomeric, in which the central aluminum atom is tetra-
coordinate by one phenolate oxygen, OH group, chloride anion and weakly coordinated thf 
molecule, assuming a distorted tetrahedral arrangement. There are very few instances of 
monomeric chloroaluminum aryloxides reported  in the literature.1 Compound [Al(OC6H2-2,6-
tBu2-4-Me)(OH)Cl(thf)] is slightly comparable to those structures of [Al(OC6H2-2,6-tBu2-p-
Me)Cl2(Et2O)],2 and [Al(OC6H2-2,6-tBu2-p-Me)Cl2(nmp)],3 the two differences being the 
existence of an unanticipated (OH) group instead of one of the chloride anion and the solvent 
associated. The Al–Cl bond length 2.101(2) Å is in the typical range described for terminal Al–
Cl bonds.1,2 The Al–Cl 2.101(2) Å and Al–O 1.695(3) Å bond lengths are shorter by 
approximately 0.011(1) Å and 0.13(1) Å, respectively, compared to those in [Al(OC6H2-2,6-
tBu2-p-Me)Cl2(Et2O)],2 and [Al(OC6H2-2,6-tBu2-p-Me)Cl2(nmp)].3  
 
 
 
 
 
 
 
APPENDIX 2 
222 
 
 
 
 
 
Figure A2.1 Molecular structure of monomeric [Al(OC6H2-2,6-tBu2-4-Me)(OH)Cl(thf)] with 
the atom numbering system; thermal ellipsoids are drawn at the 50 % probability level, and 
hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and angles (°): Al(1)–
O(1): 1.695(3), Al(1)–O(2): 1.885(3), Al(1)–O(3): 2.050(3), Cl(1)–Al(1): 2.101(2), O(2)–C(1): 
1.376(4), C(1)–O(2)–Al(1): 156.4(3), O(2)–Al(1)–Cl(1): 114.24(12), O(2)–Al(1)–O(1): 
104.54(14), O(2)–Al(1)–O(3); 120.21(13), O(1)–Al(1)–Cl(1): 105.08(13), O(1)–Al(1)–O(3): 
100.46(13), O(3)–Al(1)–Cl(1): 109.99(11), C(16)–O(1)–Al(1):  121.4(3), C(19)–O(1)–Al(1): 
127.7(3).    
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A2.4: Crystal Refinement Data. C19H32AlClO3 (M = 370.81 g/mol): monoclinic, space group 
P21/n, a = 10.4416(9) Å, b = 18.9928(17) Å, c = 10.9866(9) Å, α = 90°, β = 97.676(4)°, γ = 
90°, Volume = 2159.3(3) Å3, Z = 4, T = 296(2)  K, μ = 0.230 mm-1, Dcalc = 1.138 g/cm3, F (000) 
= 796.0, 2Θmax = 4.29 to 49.996, 18376 reflections measured, 3566 unique (Rint = 0.0809, 
Rsigma = 0.0819), 3566/0/225 parameters, GooF on F2 1.046, The final R1 was 0.0735 (I >2σ 
(I)) and wR2 was 0.2734 (all data), Largest diff. peak/hole/e = 0.76 to - 0.51 Å-3.  
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